,Rank,NCTId,Condition,BriefTitle,InterventionName,OfficialTitle,LocationCity,LocationState,LocationCountry,StartDate
0,1,NCT04125329,Mesenchymal Stem Cells|Diabetic Nephropathy,Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy,Human umbilical cord mesenchymal stem cells,Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy,Kunming,,China,"April 1, 2020"
1,2,NCT01221428,Ulcerative Colitis|Mesenchymal Stem Cells|Umbilical Cord,Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis,Umbilical Cord Mesenchymal Stem Cells,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis,Qingdao,Shandong,China,September 2010
2,3,NCT03558334,Bronchopulmonary Dysplasia,Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia,Transplantation of mesenchymal stem cell|No transplantation of mesenchymal stem cell,Intravenous Human Umbilical-Cord-Derived Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia in Premature Infants,Chongqing,Chongqing,China,"June 28, 2018"
3,4,NCT03765957,Psoriasis,Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells,Mesenchymal Stem Cells,Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells,Changsha,Hunan,China,"February 20, 2019"
4,5,NCT01219465,"Diabetes Mellitus|Diabetes Mellitus, Type 1|Mesenchymal Stem Cells|Umbilical Cord",Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus,umbilical cord mesenchymal stem cells,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes,Qingdao,Shandong,China,September 2010
5,6,NCT02824393,Urticaria|Autoimmune Diseases|Immune System Diseases|Skin Diseases,Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria,Autologous mesenchymal stem cell,Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria,Manisa,,Turkey,"March 3, 2017"
6,7,NCT02118519,"Articular Cartilage Disorder of Knee|Osteoarthritis, Knee",Mesenchymal Stem Cells in Knee Cartilage Injuries,Autologous Mesenchymal Stem Cells,Use of Mesenchymal Stem Cells for the Repair of Articular Cartilage Disorder of Knee Using Intra-articular Injection of Mesenchymal Cells Alone or Mesenchymal Cells With Platelet Lysate,Amman,,Jordan,January 2014
7,8,NCT04073472,"Crohn's Disease|Fistula|Anal Fistula|Pouch, Ileal|Pouches, Ileoanal",Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's,mesenchymal stem cells (MSCs),A Phase I Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Ileal Anal Anastomosis and Ileal Pouch Fistulas in the Setting of Crohn's Disease of the Pouch,,,,"June 1, 2021"
8,9,NCT02112500,"Respiratory Distress Syndrome, Adult",Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure,Mesenchymal Stem Cell,A Pilot Study for the Efficacy and Safety of Mesenchymal Stem Cell in Acute Severe Respiratory Failure.,Seoul,,"Korea, Republic of",February 2014
9,10,NCT01219452,Dilated Cardiomyopathy,Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy,umbilical cord mesenchymal stem cells,Effects of Intramuscular Injection of Umbilical Cord Mesenchymal Stem Cell on the Ventricular Function of Children With Idiopathic Dilated Cardiomyopathy,Qingdao,Shandong,China,October 2010
10,11,NCT03601416,Bronchopulmonary Dysplasia,Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia,Transplantation of mesenchymal stem cell|No Transplantation of Mesenchymal Stem Cell,Intravenous Human Umbilical-Cord-Derived Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasias in Children,Chongqing,Chongqing,China,"July 1, 2019"
11,12,NCT03106662,Hematopoietic Stem Cell Transplantation,Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies,mesenchymal stem cells|cyclophosphamide administration,Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies,Ankara,,Turkey,October 2014
12,13,NCT02302599,Type 2 Diabetes|Mesenchymal Stem Cells,Mesenchymal Stem Cells to Treat Type 2 Diabetes,Umbilical cord mesenchymal stem cells|Controlled suspension liquid,"Efficacy and Safety of Umbilical-cord Mesenchymal Stem Cells in Chinese Adults With Type 2 Diabetes: a Single Center, Double-blind, Randomized, Placebo-controlled Trial",Beijing,Beijing,China,January 2013
13,14,NCT02804945,Blood And Marrow Transplantation|Adult Respiratory Distress Syndrome,Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies,Mesenchymal Stem Cells (MSCs),A Pilot Study of Mesenchymal Stem Cells for Treatment of Acute Respiratory Distress Syndrome in Patients With Malignancies,Houston,Texas,United States,"February 24, 2017"
14,15,NCT03778333,Autologous Mesenchymal Stem Cells|Multiple Sclerosis,Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden,Autologous mesenchymal stem cells,Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden,Stockholm|Stockholm,,Sweden|Sweden,"December 1, 2012"
15,16,NCT01694927,Spinal Cord Injury,Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients,Autologous Mesenchymal Stem Cells,Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients,Santiago,RM,Chile,January 2012
16,17,NCT01068951,Type 1 Diabetes,Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells,Mesenchymal stem cells,Open Study to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells in Treatment of Recently Diagnosed Patients With Type 1 Diabetes Mellitus,Uppsala,,Sweden,June 2010
17,18,NCT04318600,Lupus Nephritis|Mesenchymal Stem Cells,Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis,human amniotic mesenchymal stem cell,Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis,,,,"January 1, 2014"
18,19,NCT01297972,Aplastic Anemia,Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia,Intravenous bone marrow mesenchymal stem cells infusion,Bone Marrow Mesenchymal Stem Cells in the Treatment of Refractory Severe Acquired Aplastic Anemia,Ribeirão Preto,São Paulo,Brazil,February 2011
19,20,NCT02140528,Tibial Fracture,Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures,Mesenchymal stem cell injection|Placebo,Evaluation the Safety and Efficacy of Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures,Tehran,,"Iran, Islamic Republic of",August 2013
20,21,NCT01224327,Liver Cirrhosis|Radiology|Mesenchymal Stem Cells|Umbilical Cord,Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients,umbilical cord Mesenchymal Stem Cells|Conserved therapy,The Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients.,Qingdao,Shandong,China,October 2010
21,22,NCT01763086,"Stem Cell Transplantation, Hematopoietic|Mesenchymal Stem Cells|Poor Graft Function|Hematological Diseases",Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant,Mesenchymal stem cells,Mesenchymal Stem Cells From Third-party Donors for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation,Guangzhou,Guangdong,China,January 2013
22,23,NCT00504803,Hematological Malignancies,Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease,Mesenchymal stem cell infusion,Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning: a Pilot Study,Liege,,Belgium,December 2006
23,24,NCT03863002,"Liver Failure, Acute on Chronic",Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure,Mesenchymal Stem Cell,Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure,Tianjin,Tianjin,China,"October 1, 2019"
24,25,NCT01788059,Nonunion Fracture,The Efficacy of Mesenchymal Stem Cells for Stimulate the Union in Treatment of Non-united Tibial and Femoral Fractures in Shahid Kamyab Hospital,injection the mesenchymal stem cell in non union site,The Efficacy of Mesenchymal Stem Cells for Stimulate the Union in Treatment of Non-united Tibial and Femoral Fractures in Shahid Kamyab Hospital,Mashhad,Khorasan,"Iran, Islamic Republic of",January 2013
25,26,NCT01763099,Hematopoietic Stem Cell Transplantation|Mesenchymal Stem Cells|Umbilical Cord Blood|Graft Failure|Hematological Diseases,Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure,Mesenchymal stem cells|Mesenchymal stem cells and cord blood,Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure Following Autologous Hematopoietic Stem Cell Transplantation,Guangzhou,Guangdong,China,January 2013
26,27,NCT01956903,Chronic Graft-Versus-Host Disease,Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.,Allogenic Mesenchymal Stem Cell,Phase 1/2 Study of Treatment of Refractory Acute Graft-Versus-Host Disease After First Line Therapy by Sequential Infusion of Expanded In-Vitro Allogenic Mesenchymal Stem Cell,Madrid,,Spain,January 2010
27,28,NCT03130374,Tracheal Stenosis|Laryngeal Stenosis|Mesenchymal Stem Cells,Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells,Olfactory mucosa-derived mesenchymal stem cells,Treatment of Laryngotracheal Stenosis Using Autologous Olfactory-mucosa-derived Mesenchymal Stem Cells,Minsk|Minsk,,Belarus|Belarus,"January 3, 2017"
28,29,NCT02285673,Duchenne Muscular Dystrophy,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy,Umbilical Cord Mesenchymal Stem Cell,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy: Phase 1/2 Study,Istanbul,Uskudar,Turkey,November 2013
29,30,NCT04078308,"Diabetes Mellitus|Diabetes Mellitus, Type 1|Diabetes Mellitus, Insulin-Dependent",Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients,Intravenous Injection of autologous mesenchymal stem cells|Intravenous injection of placebo,Phase I/II Clinical Trial to Examine the Safety and Efficacy of Transplantation of Mesenchymal Stem Cells in New-onset Type 1 Diabetes Patients,Tehran,,"Iran, Islamic Republic of","July 6, 2015"
30,31,NCT02166489,Chronic Renal Failure|Polycystic Kidney Disease,Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease,Intravenous injection autologous mesenchymal stem cells,Evaluation the Effect of Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Autosomal Dominant Polycystic Kidney Disease,Tehran,,"Iran, Islamic Republic of",March 2014
31,32,NCT01216865,Diabetic Foot|Critical Limb Ischemia|Mesenchymal Stem Cells|Umbilical Cord,Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot,umbilical cord mesenchymal stem cells|Standard Therapy,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot,Qingdao,Shandong,China,January 2011
32,33,NCT01941394,Graft-versus-host Disease|Relapse,Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation,Mesenchymal stem cells,Pilot Study for Safety and Effectiveness Assessment of Bone Marrow Mesenchymal Stem Cell Infusion for Acute Graft-versus-host Disease Prophylaxis and Treatment After Allogenic Bone Marrow Transplantation,Moscow,,Russian Federation,October 2007
33,34,NCT02824653,Graft Versus Host Disease,Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD,Mesenchymal Stem Cells,Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD- A Phase I/II Clinical Trial,Rawalpindi,Punjab,Pakistan,January 2015
34,35,NCT01946048,Ischemic Cardiomyopathy,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy,mesenchymal stem cells,Safety and Efficacy Investigation of Patients With Ischemic Cardiomyopathy by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells,Shijiazhuang,Hebei,China,October 2013
35,36,NCT03683953,Safety Issues|Effect of Drugs,The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells,mesenchymal stem cells therapy|0.9% sodium chloride,The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells,,,,"September 29, 2018"
36,37,NCT01429012,Nonunion Fracture,Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting,Mesenchymal Stem Cells|Culture medium without MSC.,"Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting. A Randomized, Double-blind, Controlled Study",Liège,,Belgium,November 2012
37,38,NCT03068988,Rotator Cuff Tear,Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions,mesenchymal stem cells|without mesenchymal stem cells,Mesenchymal Stem Cells in the Reconstruction Surgery of the Supraspinatus Muscle Lesions,Znojmo,Czech Republic,Czechia,"January 1, 2012"
38,39,NCT01377870,Multiple Sclerosis,Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis,intravenous injection of mesenchymal stem cells|injection of cell free media,Effect and Side Effect of Mesenchymal Stem Cell in Multiple Sclerosis,Tehran,,"Iran, Islamic Republic of",December 2011
39,40,NCT02482194,Spinal Cord Injury,Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study,mesenchymal stem cells,Autologous Transplantation of Bone Marrow Mesenchymal Stem Cells in Patients of Spinal Cord Injury-Phase I Clinical Trial,Rawalpindi,,Pakistan,June 2013
40,41,NCT02755922,Mandibular Fractures,Bone Regeneration With Mesenchymal Stem Cells,Application of autologous mesenchymal stem cells,Bone Regeneration in Mandibular Fractures After the Application of Autologous Mesenchymal Stem Cells. Randomized Clinical Trial.,,,,April 2010
41,42,NCT02945462,Erectile Dysfunction,Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED),autologous mesenchymal stem cells,The Safety and Efficacy of Using Bone Marrow-derived Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction in Diabetic Patients,,,,September 2013
42,43,NCT02172885,Osteogenesis Imperfecta,Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta,Mesenchymal Stem Cells,Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta,Barakaldo|Getafe,Bizkaia|Madrid,Spain|Spain,April 2014
43,44,NCT02116634,Amyotrophic Lateral Sclerosis,Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis,mesenchymal stem cell,"Phase 1, 2 Study of Mesenchymal Stem Cells Injection in ALS (Amyotrophic Lateral Sclerosis) Patients",Isfahan,,"Iran, Islamic Republic of",May 2015
44,45,NCT05160831,Knee Osteoarthritis,Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis,Human umbilical cord mesenchymal stem cells,Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis,,,,"January 20, 2022"
45,46,NCT02247973,Severe Aplastic Anemia,Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.,mesenchymal stem cells|mesenchymal stem cells,PhaseⅡTrial of Co-transplantation With Bone Marrow Derived Mesenchymal Stem Cells From Related Donors in Alternative Donor Transplantation of Severe Aplastic Anemia.,Guangzhou,Guangdong,China,February 2013
46,47,NCT05468502,Idiopathic Pulmonary Fibrosis,Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF),Human umbilical cord mesenchymal stem cell injection,"An Open Clinical Study to Explore the Safety, Tolerance and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)",Shanghai,Shanghai,China,August 2022
47,48,NCT02249676,Devic's Syndrome|Devic's Neuromyelitis Optica|Devic Syndrome|Devic's Disease|Devic Disease,Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders,Autologous mesenchymal stem cells,Autologous Mesenchymal Stem Cells for the Treatment of Progressive and Refractory Neuromyelitis Optica Spectrum Disorders: an Open-label Phase 2a Proof-of-concept Study,Tianjin,Tianjin,China,January 2013
48,49,NCT04441658,Type 2 Diabetes|Mesenchymal Stem Cells,Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus,Umbilical Cord Mesenchymal Stem Cells|saline,Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus,Shanghai,Shanghai,China,"April 10, 2020"
49,50,NCT00953485,Sjogren's Syndrome|Mesenchymal Stem Cells,Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS),Allogeneic Mesenchymal Stem Cells (AlloMSC),Clinical Trial of Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome - Phase Ⅰ/Ⅱ,Nanjing,Jiangsu,China,June 2009
50,51,NCT04414592,Lumbar Disc Degeneration|Lumbar Disc Herniation,Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease,human umbilical cord mesenchymal stem cells,Safety and Effectiveness of Human Umbilical Cord Mesenchymal Stem Cells For the Treatment of Lumbar Disc Degeneration Disease,Shanghai|Shanghai,Shanghai,China|China,August 2020
51,52,NCT04351932,Osteo Arthritis Knee,Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis,bone marrow mesenchymal stem cells|Adipose Mesenchymal stem cells|bone marrow & adipose mesenchymal stem cells injection,Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Randomized Non Blind Controlled Clinical Trial,Guayaquil,Guayas,Ecuador,"June 7, 2020"
52,53,NCT03956719,Knee Osteoarthritis,Treatment of Early Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells,Autologous adipose-derived mesenchymal stem cells|abdominal liposuction,Efficacy and Safety of Autologous Adipose-derived Mesenchymal Stem Cells in the Treatment of Early Knee Osteoarthritis,Jinan,Shandong,China,"March 2, 2019"
53,54,NCT01157403,Evidence of Liver Transplantation,Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes,Autologous transplantation,Autologous Transplantation of Mesenchymal Stem Cells for Treatment of Patients With Onset of Type 1 Diabetes,Chongqing,Chongqing,China,July 2010
54,55,NCT01902082,ARDS,Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome,Mesenchymal stem cells|Placebo,Phase I Study of Allogeneic Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome,Shaoxing,Zhejiang,China,November 2012
55,56,NCT02409940,Renal Transplant Rejection,To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients,Mesenchymal Stem Cells,A Randomized Trial to Elucidate Effect of Mesenchymal Stem Cells on Immune Modulation in Living Related Kidney Transplant Patients,Chandigarh,,India,September 2013
56,57,NCT01676441,Spinal Cord Injury,Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury,cellgram-spine,A Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Patients With Chronic Spinal Cord Injury.,Seoul,,"Korea, Republic of",August 2008
57,58,NCT01775774,Acute Respiratory Distress Syndrome,Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome,Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells,A Phase 1 Multi-center Clinical Trial of Allogeneic Bone Marrow-derived Human Mesenchymal Stem Cells for the Treatment of Acute Respiratory Distress Syndrome,San Francisco|Stanford|Boston|Pittsburgh,California|California|Massachusetts|Pennsylvania,United States|United States|United States|United States,July 2013
58,59,NCT04791878,Perianal Fistula Due to Crohn's Disease (Disorder),Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease,Mesenchymal stem cells,A Phase I Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease,Cleveland,Ohio,United States,"April 1, 2021"
59,60,NCT02344849,Erectile Dysfunction,Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction,mesenchymal stem cell,"An Open, Single-center, Phase 1 Study to Evaluate Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cell in Erectile Dysfunction.",Seoul,,"Korea, Republic of",July 2015
60,61,NCT03668171,Acute-On-Chronic Liver Failure,Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure,mesenchymal stem cell transplantation or placebo infusion via peripheral vein,"Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure, a Randomized, Double Blind, Placebo Controlled Trial",Xi'an,Shaanxi,China,"December 10, 2017"
61,62,NCT04446897,"Periodontitis, Chronic",Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction,mesenchymal stem cells|standard treatment,Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction Immobilised on a Biodegradable Carrier,Minsk,,Belarus,"August 3, 2020"
62,63,NCT03346967,Hormone Deficiency,Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency,adipose-derived mesenchymal stem cells,"Evaluation of Autologous Adipose Derived Mesenchymal Stem Cells (AD-MSCs) Therapy on Sexual Hormone Deficiency in the Middle-aged Patients: an Open-label, Single-group Clinical Trial",Hanoi,,Vietnam,"November 1, 2017"
63,64,NCT03219801,Systemic Lupus Erythematosus,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus,mesenchymal stem cells,Evaluation of Safety and Efficacy in Patients With Systemic Lupus Erythematosus by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells,Shijiazhuang,Hebei,China,"August 1, 2017"
64,65,NCT00659620,Kidney Transplant|Chronic Allograft Nephropathy,Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy,mesenchymal stem cell,Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy,Fuzhou,Fujian,China,May 2008
65,66,NCT03645525,Bronchopulmonary Dysplasia,Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD),Human Umbilical Cord-derived Mesenchymal stem cell|placebo,Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD),Shanghai|Shanghai|Shanghai,Shanghai|Shanghai|Shanghai,China|China|China,"December 1, 2019"
66,67,NCT01877759,Liver Cirrhosis,A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis,Mesenchymal stem cell,Role of Bone Marrow Derived Autologous Stem Cells + Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Liver Cirrhosis,"Pune,",Maharashtra,India,December 2013
67,68,NCT01962233,Hypoxic Ischemic Encephalopathy,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Hypoxic Ischemic Encephalopathy,mesenchymal stem cells,Safety and Efficacy Investigation of Patients With Hypoxic Ischemic Encephalopathy by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells,Shijiazhuang,Hebei,China,September 2013
68,69,NCT01504464,Osteoarthritis,The Effects of Intra-articular Injection of Mesenchymal Stem Cells in Knee Joint Osteoarthritis,mesenchymal stem cell|Placebo,"Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells in Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial",Tehran,,"Iran, Islamic Republic of",October 2012
69,70,NCT02266394,Renal Artery Stenosis|Ischemic Nephropathy|Renovascular Disease|Chronic Kidney Disease,Hypoxia and Inflammatory Injury in Human Renovascular Hypertension,Mesenchymal stem cell|Mesenchymal stem cell delivery with stent placement,Hypoxia and Inflammatory Injury in Human Renovascular Hypertension : Phase 1 Trial of Mesenchymal Stem Cell Therapy,Birmingham|Rochester|Jackson,Alabama|Minnesota|Mississippi,United States|United States|United States,"October 21, 2014"
70,71,NCT03055078,Aplastic Anemia,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Aplastic Anemia,mesenchymal stem cells,Evaluation of Safety and Efficacy in Patients With Aplastic Anemia by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells,Shijiazhuang,Hebei,China,January 2017
71,72,NCT02460770,Chronic Myocardial Ischemia,Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device,Autologous mesenchymal stem cells,Pilot Study of Investigation of Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device,Toulouse,,France,June 2015
72,73,NCT03668145,Primary Biliary Cirrhosis,Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis,mesenchymal stem cell transplantation or placebo infusion via peripheral vein,"Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis, a Randomized Double-blind Placebo Controlled Trial",Xi'an,Shaanxi,China,"November 8, 2017"
73,74,NCT00734396,Organ Transplantation,Mesenchymal Stem Cells and Subclinical Rejection,Mesenchymal stem cell infusion,Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Allograft Rejection After Renal Transplantation,Leiden,,Netherlands,February 2009
74,75,NCT01360164,Hereditary Ataxia,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia,human umbilical cord mesenchymal stem cells,Phase I/II Study of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia,Nanjing,Jiangsu,China,January 2010
75,76,NCT03358654,Umbilical Cord Bleeding|Knee Osteoarthritis,Evaluating Safety and Efficacy of Mesenchymal Stem Cells From Umbilical Cord,mesenchymal stem cells from umbilical cord,Evaluating the Safety and Efficacy of Mesenchymal Stem Cells From Umbilical Cord in the Treatment of Knee Joint Osteoarthritis,,,,"January 1, 2018"
76,77,NCT04302519,COVID-19,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,Dental pulp mesenchymal stem cells,Clinical Study of Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,,,,"March 5, 2020"
77,78,NCT01765634,Acute Graft-versus-host Disease,Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease,Mesenchymal stem cells|Non-mesenchymal stem cells,Mesenchymal Stem Cells From Third-party Donors for Treatment of Refractory Acute Graft-versus-host Disease,Guangzhou,Guangdong,China,January 2013
78,79,NCT01765660,Chronic Graft-versus-host Disease,Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease,Mesenchymal stem cells|Non-mesenchymal stem cells,Mesenchymal Stem Cells From Third-party Donors for Treatment of Refractory Chronic Graft-versus-host Disease,Guangzhou,Guangdong,China,January 2013
79,80,NCT03383081,"Osteoarthritis, Knee",The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis,Low dose mesenchymal stem cells|High dose mesenchymal stem cells|Intraarticular injection,A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis,Changsha,Hunan,China,"October 1, 2018"
80,81,NCT04446884,Stress Urinary Incontinence,Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells,Autologous adipose-derived mesenchymal stem cells|Standard treatment according to the Clinical protocols,Treatment of Stress Urinary Incontinence in Women With Autologous Adipose-derived Mesenchymal Stem Cells Mixed With Collagen Gel,Hrodna,,Belarus,"March 1, 2018"
81,82,NCT02414295,Klinefelter Syndrome|Azoospermia,Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection,Mesenchymal stem cell injection,Management of Azoospermic Patients With Kleinfelter Syndrome Patients With Mesenchymal Stem Cell Injection,Cairo,,Egypt,August 2013
82,83,NCT02440074,Degenerative Disc Disease,Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV),Autologous bone marrow mesenchymal stem cells,Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV),,,,June 2011
83,84,NCT01056471,"Autoimmune Diseases|Immune System Diseases|Demyelinating Diseases|Nervous System Diseases|Demyelinating Autoimmune Diseases, CNS|Autoimmune Diseases of the Nervous System",Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis,Autologous mesenchymal stem cells from adipose tissue.|Autologous mesenchymal stem cells from adipose tissue.,"Multicenter Clinical Trial Phase I / II Randomized, Placebo-controlled Study to Evaluate Safety and Feasibility of Therapy With Two Different Doses of Autologous Mesenchymal Stem Cells in Patients With Secondary Progressive Multiple Sclerosis Who do Not Respond to Treatment",Málaga|Sevilla,,Spain|Spain,January 2010
84,85,NCT01649700,The Sequelae Caused by Severe Brain Injury,Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells,autologous adipose-derived mesenchymal stem cells,Treatment of Sequelae Caused by Severe Brain Injury With Autologous Adipose-derived Mesenchymal Stem Cells,Taipei,,Taiwan,October 2011
85,86,NCT02181712,Lung Transplant Reject|Bronchiolitis Obliterans,Mesenchymal Stem Cell Therapy for Lung Rejection,Mesenchymal stem cell 0.5|Mesenchymal stem cell 1.0,A Pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells to Induce Remission in Lung Transplant Patients Experiencing Treatment-refractory Moderate to Severe Lung Rejection,Jacksonville,Florida,United States,July 2014
86,87,NCT04194671,Acute Kidney Injury|Mesenchymal Stem Cells,Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury,Mesenchymal stem cells|Saline,"A Single-center, Randomized, Placebo-controlled, Patient-blinded Study of Mesenchymal Stem Cells Therapy in Subjects With Severe Acute Kidney Injury Receiving Routine Therapy",Beijing,Beijing,China,"December 31, 2021"
87,88,NCT02963727,Knee Osteoarthrosis,Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis,Wharton Jelly derived mesenchymal stem cell,Knee Osteoarthrosis (KOA) in Jordanian Patients: a Phase I Dose-finding Study Using Wharton Jelly Derived Mesenchymal Stem Cells (WJMSC) for Advanced Stage III and IV KOA,Amman,,Jordan,"January 27, 2017"
88,89,NCT02966951,Knee Osteoarthrosis,Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis,Adipose tissue derived mesenchymal stem cell,Knee Osteoarthrosis (KOA) in Jordanian Patients: a Phase I Dose-finding Study Using Adipose Tissue Derived Mesenchymal Stem Cells (ATMSC) for Advanced Stage III and IV KOA,Amman,,Jordan,"January 17, 2017"
89,90,NCT01157650,Crohn Disease,Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue,Autologous mesenchymal stem cells,Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue,Pamplona|Pamplona|Pamplona,,Spain|Spain|Spain,June 2010
90,91,NCT02763423,"Ketoacidosis, Diabetic",Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis,umbilical cord mesenchymal stem cell,The Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation to Treat New-onset Type 1 Diabetes With Diabetic Ketoacidosis,Nanjing,Jiangsu,China,January 2009
91,92,NCT01741090,Alcoholic Liver Cirrhosis,The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis,mesenchymal stem cell injection,The Evaluation of Effectiveness and Safety for New Therapy With Bone Marrow Derived Autologous Mesenchymal Stem Cell for Hepatic Failure Caused by Alcoholic Liver Cirrhosis,Wonju,Kangwon-do,"Korea, Republic of",September 2009
92,93,NCT04519671,Perianal Crohn Disease|Perianal Fistula|Crohn Disease,Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease,Mesenchymal Stem Cells|Placebo,A Phase IB/IIA Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease,Cleveland,Ohio,United States,"November 19, 2020"
93,94,NCT03184935,Myelodysplastic Syndromes,Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS),Allogeneic umbilical cord mesenchymal stem cells|Decitabine,Research for Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Myelodysplastic Syndrome (MDS),Hohhot,Inner Mongolia,China,June 2022
94,95,NCT04519697,Rectovaginal Fistula|Crohn Disease|Crohn Disease of Vulva|Rectolabial; Fistula,Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease,Mesenchymal Stem Cells|Placebo,A Phase IB/IIA Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in the Setting of Crohn's Disease.,Cleveland,Ohio,United States,"October 28, 2020"
95,96,NCT02213705,SYSTEMIC SCLERODERMA|ALLOGENEIC MESENCHYMAL STEM CELLS|ADULT,Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells,INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS,Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells,Paris,,France,"May 6, 2014"
96,97,NCT03357575,Knee Osteoarthritis,The Comparison of Efficacy and Safety of the Mesenchymal Stem Cells From Adipose and Hyaluronic Acid,Mesenchymal Stem Cells from adipose|Hyaluronic Acid,The Comparison of Efficacy and Safety of the Mesenchymal Stem Cells From Adipose and Hyaluronic Acid in the Treatment of Adult Knee Osteoarthritis,,,,"January 1, 2018"
97,98,NCT03180463,Osteonecrosis of Femoral Head,The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH),Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)|core decompression,The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC),Hohhot,Inner Mongolia,China,June 2022
98,99,NCT03343782,Type 2 Diabetes Mellitus,Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes,Expanded autologous bone marrow-derived mesenchymal stem cell,Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type 2 Diabetes,Hanoi,,Vietnam,"November 1, 2017"
99,100,NCT03186456,Cerebral Infarction,The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction,Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)|Aspirin Tablet,Study the Safety and Efficacy of Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Acute Cerebral Infarction,Hohhot,Inner Mongolia,China,June 2022
100,101,NCT04104412,Lumbar Discogenic Pain,The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain,human umbilical cord mesenchymal stem cell,The Safety/Efficacy Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Lumbar Discogenic Pain,Beijing,Beijing,China,"August 15, 2019"
101,102,NCT02866721,Cystic Fibrosis,Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis,Mesenchymal Stem Cells,"A Phase I, Single Center, Open Label, Single Dose, Dose Escalation Study Assessing the Safety and Tolerability of AllogeneiC MEsenchymAl Stem CEll Infusion in Adults With Cystic Fibrosis-CEASE CF",Cleveland,Ohio,United States,August 2016
102,103,NCT02484950,Full Thickness Rotator Cuff Tear,Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair,Mesenchymal stem cell augmentation in rotator cuff repair|Standard arthroscopic rotator cuff repair,A Prospective Randomized Trial of Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Arthroscopic Rotator Cuff Repair,Chicago,Illinois,United States,November 2015
103,104,NCT04520022,Recessive Dystrophic Epidermolysis Bullosa,Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB,Human Umbilical Cord Blood-derived Mesenchymal Stem Cells,"Single Center, Single Group Assignment, Open Label Trial to Assess Safety and Effectiveness of Intravenous Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With Recessive Dystrophic Epidermolysis Bullosa",Seoul,,"Korea, Republic of","October 13, 2016"
104,105,NCT04234750,Evaluate the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Donor Sites,Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites,mesenchymal stem cell conditioned medium-derived pleiotropic factor,The Evaluation of the Safety and Effectiveness of Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites,Datong,Shanxi,China,"October 17, 2019"
105,106,NCT01730547,Multiple Sclerosis,Mesenchymal Stem Cells for Multiple Sclerosis,Autologous mesenchymal stem cells,Phase 1/2 Clinical Trial With Autologous Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis,Stockholm,,Sweden,February 2013
106,107,NCT02387749,Diabetic Peripheral Neuropathy,Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients .,mesenchymal stem cells,Effect Of Mesenchymal Stem Cells Transfusion on the Peripheral Neuropathy in Diabetic Patients Measured by Nerve Conduction.,,,,May 2014
107,108,NCT01573923,Liver Cirrhosis,Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis,mesenchymal stem cells|Conventional therapy,Clinical Trial of Umbilical Mesenchymal Stem Cells Transplantation for Liver Cirrhosis-Phase I/II,Beijing|Lanzhou|Qionghai|Lianyungang|Shanghai|Xi'an,Beijing|Gansu|Hainan|Jiangsu|Shanghai|Shanxi,China|China|China|China|China|China,July 2014
108,109,NCT01854957,Multiple Sclerosis,MEsenchymal StEm Cells for Multiple Sclerosis,Autologous Mesenchymal Stem Cells,MEsenchymal StEm Cells for Multiple Sclerosis (MESEMS) Phase I-II Clinical Trial With Autologous Mesenchymal Stem Cells (MSCs) for the Therapy of Multiple Sclerosis,Genova,,Italy,July 2012
109,110,NCT00659217,Lupus Nephritis,Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis,mesenchymal stem cell,Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis,Fuzhou,Fujian,China,May 2008
110,111,NCT01446614,Parkinson's Disease,Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease,bone marrow derived mesenchymal stem cells,PhaseⅠ/ⅡTrial of Autologous Bone Marrow Derived Mesenchymal Stem Cells to Patients With Parkinson's Disease.,Guangzhou,Guangdong,China,October 2011
111,112,NCT02834858,Peripheral Vascular Disease|Ischemia|Diabetic Foot,Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications,Umbilical Cord Mesenchymal Stem Cells|saline,Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications,Guangzhou,Guangdong,China,January 2016
112,113,NCT01228266,Multiple Sclerosis,Mesenchymal Stem Cell Transplantation in MS,autologous mesenchymal stem cells,"Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: a Randomized, Double-blind, Crossover With Placebo Phase II Study",Barcelona,,Spain,December 2010
113,114,NCT01446640,Spinal Cord Injury,Mesenchymal Stem Cells Transplantation to Patients With Spinal Cord Injury,bone marrow derived mesenchymal stem cells,PhaseⅠ/ⅡTrial of Autologous Bone Marrow Derived Mesenchymal Stem Cells to Patients With Spinal Cord Injury.,Guangzhou,Guangdong,China,October 2011
114,115,NCT01932164,Cleft Lip and Palate,Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate Patients,maxillary alveolar graft by tissue engineering|Bone tissue engineering using mesenchymal stem cells,Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate Patients,São Paulo,,Brazil,May 2013
115,116,NCT01436058,Osteoarthritis,Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Ankle Joint Osteoartritis,mesenchymal stem cell,Phase 1 Study of Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Patients With Ankle Joint Osteoarteritis,Tehran,,"Iran, Islamic Republic of",September 2010
116,117,NCT01919827,Idiopathic Pulmonary Fibrosis,Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis,Endobronchial infusion of adult mesenchymal stem cells|Autologous mesenchymal stem cells derived from bone marrow,Treatment of Idiopathic Pulmonary Fibrosis With Bone Marrow Derived Mesenchymal Stem Cells,Pamplona|Salamanca,Navarra,Spain|Spain,March 2013
117,118,NCT04235296,Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Residual Burn Wound,Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Residual Burn Wound,epidermal growth factor|mesenchymal stem cell conditioned medium-derived pleiotropic factor,Evaluation of the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Residual Burn Wound,Datong,Shanxi,China,"November 17, 2019"
118,119,NCT01305694,Aplastic Anemia,Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.,bone marrow derived mesenchymal stem cells,PhaseⅠ/ⅡTrial of Bone Marrow Derived Mesenchymal Stem Cell Transplantation From Related Donor to Patients With Relapsed/Refractory Aplastic Anemia.,Guangzhou,Guangdong,China,February 2011
119,120,NCT04939077,"Myocardial Ischemia|Ventricular Dysfunction, Left",Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC),Allogeneic Human Umbilical Cord Mesenchymal Stem Cells,Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC),Shanghai,Shanghai,China,"November 27, 2019"
120,121,NCT03386708,Uterus; Injury,hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury,intrauterine injection|human umbilical cord mesenchymal stem cell,A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cell (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury,Changsha,Hunan,China,"October 1, 2018"
121,122,NCT02492516,Amyotrophic Lateral Sclerosis,Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS,mesenchymal stem cells,Evaluation the Safety of Intravenous Injection of Adipose Derived Mesenchymal Stem Cell in Patients With ALS,Tehran,,"Iran, Islamic Republic of",September 2014
122,123,NCT03550183,Parkinson's Disease,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease,mesenchymal stem cells,Safety and Efficacy Investigation of Patients With Parkinson's Disease by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells,Shijiazhuang,Hebei,China,"January 10, 2018"
123,124,NCT04493918,Spinal Tuberculosis|Mesenchymal Stem Cell,Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection,Mesenchymal Stem cell + Nacl 0.9%|NaCl 0.9%,Effectivity of Local Implantation of the Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection (Clinical Trial),Jakarta Pusat,DKI Jakarta,Indonesia,"May 21, 2017"
124,125,NCT04416139,Covid 19,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,Infusion IV of Mesenchymal Stem cells,Mesenchymal Stem Cells for the Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID-19. Pilot Study,Mexico City,,Mexico,"May 1, 2020"
125,126,NCT01895439,Multiple Sclerosis,Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis,Autologous Mesenchymal Stem Cells,Phase II Study: Use of Autologus Mesenchymal Stem Cells in Multiple Sclerosis Patients Who do Not Respond to Conventional Treatment,Amman,,Jordan,October 2012
126,127,NCT02057211,Type 1 Diabetes Mellitus,Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study,autologous mesenchymal stem cell transplantation|sham transplantation of mesenchymal stem cells,Mesenchymal Stem Cells to Intervene in the Development of Type 1 Diabetes: a Blinded Randomized Study,Uppsala,,Sweden,April 2014
127,128,NCT01499459,Liver Cirrhosis,Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis,autologous mesenchymal stem cell transplantation,Efficacy of Exvivo Expanded Autologous Mesenchymal Stem Cell Transplantation Via Peripheral Vein in Patients With Liver Cirrhosis,Ankara,,Turkey,June 2008
128,129,NCT04434794,Gingival Recession,Treatment of Gingival Recession Using Mesenchymal Stem Cells,mesenchymal stem cells|standard treatment,Treatment of Gingival Recession Using Autologous Adipose-derived Mesenchymal Stem Cells,Minsk,,Belarus,"January 1, 2018"
129,130,NCT02304562,Sweat Gland Diseases,Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair,UCB Mesenchymal Stem Cells treatment,Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair,Beijing,Beijing,China,January 2013
130,131,NCT04184258,Systemic Lupus Erythematosus,Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells,Pooled mesenchymal stem cell|Standard treatment according to the Clinical protocols,Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Olfactory Mucosa Derived Mesenchymal Stem Cells,Minsk,,Belarus,"July 1, 2019"
131,132,NCT01824069,Nonrevascularizable Critical Ischemia of the Lower Limbs,Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy,Intramuscular injection of a suspension of adult mesenchymal stem cells derived,Phase IIa Clinical Trial to Safety of Treatment in Critical Ischemia Nonrevascularizable Lower Limb by Mesenchymal Stem Cells,Madrid,,Spain,April 2013
132,133,NCT04501354,Osteoporosis,Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients,Mesenchymal Stem Cell,Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients (Clinical Trial),Jakarta Pusat,DKI Jakarta,Indonesia,August 2020
133,134,NCT01322789,"Diabetes Mellitus, Insulin-Dependent",Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients,Intravenous Mesenchymal stem cell infusion,Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients,Ribeirão Preto,São Paulo,Brazil,September 2008
134,135,NCT05075811,"Pouch, Ileal|Fistula",Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease,Ossium vBM-MSC|Placebo,A Phase IB/IIA Study of Ossium Vertebral Bone Marrow Derived Mesenchymal Stem Cells (vBM-MSC) for the Treatment of Ileal Anal Anastomosis and Ileal Pouch Fistulas in the Setting of Crohn's Disease of the Pouch,Cleveland,Ohio,United States,"February 1, 2022"
135,136,NCT02287831,Diabetes|Peripheral Arterial Disease,Umbilical Cord Mesenchymal Stem Cells Injection for Diabetes Secondary Peripheral Arterial Disease,umbilical cord mesenchymal stem cells,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Injection for Diabetes Secondary Peripheral Arterial Disease,,,,February 2014
136,137,NCT02235844,Duchenne's Muscular Dystrophy,Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD),Umbilical Cord Mesenchymal Stem Cells,Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD),Wichita,Kansas,United States,September 2014
137,138,NCT01378182,Wilson's Disease,Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis,allogeneic mesenchymal stem cell transplantation,Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis,Ankara,,Turkey,April 2011
138,139,NCT05535803,Tracheal Stenosis|Laryngeal Stenosis,Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells,Olfactory mucosa-derived mesenchymal stem cells|Patients treated according to current clinical protocols,Treatment of Laryngotracheal Stenosis Using Autologous Olfactory-mucosa-derived Mesenchymal Stem Cells,Minsk,,Belarus,"June 1, 2021"
139,140,NCT04457037,Trophic Ulcer,Treatment of Patients With Trophic Ulcers Using Mesenchymal Stem Cells,Autologous adipose-derived mesenchymal stem cells,Treatment of Patients With Trophic Ulcers Using Autologous Adipose-derived Mesenchymal Stem Cells,Minsk,,Belarus,"October 1, 2009"
140,141,NCT04444271,COVID-19,Mesenchymal Stem Cell Infusion for COVID-19 Infection,Mesenchymal stem cells|Placebo,"Prospective, Randomized Phase 2 Clinical Trial of Mesenchymal Stem Cells(MSCs) for the Treatment of Coronavirus Disease 2019(COVID-19)",Rawalpindi,Punjab,Pakistan,"May 1, 2020"
141,142,NCT02705742,Liver Cirrhosis,Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis,Mesenchymal Stem Cells,Efficacy of Adipose Tissue Derived Autologous Repeated Mesenchymal Stem Cells Transplantation Via Hepatic Artery and Peripheral Vein in Patients With Liver Cirrhosis Due to HCV Hepatitis,Ankara,,Turkey,January 2016
142,143,NCT02731586,Edentulous Alveolar Ridge,Effect on Allogenic Mesenchymal Stem Cells on Osseointegration of Dental Implants,Allogenic Mesenchymal stem cells,"Comparative Clinical Evaluation of Osseointegration of Dental Implants Placed With and Without, the Use of Dental Pulp-derived Allogenic Mesenchymal Stem Cells.",Vikarabad,Telangana State,India,January 2016
143,144,NCT04432467,Chronic Endometritis|Uterus; Scar|Uterine Synechiae|Fallopian Tube Obstruction,Fertility Restoration Using Autologous Mesenchymal Stem Cells,Autologous mesenchymal stem cells|standard treatment,Fertility Restoration Using Autologous Adipose Tissue Derived Mesenchymal Stem Cells,Minsk,,Belarus,"October 1, 2020"
144,145,NCT03505034,Spinal Cord Injuries,Intrathecal Transplantation of UC-MSC in Patients With Late Stage of Chronic Spinal Cord Injury,Umbilical Cord Mesenchymal Stem Cells,"The Effect of Intrathecal Transplantation of Umbilical Cord Mesenchymal Stem Cells in Patients With Late Stage of Chronic Spinal Cord Injury：A Multicenter, Prospective, Cohort Study",Guangzhou,Guangdong,China,"September 1, 2019"
145,146,NCT03357770,Knee Osteoarthritis|Umbilical Cord Bleeding,The Maximum Tolerated Dose of Mesenchymal Stem Cells From Umbilical Cord,mesenchymal stem cells,Evaluating the Maximum Tolerated Dose of Mesenchymal Stem Cells From Umbilical,,,,"January 1, 2018"
146,147,NCT01392105,Acute Myocardial Infarction,Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction,Mesenchymal stem cell|Control group,"A Randomized, Open-label, Multicenter Trial for the Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction",Wonju|Inchon|Seoul,Gangwon-do,"Korea, Republic of|Korea, Republic of|Korea, Republic of",March 2007
147,148,NCT04047810,Chronic Obstructive Pulmonary Disease,Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD),Mesenchymal Stem Cells,A Pilot Study to Evaluate the Safety and Feasibility of Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD),Jacksonville,Florida,United States,"January 6, 2020"
148,149,NCT05227846,Decompensated Cirrhosis,Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1),Human Umbilical Cord-derived Mesenchymal Stem Cells,A Phase 1 Dose Escalation Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for the Treatment of Decompensated Cirrhosis (MSC-DLC-1),Beijing,,China,"March 22, 2022"
149,150,NCT02497443,Epilepsy,Safety of Autologous MSC Infusion to Treat Epilepsy,Autologous mesenchymal stem cells,Phase 1 Study of Autologous Mesenchymal Stem Cell Application for Therapy of Drug-Resistant Symptomatic Epilepsy,,,,April 2011
150,151,NCT02283879,Cerebral Hemorrhage,Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela,Human umbilical cord mesenchymal stem cells,Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Cerebral Hemorrhage,Guangzhou,Guangdong,China,March 2015
151,152,NCT03873506,Bronchopulmonary Dysplasia,Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia,transplantation of hUC-MSCs,Follow-Up Study of Safety and Efficacy of Mesenchymal Stem Cells in Preterm Infants With Moderate or Severe Bronchopulmonary Dysplasia,Chongqing,Chongqing,China,"July 1, 2018"
152,153,NCT02530047,Ovarian Cancer,Mesenchymal Stem Cells (MSC) for Ovarian Cancer,MSC-INFβ|Questionnaires,Phase 1 Study to Determine the Effects of Mesenchymal Stem Cells Secreting Interferon Beta in Patients With Advanced Ovarian Cancer,Houston,Texas,United States,"May 16, 2016"
153,154,NCT04713878,Coronavirus Disease 2019 (COVID-19) Pneumonia,Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,Mesenchymal stem cells,A 8-Week Trial of Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,Istanbul,,Turkey,"May 8, 2020"
154,155,NCT01759784,Amyotrophic Lateral Sclerosis,Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS,Intraventricular injection,Safety of Intraventricular Injection of Bone Marrow Derived Mesenchymal Stem Cell in Patients With ALS,Tehran,,"Iran, Islamic Republic of",March 2014
155,156,NCT00883870,Critical Limb Ischemia,Mesenchymal Stem Cells in Critical Limb Ischemia,mesenchymal stem cells|Plasmalyte A,"A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intramuscular ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With Critical Limb Ischemia (Cli)",Bangalore|Bangalore|Kochi|New Delhi,Karnataka|Karnataka|Kerala,India|India|India|India,April 2009
156,157,NCT00294112,Crohn's Disease,Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease,Prochymal™ adult human mesenchymal stem cells|adult human mesenchymal stem cells,"A Phase II, Open-label, Randomized Study to Evaluate the Safety and Efficacy of PROCHYMAL™ IBD (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Treatment of Subjects Experiencing Moderate-to-severe Crohn's Disease That is Refractory to Steroids and Immune Suppressants",Baton Rouge|Charlotte|Pittsburgh|Richmond,Louisiana|North Carolina|Pennsylvania|Virginia,United States|United States|United States|United States,"March 13, 2006"
157,158,NCT00850187,Knee Osteoarthritis,Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage,Bone marrow derived mesenchymal stem cells,Treatment of Full-thickness Articular Cartilage Defects in the Knee of Patients With Autologous Bone-marrow Mesenchymal Stem Cells and Scaffold,Tehran,,"Iran, Islamic Republic of",August 2008
158,159,NCT04519684,Ileal Pouch|Crohn Disease,Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease,Mesenchymal stem cells|Placebo,A Phase IB/IIA Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Ileal Anal Anastomosis and Ileal Pouch Fistulas in the Setting of Crohn's Disease of the Pouch,Cleveland,Ohio,United States,"October 28, 2020"
159,160,NCT03529136,Decompensated Liver Cirrhosis,Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis,UC-MSC,A Prospective Multicenter Clinical Study to Evaluate The Safety and Efficiency of Human Umbilical Cord Mesenchymal Stem Cell Transfusion in Patients With Decompensated Liver Cirrhosis.,,,,"June 1, 2018"
160,161,NCT02291926,Cartilage Diseases|Osteoarthritis,Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Articular Cartilage Defect,Human umbilical cord mesenchymal stem cells,Phase I Study of Human Umbilical Cord Mesenchymal Stem Cell Implantation in the Treatment of Articular Cartilage Defect of Knee,Guangzhou,Guangdong,China,December 2014
161,162,NCT01895413,Osteoarthritis,Autologous Bone Marrow Mesenchymal Stem Cells Transplantation for Articular Cartilage Defects Repair,Bone marrow aspiration,Autologous Bone Marrow-derived Mesenchymal Stem Cells Used in the Treatment of Articular Cartilage Injury,Curitiba,Paraná,Brazil,September 2012
162,163,NCT01459640,Osteoarthritis,Intra-Articular Autologous Bone Marrow Mesenchymal Stem Cells Transplantation to Treat Mild to Moderate Osteoarthritis,Hyaluronic Acid|Autologous bone marrow-derived mesenchymal stem cells,Phase 2 Study Assessing the Efficacy of Intra-Articular Autologous Mesenchymal Stem Cells in Patients With Mild to Moderate Osteoarthritis,Kuala Lumpur,,Malaysia,March 2011
163,164,NCT03878628,Dry Eye|Kerato Conjunctivitis Sicca|Aqueous Tear Deficiency,Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease,Adipose tissue-derived mesenchymal stem cells,Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease,Copenhagen,DK,Denmark,"October 16, 2019"
164,165,NCT00813267,Osteochondritis of the Femoral Head,Mesenchymal Stem Cell for Osteonecrosis of the Femoral Head,mesenchymal stem cell infusion|bone marrow mononuclear cell infusion,Mesenchymal Stem Cell Transplantation in the Treatment of Osteonecrosis of the Femoral Head,Fuzhou,Fujian,China,December 2009
165,166,NCT04366323,Sars-CoV2,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS,"Phase I / II Clinical Trial, Multicenter, Randomized and Controlled, to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19",Jerez de la Frontera|Córdoba|Granada|Sevilla|Sevilla|Sevilla,Cádiz,Spain|Spain|Spain|Spain|Spain|Spain,"April 27, 2020"
166,167,NCT04357600,Liver Cirrhoses,Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B,Allogeneic Umbilical Cord Mesenchymal Stem Cell,Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B: Phase I/ II Study,Jakarta,DKI Jakarta,Indonesia,"May 17, 2018"
167,168,NCT01849887,Ischemic Stroke,Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke,bone marrow-derived mesenchymal stem cells|Placebo,Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke,Orange,California,United States,January 2016
168,169,NCT02987413,Motor Neuron Disease,Escalated Application of Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis Patients,Autologous Mesenchymal stem cells (MSCs),Safety and Efficacy of Mesenchymal Stem Cells Escalated Application in Amyotrophic Lateral Sclerosis Patients: Study Design of a Phase I Trial,Santo Andre|Sao Paulo,Sao Paulo|SP,Brazil|Brazil,"April 28, 2015"
169,170,NCT03180450,Heart Failure,The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF),Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)|conventional treatment,The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC),Hohhot,Inner Mongolia,China,June 2022
170,171,NCT05167721,Multiple System Atrophy,Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy,Autologous Mesenchymal Stem Cells|Placebo,Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy,Rochester,Minnesota,United States,"December 15, 2021"
171,172,NCT04216849,Type 2 Diabetes With Renal Manifestations,Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy,human umbilical cord mesenchymal stem cells|saline,Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy,Shanghai,Shanghai,China,"July 1, 2020"
172,173,NCT04650568,Anterior Cruciate Ligament Injury|Anterior Cruciate Ligament Rupture,Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction,Autologous Bone Marrow Derived Mesenchymal Stem Cells|Sham incision,A Prospective Randomized Trial of Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction,Chicago,Illinois,United States,"November 3, 2017"
173,174,NCT02239393,Multiple Sclerosis,Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study,Mesenchymal Stem Cells,MEsenchymal Stem Cell Therapy for CAnadian MS Patients,Winnipeg|Ottawa,Manitoba|Ontario,Canada|Canada,June 2015
174,175,NCT03378414,Spinocerebellar Ataxia Type 1|Spinocerebellar Ataxia Type 2|Spinocerebellar Ataxia Type 3|Spinocerebellar Ataxia Type 6,Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia,Intravenous infusion|Intrathecal injection|umbilical cord mesenchymal stem cell,A Clinical Research on the Safety/Efficacy of Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Spinocerebellar Ataxia,,,,June 2022
175,176,NCT01649687,Cerebellar Ataxia,Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells,Allogeneic adult adipose-derived mesenchymal stem cells,Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells,Taipei,,Taiwan,May 2012
176,177,NCT03362424,Rotator Cuff Tear|Tendon Injuries|Mesenchymal Stem Cell,Mesenchymal Stem Cells in Rotator Cuff Repair,Mesenchymal stem cell|Rotator cuff repair,Mesenchymal Stem Cells in Rotator Cuff Repair - a Randomized Prospective Study,São Paulo,SP,Brazil,"November 1, 2020"
177,178,NCT00646724,Type 1 Diabetes Mellitus,Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients,cotransplantation of islet and mesenchymal stem cell,Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients,Fuzhou,Fujian,China,January 2008
178,179,NCT03826433,Hepatitis B,hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis,Peripheral iv,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosis,Changsha,Hunan,China,"October 1, 2018"
179,180,NCT03176498,Cerebral Infarction,Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.,Allogeneic umbilical cord mesenchymal stem cell|Aspirin Enteric-coated Tablets & Atorvastatin Calcium,The Effects of Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neurological Function for Cerebral Infarction Patients in Convalescent Period.,Hohhot,Inner Mongolia,China,June 2022
180,181,NCT01856140,Lateral Epicondylitis,Treatment of Tendon Injury Using Mesenchymal Stem Cells,ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection,Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells(ALLO-ASC):A Pilot Study,Seoul,,"Korea, Republic of",May 2013
181,182,NCT04014166,Thrombocytopenia|Mesenchymal Stem Cells,Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia,Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs),Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia,Tianjin,Tianjin,China,"November 21, 2019"
182,183,NCT04426643,Urinary Incontinence,Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells,Autologous adipose-derived mesenchymal stem cells|Standard treatment according to the Clinical protocols,Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells Mixed With Collagen Gel and Injected Submucousely,Minsk,,Belarus,"August 1, 2020"
183,184,NCT00962923,Systemic Sclerosis|Mesenchymal Stem Cells,Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc),Allogeneic Mesenchymal Stem Cells (AlloMSC),,Nanjing,Jiangsu,China,August 2009
184,185,NCT04456361,"ARDS, Human|Covid-19",Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords,A Study of Mesenchymal Stem Cells as a Treatment in Patients With Acute Respiratory Distress Syndrome Caused by COVID-19,Tijuana,Baja California,Mexico,"April 16, 2020"
185,186,NCT03299413,Inflammatory Bowel Diseases,Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease,Wharton Jelly Mesenchymal stem cells,Ulcerative Colitis Stem Cell Therapy,Amman,,Jordan,"June 5, 2017"
186,187,NCT04661644,Critical Limb Ischemia,Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia,Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^7 cells/1 mL/vial)|Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^8 cells/1 mL/vial),A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-derived Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia,Seoul,,"Korea, Republic of","November 4, 2020"
187,188,NCT04382547,"COVID|Covid-19|Coronavirus|Pneumonia|Pneumonia, Viral|Pneumonia, Interstitial|Sars-CoV2",Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|Standard treatment according to the Clinical protocols,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,Minsk,,Belarus,"May 11, 2020"
188,189,NCT03321942,Mesenchymal Stem Cells|Chronic Kidney Diseases|Renal Interstitial Fibrosis,Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells,Treatment group|Control group,The Biological Characteristics of Adipose Tissue-derived Mesenchymal Stem Cells and Its Role in the Treatment of Chronic Renal Failure,Xuzhou,Jiangsu,China,"January 1, 2017"
189,190,NCT02481440,Spinal Cord Injuries,Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI,human umbilical cord mesenchymal stem cells (hUC-MSCs),Repeated Subarachnoid Administrations of Human Umbilical Cord Mesenchymal Stem Cells in Treating Spinal Cord Injury,Guangzhou,Guangdong,China,"March 30, 2018"
190,191,NCT03164083,Osteoarthritis,The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis,Mesenchymal stem cell|Placebo,"Evaluation the Effects of Intra-articular Injection of Mesenchymal Stem Cells and Stromal Vascular Fraction Patients With Knee Joint Osteoarthritis, Triple Blind Randomized Clinical Trial",Tabriz,,"Iran, Islamic Republic of","November 10, 2019"
191,192,NCT02790762,Pneumoconiosis,Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis,Human umbilical cord mesenchymal stem cells,A Phase I Study of Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis,Hengyang,Hunan,China,June 2016
192,193,NCT00972660,Graft Versus Host Disease,Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease,Mesenchymal stem cell (MSC)|Prednisone and cyclosporine or primary therapies,"A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Ex-Vivo Cultured Allogenic Mesenchymal Stem Cells For the Treatment of Extensive Chronic Graft Versus Host Disease",Guangzhou,Guangdong,China,September 2009
193,194,NCT04130100,Knee Osteoarthritis,Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis,Low Dose of Mesenchymal stem cell|High Dose of Mesenchymal stem cell|Sodium Hyaluronate,To Evaluate the Safety and Efficacy of Dental Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis Using Sodium Hyaluronate as a Parallel Control.,Shanghai,,China,"April 4, 2019"
194,195,NCT02652351,Hepatic Cirrhosis,Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis,Human umbilical cord mesenchymal stem cells,Safety and Efficacy Study of Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis,Hengyang,Hunan,China,March 2016
195,196,NCT05345418,Sexual Dysfunction Male,Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency,Umbilical Cord-Derived Mesenchymal Stem Cell for Male Patients with Sexual Deficiency,Evaluation of the Safety and Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency: A Phase I/IIa Randomised Crossover Trial,Hanoi,,Vietnam,"June 1, 2022"
196,197,NCT04992832,"Heart Failure, Systolic",Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study）,human umbilical cord mesenchymal stem cells|human serum albumin,"Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells for Treatment in Heart Failure Patients With Reduced Ejection Fraction: A Randomized, Double Blind, Placebo-Controlled, Prospective Clinical Study",Shanghai,Shanghai,China,"July 28, 2021"
197,198,NCT04464213,Diabetic Foot Ulcer,Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer,Single dose experiments|Multi-dose experiments,Phase I Clinical Trials of Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer,Beijing,Beiijng,China,"November 1, 2020"
198,199,NCT04326985,"Osteoarthritis, Knee",RCT Mesenchymal Stem Cells Versus Hyaluronic Acid in OA Knee):,Autologous Mesenchymal Stem Cells Treatment (MSCs)|Hyaluronic acid (HA),A Randomized Control Clinical Trial to Evaluate the Efficacy of Intra-articular Injections of Mesenchymal Stem Cells Versus Hyaluronic Acid in Patients Affected by Osteoarthritis of the Knee,Hong Kong,,Hong Kong,"January 31, 2015"
199,200,NCT01985633,"Osteoarthritis, Knee",Mesenchymal Stem Cells Enhanced With PRP Versus PRP In OA Knee,Mesenchymal stem cell suspension|PRP,Autologous Bone Marrow Derived Mesenchymal Stem Cells Enhanced With Platelet Rich Plasma Versus Platelet Rich Plasma In Osteoarthritis Knee:A Comparative Study,Chandigarh,,India,January 2013
200,201,NCT04390152,Acute Respiratory Distress Syndrome,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,"Wharton's jelly derived Mesenchymal stem cells.|Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)",Safety and Efficacy of Intravenous Infusion of Wharton's Jelly Derived Mesenchymal Stem Cell Plus Standard Therapy for the Treatment of Patients With Acute Respiratory Distress Syndrome Diagnosis Due to COVID 19: A Randomized Controlled Trial,Medellin|Rionegro,Antioquia-CO|Antioquia,Colombia|Colombia,"January 13, 2020"
201,202,NCT03239535,Critical Limb Ischemia,Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy,Mesenchymal stem cells|Normal saline,Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy,Moscow,,Russian Federation,"October 1, 2013"
202,203,NCT04996966,Ischemic Heart Disease|Lung Injury|Non-cardiac Surgery,Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury,human umbilical cord-derived mesenchymal stem cells|saline,Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury in Patients With Ischemic Heart Disease,Shanghai,,China,August 2021
203,204,NCT04538885,MSCs-PFs in Treating Poorly Healed Wounds of Postoperative Incision,Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Poorly Healed Wounds of Postoperative Incision,The pleiotropic factor derived from mesenchymal stem cells,Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Poorly Healed Wounds of Postoperative Incision,,,,"September 10, 2020"
204,205,NCT03979898,Cerebral Palsy,Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP,ASTROSTEM,Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Cerebral Palsy (CP),Seoul,,"Korea, Republic of","June 15, 2017"
205,206,NCT03209986,Liver Cirrhosis,Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis,mesenchymal stem cell transplantation via peripheral vein|mesenchymal stem cell,Randomized Control Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis Resulted From Viral Hepatitis,Xi'an,Shaanxi,China,"November 8, 2017"
206,207,NCT02633163,Systemic Lupus Erythematosus,Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE),Low Dose Mesenchymal Stem Cells (MSCs)|High Dose Mesenchymal Stem Cells (MSCs)|Placebo Infusion,A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus,Los Angeles|San Diego|Atlanta|Chicago|Manhasset|Rochester|Chapel Hill|Oklahoma City|Charleston,California|California|Georgia|Illinois|New York|New York|North Carolina|Oklahoma|South Carolina,United States|United States|United States|United States|United States|United States|United States|United States|United States,"October 26, 2018"
207,208,NCT05331872,Liver Cirrhosis,Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis,Human umbilical cord-derived mesenchymal stem cell infusion,"A Phase I, Open-label Trial on the Safety and Efficacy of Human Umbilical Cord-derived Mesenchymal Stem Cell Administration in the Management of Adult Liver Cirrhosis",Hanoi,,Vietnam,"December 1, 2020"
208,209,NCT05039411,Perianal Fistula Due to Crohn's Disease|Fistula in Ano,Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease,Human umbilical cord mesenchymal stem cells (UC-MSCs),A Phase I Study of the Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) for Perianal Fistulas in Patients With Crohn's Disease,Kuala Lumpur,,Malaysia,"March 1, 2022"
209,210,NCT05520125,Segmental Fracture - Bone Loss,Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles,Mesenchymal stem cells enriched by extracellular vesicles|Standard treatment of bone defects,Treatment of Patients With Segmental Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles,Minsk,,Belarus,"November 1, 2022"
210,211,NCT05520112,Recurrent Pregnancy Loss,Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells,Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction|Standard treatment according to the clinical protocols,Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells Capable of Differentiation in the Endometrial-decidual Direction,Minsk,,Belarus,"November 1, 2022"
211,212,NCT03333681,Rheumatoid Arthritis,Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients,Autologous mesenchymal stem cells,Evaluation of Mesenchymal Stem Cell Therapy Effects on the Cellular and Humoral Immune Responses and Additionally Study on the Effect of Chemokines in Homing of the Immune Cells in Refractory Rheumatoid Arthritis Patients,,,,"June 20, 2016"
212,213,NCT01364246,Progressive Multiple Sclerosis|Neuromyelitis Optica.,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica,human umbilical cord mesenchymal stem cells,Phase I/II Study of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica,Nanjing,Jiangsu,China,January 2010
213,214,NCT03929120,Interstitial Lung Disease|Connective Tissue Diseases,Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD),Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs),A Phase I Study to Evaluate the Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for Interstitial Lung Disease in Patients With Connective Tissue Disorders,Jacksonville,Florida,United States,"November 5, 2019"
214,215,NCT01809769,Knee Osteoarthritis,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis,Mesenchymal stem cells low-dose group|Mesenchymal stem cells mid-dose group|Mesenchymal stem cells high-dose group,"Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis by Intra-articular Injection: A PhaseⅠ/Ⅱa, Randomized and Double-blinded Clinical Trial",Shanghai,Shanghai,China,March 2013
215,216,NCT03580291,Lupus Nephritis,Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN),Mesenchymal stem cells|Mycophenolate Mofetil|Placebo of Mesenchymal stem cells|Placebo of Mycophenolate Mofetil,"A Randomized, Double-Blind, Parallel-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells in Patients With Lupus Nephritis",Nanjing,Jiangsu,China,"August 1, 2018"
216,217,NCT02443961,Bronchopulmonary Dysplasia,Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies,Mesenchymal Stem Cell (MSC) therapy,Clinical Trial: Security and Feasibility of Mesenchymal Stem Cell Therapy in Treatment and Prevention of Bronchopulmonary Dysplasia in Preterm Babies,A Coruña|Madrid|Madrid|Valencia,,Spain|Spain|Spain|Spain,"April 2, 2019"
217,218,NCT02668068,Pneumoconiosis,A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells,large volume whole-lung lavage (WLL)|clinical grade umbilical cord mesenchymal stem cells,"A Multicenter, Randomized, Single-blind, Parallel-group Study of Combined Large Volume WLL With Clinical Grade Umbilical Cord Mesenchymal Stem Cells(MSC) Transplantation for Treatment of Pneumoconiosis",Chongqing|Nanjing,Chongqing|Jiangsu,China|China,January 2016
218,219,NCT01456819,Critical Limb Ischemia,Intramuscular Mononuclear Cells and Mesenchymal Stem Cells Transplantation to Treat Chronic Critical Limb Ischemia,Mononuclear and mesenchymal stem cells|Mononuclear cells,Phase II Efficacy Study of Intramuscular Autologous Bone Marrow Mononuclear Cells Plus Mesenchymal Stem Cell Implantation Versus Autologous Bone Marrow Mononuclear Cells Implantation Only in Patients With Chronic Critical Limb Ischemia,Kuala Lumpur,,Malaysia,March 2011
219,220,NCT02749448,Pulmonary Disease,Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients,mesenchymal stem cell,The Effect of Autologous Adipose Mesenchymal Stem Cells in Treatment of Airway Injury in Patients Exposed to Sulfur Mustard,,,,February 2015
220,221,NCT01745744,Critical Limb Ischemia,Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.,Mesenchymal stem cells from adipose tissue,"Clinical Trial Phase I / II, Multicentre, Open, Randomized Study of the Use of Mesenchymal Stem Cells From Adipose Tissue (CeTMAd) as Cell Regeneration Therapy in Critical Chronic Ischemic Syndrome of Lower Limb in Nondiabetic Patients.",Sevilla|Sevilla,,Spain|Spain,February 2011
221,222,NCT02477540,Critical Limb Ischemia,A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia,Cellgram-CLI,"An Open Labeled, Single-center, Phase I Study Assessing the Safety and Efficacy of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia",,,,December 2019
222,223,NCT01461720,Middle Cerebral Artery Infarction,Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct,Standard medical care|Autologous bone marrow-derived mesenchymal stem cells,"An Open Lable, Phase II Exploratory Study Assessing the Efficacy of Intravenous Autologous Mesenchymal Stem Cells in Patients With Middle Cerebral Artery Infarct",Kuala Lumpur,,Malaysia,March 2012
223,224,NCT00911365,Multiple System Atrophy,Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy,autologous mesenchymal stem cells|normal saline,A Double-blind Placebo-controlled Randomized Clinical Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy,Seoul,,"Korea, Republic of",May 2008
224,225,NCT02152657,Spinal Cord Injury,Evaluation of Autologous Mesenchymal Stem Cell Transplantation in Chronic Spinal Cord Injury: a Pilot Study,Mesenchymal stem cell transplantation,,Salvador,Bahia,Brazil,January 2015
225,226,NCT04522869,Primary Biliary Cirrhosis,Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia,Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation,Evaluation Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia: A Matched Control Prospective Study,Hà Nội|Hanoi,Hanoi,Vietnam|Vietnam,"August 10, 2019"
226,227,NCT05522569,"Acute Ischemic Stroke|Mesenchymal Stem Cells|Stroke, Acute|Stroke/Brain Attack|Stroke, Ischemic",Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND),Allogeneic human mesenchymal stem cells (Allo-hMSCs),Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (Allo-hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND),Miami,Florida,United States,
227,228,NCT05127122,"ARDS, Human",Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles|Saline,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Acute Respiratory Distress Syndrome: A Phase I/II Clinical Trial,,,,January 2023
228,229,NCT04594850,Erectile Dysfunction,Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously,Cellgram-ED,"An Single-blind, Multi-center, Randomization, Phase Ⅱ Study to Evaluate Efficacy and Safety of Cellgram-ED (Autologous Bone Marrow-derived Mesenchymal Stem Cells) in Erectile Dysfunction Patients With Following Radical Prostatectomy",Seoul|Seoul|Seoul,,"Korea, Republic of|Korea, Republic of|Korea, Republic of","October 19, 2020"
229,230,NCT01609283,Amyotrophic Lateral Sclerosis,A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis,autologous mesenchymal stem cells,A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis,Rochester,Minnesota,United States,May 2012
230,231,NCT03288571,Diabetic Nephropathies,Use of Wharton Jelly in Diabetic Nephropathy,Wharton Jelly Mesenchymal stem cells,The Safety of Intra-parenchymal Wharton Jelly Mesenchymal Stem Cell Injection in the Treatment of Diabetic Nephropathy,,,,November 2019
231,232,NCT04055415,Pulmonary Hypertension,Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension,adipose derived mesenchymal stem cells|Conventional drug therapy（expectorant，bronchodilator）,Safety and Efficacy of Transplantation of Adipose Derived Mesenchymal Stem Cells to Treat Pulmonary Arterial Hypertension,Liaocheng,Shandong,China,"August 1, 2019"
232,233,NCT02945449,Erectile Dysfunction Associated With Type 2 Diabetes Mellitus,Safety of Wharton Jelly in Erectile Dysfunction,Wharton Jelly Mesenchymal stem cells,Phase Ib: Evaluation of the Safety and as a Secondary End Point the Efficacy for Two Doses of Wharton Jelly Stem Cells for the Treatment of Diabetic Erectile Dysfunction,Amman,,Jordan,"January 4, 2017"
233,234,NCT02375568,Knee Injuries,Large-scale Expansion and Characterization of Mesenchymal Stem Cells for Clinical Application,103024-F,Large-scale ex Vivo Expansion and Characterization of Synovial Membrane Mesenchymal Stem Cells (SM-MSC) and Infrapatellar Fat Pad Mesenchymal Stem Cells (IF-MSC) for Clinical Application,Pan-Ciao,Taipei,Taiwan,May 2014
234,235,NCT03562065,Lupus Erythematosus|Stem Cell Transplant,Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord,mesenchymal stem cells,Treatment of Refractory Systemic Lupus Erythematosus by Injection of Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord,Paris,,France,"September 11, 2019"
235,236,NCT05122234,COVID-19,Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19,Injection of secretome - mesenchymal stem cell|Placebo|Standard treatment of Covid-19,Effectiveness and Safety Profile of Mesenchymal Stem Cell Secretomes as a Treatment for Severe Cases of COVID-19,Jakarta Pusat|Jakarta|Jakarta|Depok,DKI Jakarta|DKI Jakarta|DKI Jakarta|Jawa Barat,Indonesia|Indonesia|Indonesia|Indonesia,"August 10, 2020"
236,237,NCT05240430,COVID-19 Acute Respiratory Distress Syndrome,When to Apply to Which Patient in MSC?,"Mesenchymal Stem Cell Antigen-1, Human","Effectiveness of Mesenchymal Stem Cell in Patients With COVID-19 Associated SARS-CoV-2, Retrospective Clinical Study: When to Apply to Which Patient?",Trabzon,Yomra,Turkey,"January 1, 2022"
237,238,NCT00875654,Ischemia|Stroke,Intravenous Stem Cells After Ischemic Stroke,Autologous mesenchymal stem cells,Cell Therapy by Intravenous Injection of Mesenchymal Stem Cells After Stroke,Grenoble|Grenoble|Grenoble,,France|France|France,August 2010
238,239,NCT02857010,Acute on Chronic Hepatic Failure,Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure,Allogenic mesenchymal stem cells|Placebo,Therapeutic Effects of Allogenic Mesenchymal Stem Cells in Cirrhotic Patients With Acute-on-chronic Liver Failure. A Double-blind Randomized Placebo-controlled Trial,Barcelona,,Spain,February 2016
239,240,NCT01526850,Chronic Graft Versus Host Disease,Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease,Biological: mesenchymal stem cell|Cyclosporine and Glucocorticoid,"Phase Ⅱ/Ⅲ Clinical Trial, Multicenter, Randomized, Controlled, for the Evaluation of Efficacy and Safety of Therapy With Allogenic Mesenchymal Stem Cells in Patients With Chronic Graft Versus Host Disease",Hangzhou,Zhejiang,China,February 2012
240,241,NCT04499105,Degenerative Disc Disease|Low Back Pain|Disc Degeneration,Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients,"Mesenchymal Stem Cell + NaCl 0,9% 2ml",Effectiveness and Safety of Allogenic Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients (Clinical Trial),Jakarta Pusat,DKI Jakarta,Indonesia,"July 24, 2017"
241,242,NCT03371329,Hemorrhagic Stroke|Intracerebral Hemorrhage,Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage,MSC,Safety and Feasibility of Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage,Jacksonville,Florida,United States,"December 12, 2017"
242,243,NCT04432545,Systemic Sclerosis Pulmonary|Pulmonary Hypertension|Pulmonary Fibrosis,Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement,Mesenchymal Stem Cells from Wharton ́s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ́s jelly,Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment,Chía,Chia,Colombia,
243,244,NCT02410239,Cerebral Adrenoleukodystrophy,MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD),Mesenchymal Stem Cells,MT2014-14 Intrathecal Administration of Mesenchymal Stem Cells (IT-MSC) for the Treatment of Advanced Cerebral Adrenoleukodystrophy (cALD),,,,June 2015
244,245,NCT03876197,Radiation Toxicity|Xerostomia Due to Radiotherapy|Dry Mouth|Hyposalivation|Mesenchymal Stem Cells|Mesenchymal Stromal Cells|Long Term Adverse Effects,Mesenchymal Stem Cells for Radiation-induced Xerostomia,Autologous adipose-derived mesenchymal stem/stromal cells|Placebo,Follow-up Study of Safety and Efficacy in Subjects Who Participated in the Study of Intraglandular Mesenchymal Stem Cells in Patients With Radiation-induced Hyposalivation and Xerostomia (MESRIX),Copenhagen,,Denmark,"August 1, 2020"
245,246,NCT00781872,Multiple Sclerosis,Mesenchymal Stem Cells for the Treatment of MS,Injection of autologous bone marrow derived mesenchymal stem cells,Explorative Trial to Investigate the Safety and Clinical Effects of Autologous Mesenchymal Bone Marrow Stem Cells (MSC) Following Their Intrathecal and Intravenous Administration in Severe Cases of Multiple Sclerosis (MS),,,,October 2006
246,247,NCT01440309,Primary Biliary Cirrhosis,Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis,Biological: mesenchymal stem cell|ursodeoxycholic acid,"Phase I Clinical Trial, Randomized, Controlled, to Evaluate the Efficacy and Safety of Therapy With Allogenic Mesenchymal Stem Cells From Bone Marrow for Patients With Refractory Primary Biliary Cirrhosis",Beijing,,China,November 2011
247,248,NCT05495711,"Infertility, Female",hUC Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility,human umbilical cord mesenchymal stem cell complex collagen|intrauterine injection,A Clinical Research on Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-UT) Therapy for Patients With Thin Endometrial Infertility,Changsha,Hunan,China,"May 1, 2020"
248,249,NCT01983709,Prostate Cancer,Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer,Allogeneic Human Mesenchymal Stem Cells,A Phase 1 Study of Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer,Baltimore,Maryland,United States,October 2013
249,250,NCT03487731,Facetogenic Back Pain|Back Pain,Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain,Allogeneic Human Mesenchymal Stem Cells (hMSCs)|Placebo,"A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to EValuate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain",Miami,Florida,United States,"December 1, 2020"
250,251,NCT01257776,Critical Limb Ischemia (CLI)|Diabetes,Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients,Autologous adipose derived mesenchymal stem cells,Using Mesenchymal Stem Cells From Adipose Tissue (CeTMAd) as Cell Regeneration Therapy in Chronic Ischemic Syndrome of Lower Limbs in Diabetic Patients,Seville|Seville,,Spain|Spain,December 2010
251,252,NCT02292628,Faecal Incontinence,"Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence",Infusion of mesenchymal stem cells from adipose tissue|Infusion of placebo,"Study Phase I/II, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence",Huelva|Madrid|Málaga|Sevilla,,Spain|Spain|Spain|Spain,October 2013
252,253,NCT04811651,Ischemic Stroke,Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke,Umbilical Cord-derived Mesenchymal Stem Cells|Placebo,"Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke (UMSIS): a Prospective, Double-blinded, Randomized Controlled, Pilot Study",Shenyang,,China,"March 15, 2021"
253,254,NCT04062136,Bronchopulmonary Dysplasia,Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia,stem cell transplantation,Outcomes of Human Umbilical Cord-derived Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia,Hanoi|Hanoi,,Vietnam|Vietnam,"March 1, 2019"
254,255,NCT04823000,Multiple Sclerosis,Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis,Mesenchymal Stem Cells (MSC),Long Term Clinical and Immunological Effects of Repeated Mesenchymal Stem Cells (MSC) Injections in Patients With Progressive Forms of Multiple Sclerosis (MS),,,,"January 1, 2013"
255,256,NCT04520373,Spinal Cord Injuries|Paralysis,Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients,"Best Medical Management: Occupational and Physical Therapy|Autologous, Adipose Derived Mesenchymal Stem Cells",CELLTOP Part II: A Phase II Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury,Rochester,Minnesota,United States,"June 25, 2020"
256,257,NCT02580019,Stroke,Umbilical Cord Derived Mesenchymal Stem Cells Treatment in Ischemic Stroke,Human umbilical cord mesenchymal stem cells,Cell Therapy by Intravenous Injection of Umbilical Cord Derived Mesenchymal Stem Cells After Stroke,Beijing,Beijing,China,February 2016
257,258,NCT01720888,Ischemic Dilated Cardiomyopathy,Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy,BM-MSCs,A Controlled Open Label Phase II Study Assessing the Efficacy of Intracoronary Autologous Mesenchymal Stem Cells in Patients With Ischemic Dilated Cardiomyopathy,Cheras,Kuala Lumpur,Malaysia,July 2012
258,259,NCT04651855,Amyotrophic Lateral Sclerosis,The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS,Mesenchymal stem cells isolated from Wharton's jelly,The Evaluation of the Effect of Wharton's Jelly Mesenchymal Stem Cells (WJMSCs) on the Immune System of Patients With Amyotrophic Lateral Sclerosis (ALS),Częstochowa,,Poland,"December 2, 2020"
259,260,NCT02677350,Crohn's Disease|Fistulizing Crohn's Disease|Stem Cells,AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE),Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs),"A Phase I, Pilot Trial to Evaluate the Safety and Efficacy of Injection of Allogeneic Mesenchymal Bone-Marrow Derived Human Stem Cells in Patients With Fistulizing Crohn's Disease.",Miami,Florida,United States,"December 1, 2019"
260,261,NCT01854125,Immune Function in Blood|Liver Function in Blood|Variation of Ascites|Characters of Quality of Life|Child-Pugh Score,Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites,autologous bone marrow mesenchymal stem cells transplantation|autologous bone marrow msenchymal stem cells transplantation,Efficacy of Autologous Mesenchymal Stem Cell Transplantation Via Liver Artery in Liver Cirrhosis Patients With Refractory Ascites,Nanjing,Jiangsu,China,May 2013
261,262,NCT02883803,Septic Shock,Treatment of Severe Infections With Mesenchymal Stem Cells,Injection of mesenchymal stem cells|Injection of albumin alone,Effects of Mesenchymal Stem Cells Administration on Organ Failure During Septic Shock: Phase II Randomized Comparator-controlled Study,Dijon|Nancy|Strasbourg|Vandoeuvre-les-Nancy,,France|France|France|France,December 2019
262,263,NCT05018871,Cerebral Palsy,Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP,autologous adipose derived mesenchymal stem cells,Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Cerebral Palsy,Marousi,,Greece,December 2021
263,264,NCT01873625,Rheumatoid Arthritis,Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis,mesenchymal cell transplantation|placebo,Resurfacing Articular Cartilage With Mesenchymal Stem Cells Transplantation in Patients With Knee Joint Osteoarthritis Affected by Rheumatoid Arthritis: Randomized Triple Blind Clinical Trial Phase II/III (ACRCT),Tehran,,"Iran, Islamic Republic of",October 2009
264,265,NCT05018793,Spinal Cord Injuries,Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intrathecal Injection for SCI,autologous adipose derived mesenchymal stem cells,Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intrathecal Injection for the Treatment of Spinal Cord Injury,Marousi,,Greece,December 2021
265,266,NCT01222039,Graft Versus Host Disease|Chronic and Expanded Graft Versus Host Disease|Immune System Diseases,Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.,Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.|Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.,"Multicenter Clinical Trial Phase I/II Randomized, Controlled, for the Evaluation of Safety and Feasibility of Therapy With Two Different Doses of Allogenic Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.",Jerez de la Frontera|Granada.|Sevilla|Valencia,Cádiz.,Spain|Spain|Spain|Spain,June 2010
266,267,NCT04821479,Amyotrophic Lateral Sclerosis,Repeated Mesenchymal Stem Cell Injections in ALS,Mesenchymal stem cells (MSC),Safety and Clinical Effects of Repeated Intrathecal Injections of Autologous Mesenchymal Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS),,,,"January 1, 2016"
267,268,NCT03171194,System; Lupus Erythematosus,Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus,Low Dose Mesenchymal Stem Cells (MSCs),A Phase I Safety Trial of Allogeneic Mesenchymal Stem Cells for Systemic Lupus Erythematosus,Atlanta|Charleston,Georgia|South Carolina,United States|United States,"April 27, 2017"
268,269,NCT04615455,"Keratoconjunctivitis Sicca, in Sjogren's Syndrome",Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome,ASCs|Cryostor CS10,A Randomized Clinical Trial Evaluating Allogeneic Adipose-derived MesenchymAl Stem Cells as a Treatment of Dry Eye Disease in Patients With Sjögren's Syndrome,Copenhagen,DK,Denmark,"November 3, 2020"
269,270,NCT03608592,Acute Respiratory Distress Syndrome,Human Umbilical Cord Mesenchymal Stem Cells (MSCs) Therapy in ARDS,umbilical cord derived mesenchymal stem cells (UCMSCs) suspension|normal saline,Human Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Acute Respiratory Distress Syndrome,Guangzhou,Guangdong,China,"June 1, 2018"
270,271,NCT05152160,Graft Vs Host Disease,Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease,Umbilical Cord Mesenchymal Stem Cell Therapy,Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease,Shenzhen,Guangdong,China,"August 1, 2021"
271,272,NCT03745417,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis,Umbilical cord mesenchymal stem cells,Efficacy and Safety of Expanded Umbilical Cord Mesenchymal Stem Cells On Patients With Moderate to Severe Psoriasis,Guangzhou,Guangdong,China,"August 31, 2021"
272,273,NCT02675556,Treatment Resistant Depression,Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression,Allo-hMSCs|Placebo,"A Phase I, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Treatment Resistant Depression.",Miami,Florida,United States,"October 31, 2017"
273,274,NCT03751735,Erectile Dysfunction Associated With Type 2 Diabetes Mellitus,Efficacy of Wharton Jelly in Erectile Dysfunction,Wharton Jelly Mesenchymal stem cells,Evaluation of the Efficacy for Two Doses of Intracavernous Injection of Wharton Jelly Stem Cells for the Treatment of Diabetic Erectile Dysfunction,Amman,,Jordan,"January 27, 2017"
274,275,NCT04876326,"Multiple System Atrophy|Parkinsonism|Multiple System Atrophy, Parkinson Variant",Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy,Autologous Adipose Mesenchymal Stem Cell Implantation|Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation|Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation,Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy,Jakarta Pusat,DKI Jakarta,Indonesia,"October 5, 2020"
275,276,NCT01610440,Duchenne Muscular Dystrophy,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy,human umbilical cord mesenchymal stem cells,Phase I/II Study of Stem Cell Therapy in Patients With Duchenne Muscular Dystrophy,Kunming,Yunnan,China,October 2011
276,277,NCT04388761,Ischemia Reperfusion Injury,Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI),Allogeneic adipose derived mesenchymal stem cells,Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI),Jacksonville,Florida,United States,"September 28, 2020"
277,278,NCT02403947,Multiple Sclerosis,MEsenchymal StEm Cells for Multiple Sclerosis,Mesenchymal stem cells|Suspension media,Treatment of Multiple Sclerosis With Mesenchymal Stem Cells: Phase I/II Study,Toulouse,,France,February 2015
278,279,NCT01302015,Buerger's Disease,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease,RNL-Vascostem®,Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease,Seoul|Seoul,,"Korea, Republic of|Korea, Republic of",December 2007
279,280,NCT00836732,Pened Chest Surgery for Programmes Coronary Bypass,Mesenchymal Stem Cells: Alterations in Genome,harvest of a small bone marrow sample,MESenchymal Stem Cells: Alterations in GEnome,Nantes,,France,November 2008
280,281,NCT00813969,Relapsing-Remitting Multiple Sclerosis|Secondary Progressive Multiple Sclerosis|Progressive Relapsing Multiple Sclerosis,Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS,Autologous mesenchymal stem cell transplantation,"A Phase I Study to Assess the Feasibility, Safety, and Tolerability of Autologous Mesenchymal Stem Cell Transplantation in Patients With Relapsing Forms of Multiple Sclerosis",Cleveland,Ohio,United States,March 2011
281,282,NCT03521323,Spinal Cord Injuries,Intrathecal Transplantation of UC-MSC in Patients With Early Stage of Chronic Spinal Cord Injury,Umbilical Cord Mesenchymal Stem Cells|Placebos,"The Effect of Intrathecal Transplantation of Umbilical Cord Mesenchymal Stem Cells in Patients With Early Stage of Chronic Spinal Cord Injury：A Multicenter, Randomized, Controlled Trial",Guangzhou,Guangdong,China,"September 1, 2019"
282,283,NCT03521336,Spinal Cord Injury,Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury,Umbilical Cord Mesenchymal Stem Cells|Placebo,"The Effect of Intrathecal Transplantation of Umbilical Cord Mesenchymal Stem Cells in Patients With Sub-Acute Spinal Cord Injury：A Multicenter, Randomized, Controlled Trial",Guangzhou,Guangdong,China,"September 1, 2019"
283,284,NCT01716481,"Stroke, Ischemic",The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study,Mesenchymal stem cell,"Intravenous Administration of Autoserum-cultured Autologous Mesenchymal Stem Cells in Ischemic Stroke: A Single Center, Randomized, Open Label, Prospective, Phase 3 Study",Seoul,,"Korea, Republic of",November 2012
284,285,NCT01914887,Ulcerative Colitis,Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis,Allogeneic adipose tissue-derived mesenchymal stem cells,A Phase I/IIa Clinical Trial to Evaluate Safety and Efficacy of Adipose Tissue-derived Mesenchymal Stem Cells (ASC) on Induction to Remission in Ulcerative Colitis,Madrid,,Spain,June 2013
285,286,NCT04919135,Frailty,Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty,Umbilical Cord Mesenchymal Stem Cells transplantation|standard frailty treatment and supplementary medication,Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation,,,,"July 1, 2021"
286,287,NCT02218437,Complications of Organ Transplant Stem Cells Umbilical Cord,Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived）,MSC+ATG,Child With Severe Aplastic Anemia (SAA) Therapy: the Injection of Umbilical Cord Derived Mesenchymal Stem Cells.,Tianjin,,China,October 2013
287,288,NCT00314483,Graft vs Host Disease,Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease,Mesenchymal Stem Cell Infusion,Evaluation of Potential Mesenchymal Stem Cells for the Treatment of Graft Versus Host Disease Following an Allogeneic Stem Cell Transplant,Vellore,Tamil Nadu,India,June 2007
288,289,NCT05167552,Allergic Rhinitis|Rhinosinusitis Chronic,Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells,Olfactory mucosa-derived mesenchymal stem cells|Standard treatment of type Allergic Rhinitis according to the clinical protocols|Standard treatment of type Chronic Polypous Rhinosinusitis according to the clinical protocols,Treatment of Patients With Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells,,,,"March 1, 2022"
289,290,NCT02643823,Rheumatoid Arthritis,Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis,hUC-MSC + DMARDs|DMARDs,Safety and Efficacy Study of Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis,Shenzhen,Guangdong,China,January 2016
290,291,NCT00891501,Degenerative Arthritis|Chondral Defects|Osteochondral Defects,The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects,Bone Marrow Aspiration|Bone marrow mesenchymal stem cell implantation,The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects,Cairo,,Egypt,November 2006
291,292,NCT02330978,Retinal Degeneration|Primary Open-angle Glaucoma,Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.,Intravitreal transplantation of mesenchymal stem cell|Culture and isolation of autologous bone-marrow mesenchymal stem cells,Intravitreal Autologous Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Patients With Advanced Glaucoma. Phase I: Safety Study.,Ribeirao Preto,Sao Paulo,Brazil,January 2014
292,293,NCT03869229,Knee Osteoarthritis|Hip Osteoarthritis|Glenohumeral Osteoarthritis|Osteoarthritis,Adipose-derived Mesenchymal Stem Cells in Osteoarthritis,Intra-articular injection of ADMSC,"Effectiveness of Adipose-derived Mesenchymal Stem Cells in Patients With Osteoarthritis of the Knee, Hip or Glenohumeral Joint and Analysis of the Regeneration Processes Based on Inflammatory Markers, microRNAs and Clinical Features.",Warsaw,Mazovian,Poland,"April 5, 2019"
293,294,NCT05011474,Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc,Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration,administered an autologous adipose-derived mesenchymal stem cell spheroid pretreated with matrillin 3,Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration,Seongnam-si,Gyeonggi-do,"Korea, Republic of","April 23, 2021"
294,295,NCT02751125,Bone Atrophy,Reconstruction of Jaw Bone Using Mesenchymal Stem Cells,BCP with autologous mesenchymal stem cells (MSC).,Jaw Bone Reconstruction Using a Combination of Autologous Mesenchymal Stem Cells and Biomaterial Prior to Dental Implant Placement,Bergen,Hordaland,Norway,June 2014
295,296,NCT01700920,Osteonecrosis of the Femoral Head,"PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells",bone marrow aspirate,"PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells",Salamanca,Castilla y León,Spain,July 2012
296,297,NCT00603330,Graft-versus-host Disease|Poor Graft Function|Low Donor T-cell Chimerism,Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function,Mesenchymal stem cells,Infusion of Mesenchymal Stem Cells as Treatment for Steroid-Resistant Grade II to IV Acute GVHD or Poor Graft Function: a Multicenter Phase II Study,Edeghem|Brussels|Brussels|Brussels|Leuven|Gent|Haine St Paul|Yvoir|Brugge|Antwerpen|Liege|Maastricht,Antwerpen|Brabant|Brabant|Brabant|Flamish Brabant|Flanders Ost|Hainaut|Namur|West Flanders|Limburg,Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Netherlands,January 2008
297,298,NCT02277145,Post-radiotherapy Pulmonary Fibrosis,A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells,clinical grade umbilical cord mesenchymal stem cells,Phase I Study of Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells,Chongqing,Chongqing,China,October 2014
298,299,NCT01547091,Rheumatoid Arthritis,Safety and Efficacy Study of Umbilical Cord-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis,Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs)|Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)|UC-MSC+DMARDS,Clinical Trial of Umbilical Cord-Derived Mesenchymal Stem Cells Transplantation for Rheumatoid Arthritis-Phase I/II,Xi'an,Shaanxi,China,April 2013
299,300,NCT02068794,Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|Malignant Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma,"MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer",Laboratory Biomarker Analysis|Mesenchymal Stem Cell Transplantation|Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter,Phase I/II Trial of Intraperitoneal Administration of Adipose Tissue Derived Mesenchymal Stem Cells Infected With a NIS-Expressing Derivative Manufactured From a Genetically Engineered Strain of Measles Virus in Patients With Recurrent Ovarian Cancer,Rochester,Minnesota,United States,"March 31, 2014"
300,301,NCT04429763,COVID-19,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,Umbilical cord derived mesenchymal stem cells|Placebo,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19,,,,July 2020
301,302,NCT00476060,Cirrhosis,Mesenchymal Stem Cell Transplantation in Decompensated Cirrhosis,Autologous mesenchymal stem cell transplantation,Autologous Mesenchymal Stem Cell Transplantation in Patients With Decompensated Cirrhosis: A Randomized Placebo-controlled Trial,Tehran,,"Iran, Islamic Republic of",January 2007
302,303,NCT03800810,"Osteoarthritis, Knee",Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management,Hyaluronic Acid|Umbilical Cord Mesenchymal Stem Cell|Recombinant Human Somatropin,Potency of Allogenic Umbilical Cord Mesenchymal Stem Cells for Osteoarthritis Management,Jakarta Pusat,Jakarta,Indonesia,May 2015
303,304,NCT05008588,Ischemic Stroke,Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct,Conditioned Medium|Umbilical Cord Mesenchymal Stem Cells|Neurologic and Neutrophic Drugs,Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Acute Stroke Infarct,Jakarta Pusat|Jakarta,DKI Jakarta,Indonesia|Indonesia,"May 30, 2022"
304,305,NCT03173638,Non Arteritic Ischemic Optic Neuropathy,Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy,intravitreal injection of MSV,Phase II Safety Assessment of Intravitreal Injection of Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy (NAION),Valladolid,,Spain,"March 23, 2018"
305,306,NCT02625246,Bronchiectasis,Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis,hMSCs,"A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell (hMSC) Infusion in Patients With Non-Cystic Fibrosis Bronchiectasis",Miami,Florida,United States,"February 4, 2016"
306,307,NCT01540292,Crohn's Disease,Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders,Mesenchymal Stem Cells (MSC),Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders,Liège,,Belgium,"February 1, 2013"
307,308,NCT00420134,Liver Failure|Cirrhosis,Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial,injection of progenitor of hepatocyte drived from Mesenchymal stem cell,A Phase One/Two Clinical Trial on the Use of Autograft Mesenchymal Stem Cells Differentiated Into Progenitor of Hepatocytes for the Salvage Treatment of Patients With End-stage Liver Disease,Tehran|Tehran,,"Iran, Islamic Republic of|Iran, Islamic Republic of",February 2006
308,309,NCT05329662,Sexual Dysfunction Female,Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female,Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency,Evaluation of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Efficacy for the Treatment of Sexual Function Impairment in Female,Hanoi,,Vietnam,"November 1, 2022"
309,310,NCT04421274,Myocardial Infarction,Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction,Bone marrow mesenchymal stem cells transfer|Best medical treatment|Percutaneous coronary intervention,"Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction: Single-blind, Randomized Controlled Muticentre Trial",Mianyang,Sichuan,China,"May 1, 2008"
310,311,NCT01513694,Intervertebral Disc Disease,Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease,Instrumented posterolateral arthrodesis,"Clinical Trial Phase I / II Prospective, Open, Non-randomized for Treatment of Lumbar Intervertebral Degenerative Disc Disease With Posterolateral Instrumented and Autologous Mesenchymal Stem Cells.",Salamanca,Castilla-León,Spain,January 2010
311,312,NCT01413035,Type 2 Diabetes,Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes,MSC,Safety/Efficacy Assessed Study on Transplantation Therapy Using Human Umbilical Cord/Placenta-derived Mesenchymal Stem Cells for Type 2 Diabetes Mellitus,Jinan,Shandong,China,July 2011
312,313,NCT05362786,Chronic Kidney Diseases,Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease,Allogeneic adipose-derived mesenchymal stem cells (MSC)|Allogeneic adipose-derived mesenchymal stem cells (MSC),Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease,Jacksonville|Rochester,Florida|Minnesota,United States|United States,"July 1, 2022"
313,314,NCT02564328,Stroke,Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke,Intravenous stem cell transplantation,Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke,Guangzhou,Guangdong,China,November 2014
314,315,NCT01389661,Maxillary Cyst|Bone Loss of Substance,Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H),MSV treatment,Regeneration of Maxillary Bone Cystic Cavities by Bio Implant of MSHV-H Cells Associated to a Cross-linked Serum Scaffold,Valladolid|Malaga|Valladolid,Valladid,Spain|Spain|Spain,April 2011
315,316,NCT05284604,Frailty,Mesenchymal Stem Cells for Age-Related Frailty,Mesenchymal Stem Cells (MSCs),A Pilot Study of Mesenchymal Stem Cells as Novel Therapy for Age-Related Frailty in Veterans,Houston,Texas,United States,"October 15, 2022"
316,317,NCT01586312,"Osteoarthritis, Knee|Arthritis of Knee|Knee Osteoarthritis",Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells,Allogenic mesenchymal stromal cells injection|Hyaluronic Acid,Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Mesenchymal Stromal Cells From Valladolid,Barcelona|Valladolid,,Spain|Spain,April 2012
317,318,NCT01076920,Chronic Myocardial Ischemia|Left Ventricular Dysfunction,Mesenchymal Stem Cells and Myocardial Ischemia,Mesenchymal stem cells,Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy,Toulouse,,France,October 2009
318,319,NCT01758055,Emphysema,Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients,Autologous MSCs transplantation,Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells Derived Bone Marrow in Patients With Emphysema,Tehran,,"Iran, Islamic Republic of",December 2012
319,320,NCT02808208,End Stage Renal Disease (ESRD)|Vascular Access Complication,Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure,Single Application of Adipose Derived Mesenchymal Stem Cells (AMSC)|Placebo|Two Applications of Adipose Derived Mesenchymal Stem Cells (AMSC),"A Phase I, Open Label, Randomized Study of Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure",Rochester,Minnesota,United States,"June 7, 2017"
320,321,NCT02462330,Chronic Myocardial Ischemia,Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2),Autologous MSC from bone marrow|Placebo comparator,Effect of Intramyocardial Mesenchymal Stem Cells Injection in Patients With Chronic Ischemic Cardiomyopathy and Left Ventricular Dysfunction Guide by NogaStar XP System Catheter.,Créteil|Grenoble|Lille|Nantes|Paris|Toulouse,,France|France|France|France|France|France,"February 19, 2016"
321,322,NCT01374854,Type 1 Diabetes Mellitus,Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus,Umbilical mesenchymal stem cell (UC-MSCs) infusion|traditional therapy,Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus: A Randomized Controlled Open-label Study,Fuzhou,Fujian,China,January 2009
322,323,NCT04565665,COVID-19 Infection|COVID-19-Associated Acute Respiratory Distress Syndrome|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,Best Practice|Mesenchymal Stem Cell,Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment Acute Respiratory Distress Syndrome,Houston,Texas,United States,"July 29, 2020"
323,324,NCT04315987,COVID-19 Pneumonia,NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,NestaCell®|Placebo,Exploratory Clinical Study to Assess the Efficacy of NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,Campinas|São Paulo|São Paulo|São Paulo,São Paulo,Brazil|Brazil|Brazil|Brazil,June 2020
324,325,NCT01218464,Liver Failure|Mesenchymal Stem Cells,Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure,Conventional plus MSC treatment|Conventional plus pacebo treatment,Phase Ⅰ/Ⅱ Study of Human Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs) for Treatment of Liver Failure,Beijing,Beijing,China,March 2009
325,326,NCT01643681,Lumbar Intervertebral Disc Degeneration,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration,Autologous Adipose Tissue derived MSCs Transplantation,Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration,Seoul,,"Korea, Republic of",July 2012
326,327,NCT02223897,Ischemic-type Biliary Lesions,Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions,huc-MSCs|Placebo,Umbilical Cord Mesenchymal Stem Cells Transplantation for Treatment of Patients With Ischemic-type Biliary Lesions After Liver Transplantation,Guangzhou,Guangdong,China,July 2014
327,328,NCT01142856,Amyotrophic Lateral Sclerosis,Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS),autologous mesenchymal stem cells,A Single Patient Treatment Protocol for Autologous Mesenchymal Stem Cell Intraspinal Therapy in Amyotrophic Lateral Sclerosis (ALS),Rochester,Minnesota,United States,June 2010
328,329,NCT04228666,Alzheimer Disease,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease,HB-adMSCs,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease,Houston,Texas,United States,"March 1, 2020"
329,330,NCT05308836,Type 1 Diabetes,Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment,adipose-derived messenchymal stem cell,Phase I Open Label Clinical Trial to Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment,Hanoi,,Vietnam,"October 4, 2021"
330,331,NCT04280003,Ischemic Stroke|Adipose Tissue-derived Stem Cell|Functional Status,Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke,Alogenic adipose tissue-derived stem cells|Placebo solution,Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke. A Phase IIB Multicenter Double Blind Placebo Controlled Clinical Trial,Madrid,,Spain,"January 20, 2021"
331,332,NCT04314661,"Osteoarthritis, Knee",Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis,Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome|Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome|Non Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome|Non Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome,Innovative Osteoarthritis Therapy Using Combination of Mesenchymal Stem Cell (MSC) and Conditioned Medium (CM): A Comparative Study on Arthroscopy and Non-Arthroscopy,Jakarta Pusat,DKI Jakarta,Indonesia,"August 3, 2020"
332,333,NCT04093336,"Infarction, Middle Cerebral Artery|Infarction, Anterior Cerebral Artery|Cerebral Infarction|Stroke, Ischemic|Acute Stroke|Brain Infarction|Infarction, PCA|Infarction, Posterior Circulation, Brain",Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients,human umbilical cord mesenchymal stem cells|Placebo|standardized treatment,Effect of Human Umbilical Cord Mesenchymal Stem Cells(MSCs) Transplantation for on Prognosis of Acute Cerebral Infarction Patients,Shanghai,Shanghai,China,"January 13, 2019"
333,334,NCT04506073,Parkinson's Disease,Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for iPD,MSC+placebo|MSC|Placebo,"A Randomized, Double-blind, Placebo-controlled Trial of Allogeneic Bone Marrow-derived Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease",Houston,Texas,United States,"November 9, 2020"
334,335,NCT04235868,Mesenchymal Stem Cell-derived Bioactivator for Treating Chronic Wounds,Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Non-healing Wounds,Stem cell-derived derived pleiotropic factor|fibroblast growth factor,Clinical Trial of Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Non-healing Wounds,Beijing,,China,"October 20, 2019"
335,336,NCT01759797,Amyotrophic Lateral Sclerosis,Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALS,intra venous injection of stem cell,Safety of Intravenous Transplantation of Bone Marrow Derived Mesenchymal Stem Cell in Patients With ALS,Tehran,,"Iran, Islamic Republic of",January 2013
336,337,NCT01714167,Stroke,Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Stroke,intracerebral stem cell transplantation,Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Treatment of Chronic Stroke,Wenzhou,Zhejiang,China,June 2012
337,338,NCT02192749,Autism,Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism,Umbilical cord mesenchymal stem cells,"Open, Prospective Trial of Treatment of Autism Spectrum Disorders (ASD) Using Intravenous Infusion of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC)",Panama City,,Panama,July 2014
338,339,NCT00395200,Multiple Sclerosis,Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS),MSC Treatment,Autologous Adult Human Mesenchymal Stem Cells: a Neuroprotective Therapy for Multiple Sclerosis,Cambridge|London,Cambridgeshire,United Kingdom|United Kingdom,July 2008
339,340,NCT02544802,Osteoarthritis Knee,Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee,Adipose-Derived Mesenchymal Stem Cells,Treatment of Primary Osteoarthritis of the Knee Joint With Autologous Mesenchymal Stem Cells,Taipei,,Taiwan,June 2015
340,341,NCT02941666,Osteonecrosis,Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip,,Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip in Patients With Osteonecrosis of the Femoral Head,Rochester,Minnesota,United States,September 2016
341,342,NCT01771640,Amyotrophic Lateral Sclerosis,Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS,intrathecal injection,Intrathecal Transplantation of Autologous Bone Marrow Derived Mesenchymal Stem Cell in Patients With ALS,Tehran,,"Iran, Islamic Republic of",August 2013
342,343,NCT01985464,Rheumatoid Arthritis,Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis,Umbilical cord mesenchymal stem cells,Feasibility Study of Umbilical Cord Tissue Derived Mesenchymal Stem Cells (UC-MSC) in Disease Modifying Anti-Rheumatic Drugs (DMARD) Resistant Rheumatoid Arthritis,Panama City,,Panama,October 2013
343,344,NCT01429038,Liver Failure|Kidney Failure,Mesenchymal Stem Cells After Renal or Liver Transplantation,Mesenchymal Stem Cells,"Infusion of Third-party Mesenchymal Stem Cells After Renal or Liver Transplantation. A Phase I-II, Open-label, Clinical Study",Liege,,Belgium,"February 1, 2012"
344,345,NCT04433104,COPD,Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease,Umbilical Cord Mesenchymal Stem Cells transplantation|drug therapy according to Vietnamese MOHS procedure,"Allogeneic Human Umbilical Cord-derived Mesenchymal Stem/Stromal Cells for Chronic Obstructive Pulmonary Disease (COPD): Study Protocol for a Matched Case-control, Phase I/II Trial",Hà Nội,Hanoi,Vietnam,"June 9, 2020"
345,346,NCT02034188,Multiple Sclerosis,Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis,Umbilical cord mesenchymal stem cells,Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis,Panama City,,Panama,January 2014
346,347,NCT04064879,"Chronic Migraine, Headache",The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine,AD-SVF,The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine,Santa Monica,California,United States,"August 16, 2018"
347,348,NCT03279796,Rotator Cuff Tear|Lateral Epicondylitis,Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells,Autologous adipose-derived MSCs|Compound betamethasone,Autologous Adipose-derived Mesenchymal Stem Cells in the Treatment of Tendon Disease: a Randomized Controlled Trial,Hangzhou,Zhejiang,China,"October 1, 2018"
348,349,NCT04282928,Severe Pneumonia,Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral Pneumonian,Human umbilical cord mesenchymal stem cells|Routine treatment,"A Singlecenter, Randomized, Open Lable, Intervention Controlled Clinical Study on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral Pneumonia",Shanghai,Shanghai,China,February 2020
349,350,NCT00250302,Tibial Fracture,Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures,autologous mesenchymal stem cells implantation,Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures,Jerusalem,,Israel,April 2009
350,351,NCT02957552,Pediatric Liver Transplantation,Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation,Mesenchymal Stem Cells,"Safety and Tolerance of Immunomodulating Therapy With Donor-specific Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation, a 24-month, Non-randomized, Open-label, Prospective, Single-center Pilot Trial",Tuebingen,,Germany,"March 10, 2017"
351,352,NCT03259217,Stem Cell Transplant,Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers,Stem Cell Product,Prospects of Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers,,,,October 2017
352,353,NCT00587990,"Stem Cell Transplantation|Ventricular Dysfunction, Left",Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS),Lower dose mesenchymal stem cell (MSC) injection|Placebo|Higher dose MSC injection,"A Phase I/II, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Intramyocardial Injection of Autologous Human Mesenchymal Stem Cells (MSCs) in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction (MI) Undergoing Cardiac Surgery for Coronary Artery Bypass Grafting (CABG)",Miami|Baltimore,Florida|Maryland,United States|United States,November 2007
353,354,NCT03798353,Myocardial Infarction,Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue,PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.|Surgery by sternotomy,Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue (The PERISCOPE Trial),Badalona,Barcelona,Spain,"May 13, 2019"
354,355,NCT04392206,End Stage Renal Disease,AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses,Adipose Derived Mesenchymal Stem Cells,"A Phase I, Open Label Study of Allogeneic Adipose Derived Mesenchymal Stem Cells in Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses",Jacksonville,Florida,United States,"May 15, 2020"
355,356,NCT00823316,Acute Leukemia,Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation,Human umbilical cord blood-derived mesenchymal stem cells|Human umbilical cord blood-derived mesenchymal stem cells,Phase 1/2 Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells Infusion for Promotion of Engraftment and Prevention of an Graft Rejection and Graft-versus-Host Disease After Unrelated Hematopoietic Stem Cell Transplantation.,Seoul,,"Korea, Republic of",August 2008
356,357,NCT03945487,Decompensated Liver Cirrhosis,Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis,umbilical cord-derived mesenchymal stem cell|Comprehensive treatment,Safety and Efficacy of Human Unbilical Cord Derived-mesenchymal Stem Cells Treatment for Patients With Decompensated Liver Cirrhosis,Beijing,,China,"May 20, 2019"
357,358,NCT04312113,Ulcerative Colitis,Angiographic Delivery of AD-MSC for Ulcerative Colitis,"Adipose derived, autologous mesenchymal stem cells",A Phase I Single Site Open Label Study of Intra-arterial Delivery of Mesenchymal Stem Cells for Luminal Ulcerative Colitis,Rochester,Minnesota,United States,"November 16, 2020"
358,359,NCT03477942,Musculoskeletal Pain|Knee Osteoarthritis|Cartilage Injury|Cartilage Degeneration,Impact of Mesenchymal Stem Cells in Knee Osteoarthritis,Autologous Mesenchymal Stem Cells,A Phase I Single Center Open Study to Assess the Safety and Efficacy of Intra-articular Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis and Chondral Defects of the Knee,Cleveland,Ohio,United States,"October 1, 2018"
359,360,NCT04224207,Retinitis Pigmentosa|Inherited Retinal Dystrophy,Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells,Wharton's jelly derived mesenchymal stem cell,Management of Retinitis Pigmentosa by Wharton's Jelly Derived Mesenchymal Stem Cells: Preliminary Clinical Results,Ankara|Ankara,Türkiye|Türkiye,Turkey|Turkey,"April 1, 2019"
360,361,NCT01183728,"Osteoarthritis, Knee|Knee Degenerative Disease|Knee Osteoarthritis",Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells,Autologous bone marrow mesenchymal stem cells (MSV),"Regeneration of Articular Cartilage in Grade II, III and IV Knee Osteoarthritis by Intraarticular Injection of Autologous Bone Marrow Stem Cells Expanded ex Vivo With a GMP Procedure Developed by IBGM-Valladolid (MSV)",Barcelona|Valladolid,,Spain|Spain,May 2010
361,362,NCT04869761,"Chronic Kidney Diseases|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Diabetes Mellitus|Diabetic Nephropathies",Stem Cell Therapy for Chronic Kidney Disease,Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion|Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions,Allogeneic Mesenchymal Stem Cell Therapy in Patients With Chronic Kidney Disease: A Phase I Study,Jacksonville|Rochester,Florida|Minnesota,United States|United States,"October 7, 2021"
362,363,NCT04326959,Keloid,"Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid",Umbilical Cord-Mesenchymal Stem Cells and Conditioned Medium|Conditioned Medium|Triamcinolone Acetonide,"Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid Regression: Immunohistochemistry, Histopathology and Imaging Study",,,,"September 1, 2020"
363,364,NCT04898088,COVID-19 Pneumonia,A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients,Mesenchymal Stem Cells Transplantation,A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients,Istanbul|Istanbul,,Turkey|Turkey,"January 1, 2020"
364,365,NCT02298023,Rotator Cuff Tear,Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear),allogenic adipose stem cell injection|fibrin glue/normal saline injection|normal saline injection,Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells: Phase II Double-Blind Placebo-Controlled Randomized Clinical Trials.,Seoul,,"Korea, Republic of",September 2014
365,366,NCT01552707,"Lumbar Spondylolisthesis Involving L4-L5, and/or|Degenerative Discopathy Involving L4-L5",Safety Study of Mesenchymal Stem Cells and Spinal Fusion,XCEL-MT-OSTEO-ALPHA|Standard treatment,"""Ex Vivo"" Expanded Autologous Bone Marrow Mesenchymal Stem Cells Fixed in Allogenic Human Bone Tissue for Spinal Fusion in Spine Degenerative Disease",Badalona|Barcelona|Barcelona|Barcelona|Barcelona,Barcelona,Spain|Spain|Spain|Spain|Spain,"July 19, 2012"
366,367,NCT03673748,Lupus Nephritis|Lupus Erythematosus,Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells,Mesenchymal stromal cells (MSC)|Placebo,A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Lupus Nephritis,Valladolid,,Spain,December 2022
367,368,NCT02881489,Amyotrophic Lateral Sclerosis,Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis,Biological: Cell-based therapy,Evaluation of Mesenchymal Stem Cell Culturing Protocols in the Treatment of Amyotrophic Lateral Sclerosis,,,,November 2015
368,369,NCT02981576,Spinal Cord Injuries,Safety and Effectiveness of BM-MSC vs AT-MSC in the Treatment of SCI Patients.,Autologous Mesenchymal Stem Cells,Comparative Evaluation of Safety and Effectiveness of Autologous Bone Marrow Derived Mesenchymal Stem Cells (BM-MSC) vs Adipose Tissue Derived Mesenchymal Stem Cells (AT-MSC) in the Treatment of Spinal Cord Injury (SCI) Patient.,Amman,,Jordan,November 2016
369,370,NCT00447460,Graft-vs-Host Disease (GVHD),Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell,Mesenchymal stem cell (MSC),A Phase I/II Trial in Treating Patients With Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell,Navarra|Barcelona|Barcelona|Salamanca,Pamplona,Spain|Spain|Spain|Spain,January 2007
370,371,NCT04153630,"Epidermolysis Bullosa Dystrophica, Recessive",Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa,mesenchymal stem cells derived from bone marrow (BM-MSCs),Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa,Madrid,,Spain,"May 17, 2018"
371,372,NCT01549665,Graft-Versus-Host Disease|GVHD|Allogeneic Hematopoietic Transplant|Disorder Related to Transplantation,Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease,Human umbilical cord blood-derived mesenchymal stem cells,Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease,Seoul,,"Korea, Republic of",January 2012
372,373,NCT05262829,Crohn Disease,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease,Human Umbilical Cord Mesenchymal Stem Cells,"A Single-arm, Open-label Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Refractory Moderate to Severe Crohn's Disease",Shanghai,Pudong New Area,China,"February 28, 2022"
373,374,NCT01668576,Lung Transplantation,Properties of Mesenchymal Stem Cells in Lung Transplant,,Properties of Mesenchymal Stem Cells in Lung Transplant Candidates,Atlanta,Georgia,United States,August 2012
374,375,NCT02338271,Low Back Pain,Autologous Adipose Derived Stem Cell Therapy for Intervertebral Disc Degeneration,autologous adipose derived mesenchymal stem cell,Safety and Efficacy Study of Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration,Seongnam-si,Gyeonggi-do,"Korea, Republic of",January 2015
375,376,NCT03570333,Gingival Recession|Lack of Keratinized Gingiva (Disorder),Progenitor Potential of Mesenchymal Stem Cells in Palatal Tissue Harvested From Molar and Premolar Sites,progenitor potential of Gingival Mesenchymal cells,Identification and Application of Gingival Mesenchymal Stem Cells for Dental Tissue Regeneration.,Birmingham,Alabama,United States,"September 17, 2018"
376,377,NCT01092026,Allogeneic Stem Cell Transplantation,Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells,cord blood transplantation,A Pilot Study to Assess the Feasibility of Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Third-party Mesenchymal Stem Cells After Myeloablative or Nonmyeloablative Conditioning in Patients With Hematological Malignancies,Brussel,,Belgium,November 2010
377,378,NCT02035514,Relapsing Remitting Multiple Sclerosis (RRMS),Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis,Bone marrow autologous mesenchymal stem cells transplantation,Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis,Badalona,Barcelona,Spain,December 2013
378,379,NCT05442437,HBV,Human Umbilical Cord Mesenchymal Stem Cells for Treating HBV Clinical Study,hUCMSCs,Human Umbilical Cord Mesenchymal Stem Cells for Treating HBV Clinical Study,Wuhan,Hubei,China,"September 8, 2019"
379,380,NCT01499056,Hip Osteoarthritis,Mesenchymal Stem Cell Transplantation in Osteoarthritis of Hip Joint,stem cell injection,Evaluation the Side Effect of Bone Marrow Derived Mesenchymal Stem Cell in Patients With Osteoarthritis of Hip Joint,Tehran,,"Iran, Islamic Republic of",June 2010
380,381,NCT03181087,Uterine Scar,Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars,Umbilical cord MSCs,"A Phase I, Single-arm, Open Study of the Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",Foshan,Guangdong,China,"December 11, 2021"
381,382,NCT04314011,Aging Frailty,Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty,Human umbilical cord mesenchymal stem cells（HUC-MSCs）|Placebo,"A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty",Shanghai,,China,"June 1, 2020"
382,383,NCT03308565,Spinal Cord Injuries|Paralysis,Adipose Stem Cells for Traumatic Spinal Cord Injury,"Autologous, Adipose derived Mesenchymal Stem Cells",Phase I Clinical Trial of Autologous Adipose Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury,Rochester,Minnesota,United States,"December 5, 2017"
383,384,NCT03414697,Cerebral Palsy,Transplantation of Umbilical Cord-derived Mesenchymal Stem Cells Via Different Routes,Control group|UC-MSCs,Transplantation of Umbilical Cord-derived Mesenchymal Stem Cells Via Different Routes for the Treatment of Cerebral Palsy in Children,Dalian,Liaoning,China,April 2018
384,385,NCT01958502,Nonunion of Fracture,Evaluation the Treatment of Nonunion of Long Bone Fracture of Lower Extremities (Femur and Tibia) Using Mononuclear Stem Cells From the Iliac Wing Within a 3-D Tissue Engineered Scaffold,surgical treatment of non union with mesenchymal stem cells with BMP2 within a 3-D tissue engineered scaffold,,Mashhad,Khorasan,"Iran, Islamic Republic of",July 2013
385,386,NCT02688049,Spinal Cord Injury,NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair,NeuroRegen scaffold/mesenchymal stem cells transplantation|NeuroRegen scaffold/neural stem cells transplantation,The Efficacy and Safety of NeuroRegen Scaffold™ Combined With Mesenchymal Stem Cells or Neural Stem Cells for Chronic Spinal Cord Injury Repair,Tianjin,,China,January 2016
386,387,NCT04543994,Ulcerative Colitis,Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC),Remestemcel-L|Remestemcel-L|Placebo,"A Phase IB/IIA Study of Remestemcel-L, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cell Product, for the Treatment of Medically Refractory Ulcerative Colitis",Cleveland,Ohio,United States,"November 10, 2020"
387,388,NCT03326505,Multiple Sclerosis,Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment,Umbilical cord derived Mesenchymal Stem Cells|Supervised physical therapy,The Effect of Stem Cell Therapy and Comprehensive Physical Therapy in Motor and Non-Motor Symptoms in Patients With Multiple Sclerosis: A Comparative Study.,Amman|Amman,,Jordan|Jordan,"September 25, 2017"
388,389,NCT02237846,Osteoarthritis of the Knee,Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis,Human umbilical cord tissue-derived mesenchymal stem cells,Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis,Panama City,,Panama,September 2014
389,390,NCT02985346,Idiopathic Pulmonary Hemosiderosis,Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis,Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis,Sun Yat-sen Memorial Hospital,,,,January 2017
390,391,NCT02574585,Spinal Cord Injury,Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury Spinal Cord Injury,Autologous mesenchymal cells transplantation,Randomized Clinical Trial for the Evaluation of Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury,,,,December 2019
391,392,NCT02855112,"Infantile Spinal Muscular Atrophy, Type I [Werdnig- Hoffman]",Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients,Adipose derived mesenchymal stem cell,The Effectiveness of Allogeneic Adipose Derived Mesenchymal Stem Cells (ADMSCs) in the Phenotypic Changes of Werdnig Hoffman Patients,Tehran,,"Iran, Islamic Republic of",June 2015
392,393,NCT00366145,Graft Versus Host Disease,Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD),Prochymal®|Placebo|Standard of Care for GVHD,"A Phase III, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD",Birmingham|Tucson|Duarte|San Francisco|New Haven|Miami|Saint Petersburg|Atlanta|Atlanta|Chicago|Chicago|Chicago|Beech Grove|Iowa City|Kansas City|Louisville|Shreveport|Baltimore|Boston|Boston|Boston|Detroit|Rochester|Jackson|Omaha|Hackensack|Buffalo|New York|New York|New York|Rochester|Valhalla|Durham|Winston-Salem|Portland|Hershey|Pittsburgh|Charleston|Dallas|Dallas|Dallas|Houston|San Antonio|Richmond|Seattle|Madison|Milwaukee|Herston|Parkville|Perth|Calgary|Vancouver|Winnipeg|Halifax|Hamilton|London|Ottawa|Toronto|Toronto|Montreal|Quebec|Quebec|Pesaro|Pavia|Basel|London|Headington|Bristol|Glasgow|Leeds,Alabama|Arizona|California|California|Connecticut|Florida|Florida|Georgia|Georgia|Illinois|Illinois|Illinois|Indiana|Iowa|Kansas|Kentucky|Louisiana|Maryland|Massachusetts|Massachusetts|Massachusetts|Michigan|Minnesota|Mississippi|Nebraska|New Jersey|New York|New York|New York|New York|New York|New York|North Carolina|North Carolina|Oregon|Pennsylvania|Pennsylvania|South Carolina|Texas|Texas|Texas|Texas|Texas|Virginia|Washington|Wisconsin|Wisconsin|Queensland|Victoria|Western Australia|Alberta|British Columbia|Manitoba|Nova Scotia|Ontario|Ontario|Ontario|Ontario|Ontario|Quebec|PU|England|Oxford|UK|UK|UK,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|Australia|Australia|Australia|Canada|Canada|Canada|Canada|Canada|Canada|Canada|Canada|Canada|Canada|Canada|Canada|Italy|Italy|Switzerland|United Kingdom|United Kingdom|United Kingdom|United Kingdom|United Kingdom,"August 17, 2006"
393,394,NCT02304588,Diabetic Foot|Lower Limb Ischemia,Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot,Mesenchymal stem cells,Vascular Occlusive Diseases Such as Diabetic Foot Treated With Mesenchymal Stem Cell,Beijing,Beijing,China,January 2013
394,395,NCT04657458,Covid19|ARDS|Hypoxia|Cytokine Storm,A Global Expanded Access Protocol on Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion Treatment for Patients With COVID-19 Associated ARDS,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment: A Global Expanded Access Protocol for Patients With COVID-19 Associated ARDS Who Do Not Qualify for Phase II Randomized Control Trial,,,,
395,396,NCT03816852,Premature Ovarian Failure,The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency,hucMSCs,Clinical Study on the Safety and Effectiveness of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency,Zhengzhou,Henan,China,"October 1, 2018"
396,397,NCT02770430,Graft vs Host Disease,Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease,mesenchymal stem cells|conventional treatment,"A Phase II, Randomized Study to Evaluate the Human Mesenchymal Stem Cells as a First-line Treatment for aGVHD in Patients Steroids Resistant.",Porto Alegre,Rio Grande do Sul,Brazil,September 2015
397,398,NCT04371601,COVID-19 Pneumonia,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,Oseltamivir|hormones|oxygen therapy|mesenchymal stem cells,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,Fuzhou,Fujian,China,"March 1, 2020"
398,399,NCT03361631,"Erectile Dysfunction|Stem Cells|Diabetes Mellitus, Type 1",Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes,Autologous Bone Marrow derived Mesenchymal Stem Cells,Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Curative Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes: Dose Escalation Trial,,,,"June 30, 2018"
399,400,NCT01860417,Degenerative Disc Disease|Intervertebral Disc Disease|Low Back Pain,Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV),Allogenic Mesenchymal Stromal Cells|Mepivacaine,Treatment of Lumbar Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV*) *MSV: Bone Marrow Mesenchymal Stromal Cells Expanded Using the Valladolid IBGM Procedure,Valladolid|Valladolid,,Spain|Spain,April 2013
400,401,NCT02611167,Parkinson's Disease,Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease,Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg)|Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg)|Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg)|Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg),Pilot Phase I Study of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease,Houston,Texas,United States,"November 1, 2017"
401,402,NCT03874572,Xerostomia Due to Radiotherapy|Hyposalivation|Xerostomia|Oropharynx Cancer|Salivary Gland Diseases|Dry Mouth|Mesenchymal Stem Cells|Mesenchymal Stromal Cells|Stem Cells,Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth,Allogeneic adipose derived stem/stromal cells,A Phase I Open Label Study Evaluating the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia in Previous Oropharynx Cancer Patients,Copenhagen|Copenhagen,,Denmark|Denmark,"March 18, 2019"
402,403,NCT03265613,Mesenchymal Stromal Cells|Psoriasis|Drug Toxicity|Drug Effect,Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis,adipose-derived multipotent mesenchymal stem cells,Safety and Efficacy of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis,Guangzhou,Guangdong,China,"September 24, 2017"
403,404,NCT05413148,Retinitis Pigmentosa,The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa,Subtenon injection of Wharton jelly derived mesenchymal stem cells|Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes|Placebo,The Effect of Wharton Jelly-derived Mesenchymal Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa,Kayseri,,Turkey,"August 5, 2022"
404,405,NCT02034786,Lipodystrophies|Aesthetics Procedure,Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic Acid,Adipose tissue collection|Transdermal injection|Transdermal injection,Phase I Study of a Filler Agent Composed of Mesenchymal Stem Cells Obtained From Autologous Adipose Tissue Associated With Hyaluronic Acid,Rio de Janeiro,,Brazil,March 2015
405,406,NCT01207869,Bronchopulmonary Dysplasia|Extremely Premature Infants|Severe BPD That Conventional Therapies Has Failed|No Severe Congenital Anomalies|no Severe IVH Neither Cystic PVL,Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia,ucMSCs|Normal saline,Intratracheal Instillation of Umbilical Cord-derived Mesenchymal Stem Cells as a Rescue Treatment for Severe Bronchopulmonary Dysplasia,"Taichung,",,Taiwan,July 2010
406,407,NCT04314687,Cerebral Palsy,Stem Cell and Conditioned Medium for Cerebral Palsy,Umbilical Cord Mesenchymal Stem Cells|Conditioned Medium|Standard Therapy,Allogeneic Umbilical Cord Mesenchymal Stem Cells and Conditioned Medium for Cerebral Palsy in Children,Jakarta,,Indonesia,"October 13, 2021"
407,408,NCT02108132,Hemophilia,Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia,Cellular therapy|cellular therapy,Allogenic Mesenchymal Stem Cells in Hemophilia: a Pilot Study,Cairo,,Egypt,August 2014
408,409,NCT04548583,Crohn Colitis,Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis,Remestemcel-L|Remestemcel-L|Placebo,"A Phase IB/IIA Study of Remestemcel-L, an Ex-vivo Culture-expanded Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cell Product for the Treatment of Medically Refractory Crohn's Colitis",Cleveland,Ohio,United States,"November 4, 2020"
409,410,NCT01162915,Spinal Cord Injury,Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury,Autologous bone marrow-derived mesenchymal stem cells.,"Phase I, Single Center, Trial to Asses Safety and Tolerability of the Intrathecal Infusion of Ex-vivo Expanded Bone-marrow Derived Mesenchymal Stem Cells for the Treatment of Spinal Cord Injury",Covington,Louisiana,United States,July 2010
410,411,NCT02594839,Idiopathic Interstitial Pneumonia|Interstitial Lung Disease|Idiopathic Pulmonary Fibrosis,Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease,Bone marrow mesenchymal stem cells|Placebo,A Phase I-II Study to Evaluate Safety and Efficacy of Allogeneic Bone-Marrow Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease,Moscow,,Russian Federation,February 2013
411,412,NCT03458156,Lupus Nephritis,Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis,SLE group|LN group|the control group,Clinical Study of Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis,,,,January 2017
412,413,NCT04592640,Chronic Kidney Diseases|Calciphylaxis|Calcific Uremic Arteriolopathy|Treatment,Stem Cells for Uremic Calciphylaxis Patients,Human amniotic mesenchymal stem cells,Effects of Human Amniotic Mesenchymal Stem Cells (hAMSCs) on Wound Healing in Uremic Calciphylaxis Patients: an Open Label Single Arm Study,Nanjing,Jiangsu,China,"September 17, 2018"
413,414,NCT04602104,Acute Respiratory Distress Syndrome,A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS,low dose hMSC-Exos|medium dose hMSC-Exos|high dose hMSC-Exos|Dosage 1of hMSC-Exos|Dosage 2 of hMSC-Exos|No hMSC-derived exosomes,"A Multiple, Randomized, Double-blinded, Controlled Clinical Study of Allogeneic Human Mesenchymal Stem Cell Exosomes (hMSC-Exos) Nebulized Inhalation in the Treatment of Acute Respiratory Distress Syndrome",Shanghai,Shanghai,China,"November 30, 2020"
414,415,NCT02315027,MSA,Mesenchymal Stem Cell Therapy in Multiple System Atrophy,Autologous Mesenchymal Stem Cells|Autologous Mesenchymal Stem Cells|Autologous Mesenchymal Stem Cells|Autologous Mesenchymal Stem Cells|Autologous Mesenchymal Stem Cells,Intrathecal Autologous Mesenchymal Stem Cell Therapy in Multiple System Atrophy (MSA) - Effect of Dose and Natural History,Rochester,Minnesota,United States,October 2012
415,416,NCT02307435,Non Union Fracture|Metaphyseal Fibrous Defect,Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture,MSC,"Potency of Allogenic Bone Marrow, Umbilical Cord, Adipose Mesenchymal Stem Cell for Non Union Fracture and Long Bone Defect, Directly and Cryopreserved",Jakarta Pusat|Propinsi DKI Jakarta,Jakarta|Jakarta,Indonesia|Indonesia,August 2014
416,417,NCT05016011,"Osteoarthritis, Knee",Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury,Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)|Marrow cellution,Phase IIb Study Assessing the Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells for Knee Cartilage Injury,Bandar Tun Razak,Wilayah Persekutuan Kuala Lumpur,Malaysia,"July 1, 2020"
417,418,NCT02833792,Alzheimer Dementia,Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease,Human Mesenchymal Stem Cells and Lactated Riunger's Solution|Placebo,A Phase IIa Study of Allogeneic Human Mesenchymal Stem Cells in Subjects With Mild to Moderate Dementia Due to Alzheimer's Disease,Santa Monica,California,United States,June 2016
418,419,NCT03237442,Ocular Corneal Burn,Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn,human umbilical cord mesenchymal stem cells|placebo,"Placebo-Controlled,Randomized,Double-blind Trial of Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn",Guangzhou,Guangdong,China,"January 1, 2018"
419,420,NCT02893306,Type 1 Diabetes Mellitus,MSC Administration for the Management of Type 1 Diabetic Patients,MSCs,Phase 2 Study of Intravenous Administration of Allogeneic Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus.,Santiago,Region Metropolitana,Chile,March 2012
420,421,NCT03692221,Disc Degeneration,Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease,MSC Treatment group 1 (low dose)|MSC Treatment group 2 (high dose)|Healthy Control (no treatment),Percutaneous Image Guided Delivery of Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Symptomatic Degenerated Intervertebral Disc Disease,Cleveland,Ohio,United States,June 2019
421,422,NCT00114452,Myocardial Infarction,Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction,Provacel|Placebo,"A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose Escalation, Multicenter Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction",Phoenix|San Diego|Washington|Chicago|Indianapolis|Louisville|Baltimore|Takoma Park|Minneapolis|New York|Rochester|Oklahoma City|Philadelphia|Austin|Houston,Arizona|California|District of Columbia|Illinois|Indiana|Kentucky|Maryland|Maryland|Minnesota|New York|New York|Oklahoma|Pennsylvania|Texas|Texas,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States,"March 22, 2005"
422,423,NCT01724398,Liver Failure,Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure,Conventional plus UC-MSC treatment|Conventional plus PE treatment|Conventional plus UC-MSC and PE therapy|Conventional treatment,Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Acute-on-Chronic Liver Failure Caused by Hepatitis B Virus (HBV),Guangzhou,Guangdong,China,November 2012
423,424,NCT03044119,Dental Implants,The Effect of Platelet Rich Fibrin Matrix With and Without Peripheral Blood Mesenchymal Stem Cells on Implant Stability,Dental Implant with PRFM|Dental Implant with PRFM and PBMSCs,A Comparative Evaluation of the Effect of Platelet Rich Fibrin Matrix With and Without Peripheral Blood Mesenchymal Stem Cells on Implant Stability : A Randomized Controlled Clinical Trial,Bengaluru,Karnataka,India,"March 15, 2018"
424,425,NCT01322906,Liver Failure,Allogeneic Bone Marrow Mesenchymal Stem Cells Transplantation in Patients With Liver Failure Caused by Hepatitis B Virus (HBV),Group 1|Group 2|Group 3,Allogeneic Bone Marrow Mesenchymal Stem Cells Transplantation in Patients With Liver Failure Caused by HBV,,,,March 2011
425,426,NCT05319106,Venous Leg Ulcer,Phase Ⅱ Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Venous Leg,stem cell preparation combined with silver ion dressing|silver ion dressing,Transplantation of Human Umbilical Cord Derived Mesenchymal Stem Cell for Refractory Skin Ulcer Therapy,Chongqing,Chongqing,China,"April 1, 2022"
426,427,NCT04146519,Transplantation:Mesenchymal Stem Cell Transplantation,Parkinson's Disease Therapy Using Cell Technology,Autologous mesenchymal stem cells|Placebo,Developent and Implement a Method of Parkinson's Disease Therapy Using Cell Technology,Minsk,,Belarus,"July 1, 2017"
427,428,NCT01213953,Lower Back Pain|Disc Degeneration,Isolation and Authentication of Mesenchymal Stem Cell-like Progenitor Cells From the Degenerated Intervertebral Disc of Lumbar Spine,,Isolation and Authentication of Mesenchymal Stem Cell-like Progenitor Cells From the Degenerated Intervertebral Disc of Lumbar Spine,Taipei,,Taiwan,September 2010
428,429,NCT01323894,Primary Disease,Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling,,Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling/Hydroxyapatite Nanoparticles--Comparisons Between Non-viral and Viral Administration in Tissue Engineered Bone Regeneration,Taichung,,Taiwan,August 2011
429,430,NCT04654286,Brachial Plexus Neuropathies,Human Amniotic Membrane and Mesenchymal Stem Cells Composite,Nerve transfer procedure|Nerve transfer with HAM-AdMSC composite wrapping,Clinical Outcomes of Human Amniotic Membrane and Allogeneic Mesenchymal Stem Cells Composite Augmentation for Nerve Transfer Procedure in Brachial Plexus Injury Patients,Surabaya,East Java,Indonesia,"November 17, 2016"
430,431,NCT03137979,Periodontitis,Gingiva Mesenchymal Stem Cells Treatment of Chronic Periodontitis,GMSCs and collagen scaffolds|Collagen scaffolds|Open flap debridement,The Safety and Efficacy Evaluation of Gingiva Mesenchymal Stem Cells Transplantation in Chronic Periodontitis Patients,Shijiazhuang,Hebei,China,January 2017
431,432,NCT05187936,Hemophilia A|Hemophilia B|Arthropathy,Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy,,Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy,Montpellier,,France,"October 1, 2021"
432,433,NCT04692376,Chronic Graft-versus-host Disease,MSC for Treatment of cGVHD After Allo-HSCT,Mesenchymal stem cells|Glucocorticoids|cyclosporine,Mesenchymal Stem Cell for Treatment of Chronic Graft-versus-host Disease After Allogenetic Hematopoietic Stem Cell Transplantation,Guangzhou,Guangdong,China,"January 10, 2021"
433,434,NCT02408432,Cardiomyopathy|Heart Failure,Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines,Laboratory Biomarker Analysis|Standard of Care|Mesenchymal Stem Cell Transplantation,Intravenous Administration of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) in Patients With Recent Onset Anthracycline-Associated Cardiomyopathy,Houston,Texas,United States,"January 11, 2016"
434,435,NCT03648463,"Cartilage Degeneration|Rotator Cuff Tear|Osteoarthritis, Knee",Use of MRI Labeling Technique to Track Mesenchymal Stem Cell Survival in Orthopaedic Conditions,arthroscopy of the affected knee/ Bone Marrow Concentrate Injection,Effect of Surgical Intervention on Mesenchymal Stem Cell Survival in Soft Tissue Reconstructive Procedures Using a Novel MRI Labeling Technique,,,,"October 1, 2019"
435,436,NCT05499156,Perianal Fistula in Patients With Crohn's Disease,Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients,placenal MSC derived exosomes,Safety of Injection of Placental Mesenchymal Stem Cell Derived Exosomes for Treatment of Resistant Perianal Fistula in Crohn's Patients,Tehran,,"Iran, Islamic Republic of","January 20, 2022"
436,437,NCT03437759,Macular Holes,MSC-Exos Promote Healing of MHs,exosomes derived from mesenchymal stem cells (MSC-Exo),Mesenchymal Stem Cells Derived Exosomes Promote Healing of Large and Refractory Macular Holes,Tianjin,,China,"March 1, 2017"
437,438,NCT03955497,Knee Osteoarthritis|Cartilage Degeneration,Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury,Autologous Adipose-derived Mesenchymal Stem Cell Gel|Sodium Hyaluronate|Extraction of abdominal fat,Efficacy and Safety Research of Autologous Adipose-derived Mesenchymal Stem Cell Gel in the Treatment of Cartilage Damage in the Knee,Jinan,Shandong,China,"October 1, 2018"
438,439,NCT03265808,Major Depressive Disorder|Alcohol Use Disorder,Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.,allogeneic human mesenchymal stem cells (allo-hMSCs)|Placebo,"A Phase I/II, Prospective, Randomized, Double-Blind, PlAcebo-ControLled Trial to EvAluate the Potential Efficacy of Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.",Harlingen,Texas,United States,"March 18, 2018"
439,440,NCT03102879,Periapical Periodontitis,Encapsulated Mesenchymal Stem Cells for Dental Pulp Regeneration.,Regenerative Endodontic Procedure|Conventional Root Canal Treatment,Encapsulated Mesenchymal Stem Cells for Endodontic Treatment of Permanent Teeth With Apical Lesion: a Controlled Clinical Trial.,Santiago,,Chile,"September 23, 2016"
440,441,NCT02065245,Frailty,AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery,Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)|Placebo|Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs),"A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty",Miami,Florida,United States,"March 3, 2014"
441,442,NCT00136903,Graft Vs Host Disease,Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD),Prochymal® - 2 Million cells/kg|Prochymal®- 8 Million cells/kg|Methylprednisolone|Prednisone|Cyclosporine|Tacrolimus|Mycophenolate Mofetil,"A Phase II, Randomized Study to Evaluate the Safety and Efficacy of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) For the Treatment of Acute GVHD in Patients Who Receive Allogeneic Hematopoietic Stem Cell Transplantation",Indianapolis|Kansas City|Hackensack|Buffalo|New York|Rochester|Valhalla|Houston|Milwaukee,Indiana|Missouri|New Jersey|New York|New York|New York|New York|Texas|Wisconsin,United States|United States|United States|United States|United States|United States|United States|United States|United States,"April 27, 2005"
442,443,NCT02776943,Cartilage Damage|Degenerative Osteoarthritis,UCMSC Transplantation in the Treatment of Cartilage Damage,umbilical cord mesenchymal stem cells|Hyaluronic acid,Phase I/II Study of Umbilical Cord Mesenchymal Stem Cell Implantation in the Treatment of Articular Cartilage Defect of Knee and Knee Osteoarthritis,,,,June 2016
443,444,NCT02685098,Ischemia|Peripheral Arterial Disease|Peripheral Vascular Disease|Vascular Disease|Arterial Occlusive Disease|Arteriosclerosis|Atherosclerosis|Cardiovascular Disease|Pathologic Processes|Orthopedic Procedures|Amputation,A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation,Allogeneic bone marrow derived mesenchymal stem cells,A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation,Indianapolis,Indiana,United States,January 2017
444,445,NCT01725698,Union,"The Combined Effect of Mesenchymal Stem Cell, HA-CaSO4,BMP-2, and Implant in Inducing The Healing of Critical-Sized Bone Defect","Mesenchymal stem cell, HA-CaSO4, ¬BMP-2, and Implant",,"Jakarta, Singapore","Indonesia, Singapore",Indonesia,November 2012
445,446,NCT01385644,Idiopathic Pulmonary Fibrosis,A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis,Placental MSC,A Phase I Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis,Brisbane,Queensland,Australia,October 2010
446,447,NCT02854579,Hypoxic-Ischemic Encephalopathy,Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy,neural progenitor cell|Paracrine factors|progenitor cell and paracrine factors,Safety and Efficacy Study of Neural Progenitor Cell Transplantation and Paracrine Factors From Human Mesenchymal Stem Cells to Treat Newborn With Hypoxic-ischemic Encephalopathy,Beijing|Beijing,Beijing,China|China,January 2013
447,448,NCT03552848,Multiple Organ Dysfunction Syndrome,Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection,MSC,Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection: a Pilot Study,Fuzhou,Fujian,China,"July 1, 2018"
448,449,NCT03840343,"Diabetic Kidney Disease|Diabetic Nephropathies|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Chronic Kidney Disease|Diabetic Nephropathy Type 2|Kidney Failure|Kidney Insufficiency",Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease,Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose|Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose,Intra-arterially Delivered Autologous Mesenchymal Stem/Stromal Cell Therapy in Patients With Diabetic Kidney Disease: A Phase I Study,Rochester,Minnesota,United States,"October 23, 2019"
449,450,NCT03449082,Lateral Epicondylitis,Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC),High concentration of Allo-ASC|Low concentration of Allo-ASC|Fibrin glue|Normal saline,Treatment of Intractable Common Extensor Tendon Injury Using Allogeneic Adipose-derived Mesenchymal Stem Cells (Allo-ASC): a Phase II Randomized Controlled Trial,Seoul,,"Korea, Republic of","May 4, 2018"
450,451,NCT03070275,Implant Therapy,Dental Implant Placement in Adjunction With Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells (aBM-MSCs),Biocomplex: aBM-MSCs/fibrin glue/collagen fleece|Two-stage surgical implant placement,Preservation of Alveolar Crestal Bone From Implant Placement to Implant Exposure Using Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells (aBM-MSCs),,,,February 2015
451,452,NCT03484741,Type 1 Diabetes Mellitus,Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients,MSC and PRP,A Preliminary Safety and Efficacy Evaluation of Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Mellitus (T1DM) Patients,Ho Chi Minh City,Ho Chi Minh,Vietnam,"April 1, 2017"
452,453,NCT04971980,Rheumatoid Arthritis,Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis,hUC-MSC infusion (BC-U001),"A Phase 1/2a, Open-Label Study to Evaluate the Safety and Efficacy of a Single Intravenous Infusion of BC-U001, a Human Umbilical Cord-Derived Mesenchymal Stem Cell Product, for Rheumatoid Arthritis",Beijing,Beijing,China,"April 12, 2021"
453,454,NCT01207661,Osteoarthritis,Articular Cartilage Resurfacing With Mesenchymal Stem Cells In Osteoarthritis Of Knee Joint,Mesenchymal Injection,Mesenchymal Stem Cells Transplantation for Articular Cartilage Resurfacing in Patient With Osteoarthritis of Knee Joint,Tehran,,"Iran, Islamic Republic of",August 2009
454,455,NCT01751282,Non Healing Wounds,Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds,Stem Cell,"A Randomized, Double-Blind, Controlled Study to Evaluate the Effectiveness of the Use of Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) in Fibrin in the Treatment of Chronic Wounds",Providence,Rhode Island,United States,June 2010
455,456,NCT03166865,Osteoarthritis of the Knee,Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis,Umbilical-cord mesenchymal stromal cells (UC-MSCs)|Hyaluronic acid,Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis,Liaocheng,Shandong,China,"October 1, 2018"
456,457,NCT01643655,Avascular Necrosis of the Femoral Head,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head,Autologous Adipose Tissue derived MSCs Transplantation,Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head,Seoul,,"Korea, Republic of",May 2012
457,458,NCT01769872,Spinal Cord Injury,Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury,Autologous Adipose Tissue derived MSCs Transplantation,Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury,Seoul,,"Korea, Republic of",January 2013
458,459,NCT01874015,Crohn's Disease,Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease,mesenchymal cell transplantation|mesenchymal cell and fibroblast injection,Transplantation of Bone Marrow Mesenchymal Stem Cell in Moderate to Severe Fistulizing Crohn's Disease,Tehran,,"Iran, Islamic Republic of",February 2013
459,460,NCT02208713,Dystrophy,Intramuscular Transplantation of Muscle Derived Stem Cell and Adipose Derived Mesenchymal Stem Cells in Patients With Facioscapulohumeral Dystrophy (FSHD),Intramuscular injection,"Intramuscular Transplantation of Autologous Muscle Derived Stem Cell(MDSC) and Adipose Derived Mesenchymal Stem Cells (AD-MSC) in Patients With Facioscapulohumeral Dystrophy (FSHD), Phase I Clinical Trial",Tehran,,"Iran, Islamic Republic of",May 2014
460,461,NCT00955669,Autologous Transplantation|Diabetic Foot,Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer,Symptoms and Objective Examination,Comparison of Autologous Transplantation of Bone Marrow Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer,Chongqing,Chongqing,China,August 2009
461,462,NCT03609905,Ulcerative Colitis (UC),Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis,Adipose-cord mesenchymal stromal cells (A-MSCs)|Conventional drugs,"A Phase I/II Randomized, Controlled, Clinical Trial for Assessment of the Safety and Efficacy of Allogeneic Adipose Mesenchymal Stem Cells in Moderate to Severe Ulcerative Colitis Patients",Liaocheng,Shandong,China,"July 1, 2018"
462,463,NCT04061746,"Diabetes Mellitus, Type 1",Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells,Mesenchymal Stem Cells (MSCs)|Placebo Infusion (Plasmalyte A with 0.5% human serum albumin),Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells,Charleston,South Carolina,United States,"February 13, 2020"
463,464,NCT03969680,Knee Osteoarthritis,Mesenchymal Stem Cell Transplantation for Osteoarthritis,Auotologous BMSCs plus autologous PRP|Auotologous PRP,Autologous Mesenchymal Stem Cell Transplantation for the Treatment of Knee Osteoarthritis,Yantai,Shandong,China,"July 8, 2019"
464,465,NCT05152290,Spinal Cord Injuries,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Spinal Cord Injury,St. John's,,Antigua and Barbuda,January 2022
465,466,NCT01342250,Liver Cirrhosis,Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis,conventional therapy plus low dose hUC-MSCs treatment|conventional therapy plus medium dose hUC-MSCs treatment|conventional therapy plus high dose hUC-MSCs treatment,Phase Ι/Π Study of Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis,Shanghai,Shanghai,China,October 2010
466,467,NCT02384499,Fecal Incontinence,"Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study",ALLO-ASC injection|Placebo,"Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study",Seoul,,"Korea, Republic of",December 2014
467,468,NCT05158127,Skin Ulcer,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Skin Ulcer,St. John's,,Antigua and Barbuda,January 2022
468,469,NCT05078385,Burns,Safety of Mesenchymal Stem Cell Extracellular Vesicles (BM-MSC-EVs) for the Treatment of Burn Wounds,AGLE-102,A Pilot Safety Study of the Administration of Mesenchymal Stem Cell Extracellular Vesicles in the Treatment of Burn Wounds.,,,,July 2022
469,470,NCT05147675,Osteoarthritis|Spinal Arthritis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Osteoarthritis,St. John's,,Antigua and Barbuda,December 2021
470,471,NCT03384433,Cerebrovascular Disorders,Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke,exosome,"Safety and Efficacy of Allogenic Mesenchymal Stem Cells Derived Exosome on Disability of Patients With Acute Ischemic Stroke: a Randomized, Single-blind, Placebo-controlled, Phase 1, 2 Trial",Tehran,,"Iran, Islamic Republic of","April 17, 2019"
471,472,NCT05147701,Eye Diseases|Retinitis Pigmentosa|Glaucoma|Diabetic Retinopathy|Macular Degeneration|Traumatic Optic Neuropathy|Optic Atrophy,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Eye Diseases,St. John's,,Antigua and Barbuda,January 2022
472,473,NCT01605383,Avascular Necrosis of Femur Head,Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head,XCEL-MT-OSTEO-ALPHA|Standard treatment,"A Pilot Clinical Trial of ""ex Vivo"" Expanded Autologous Bone Marrow Mesenchymal Stem Cells Fixed in Allogenic Human Bone Tissue (XCEL-MT-OSTEO- ALPHA) in Osteonecrosis of the Femoral Head",Barcelona,,Spain,"May 5, 2015"
473,474,NCT05158933,Ovarian Failure,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Ovarian Failure,St. John's,,Antigua and Barbuda,January 2022
474,475,NCT05158101,Stroke,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Stroke,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Stroke,St. John's,,Antigua and Barbuda,February 2022
475,476,NCT05003960,Autism,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Autism,St. John's,,Antigua and Barbuda,February 2022
476,477,NCT05158439,Tourette Syndrome,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Tourette Syndrome,St. John's,,Antigua and Barbuda,January 2022
477,478,NCT04484402,Corneal Ulcer|Corneal Disease|Corneal Dystrophy,Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells,mesenchymal stem cells|limbal stem cells|standard treatment,Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Limbal Stem Cells (Corneal Epithelial Stem Cells) or Adipose-derived Mesenchymal Stem Cells,Minsk,,Belarus,"October 3, 2016"
478,479,NCT05018858,Lupus,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Lupus,St. John's,,Antigua and Barbuda,February 2022
479,480,NCT05003908,Diabetes,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Diabetes,St. John's,,Antigua and Barbuda,February 2022
480,481,NCT05147766,Congestive Heart Failure|Angina,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Heart Disease,St. John's,,Antigua and Barbuda,February 2022
481,482,NCT05152394,Parkinson Disease,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Parkinson's Disease,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Parkinson's Disease,St. John's,,Antigua and Barbuda,January 2022
482,483,NCT05018819,Cerebral Palsy,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Cerebral Palsy,St. John's,,Antigua and Barbuda,February 2022
483,484,NCT04855955,Alzheimer Disease,Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease,Adipose-Derived Mesenchymal Stem Cells,Individual Patient Expanded Access Investigation New Drug (IND) Application for Administration of Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease,,,,
484,485,NCT04642911,Diabete Type 2|Mesenchymal Stem Cell,Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy,Long term follow up,Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy Using Autologous Mesenchymal Stem Cell,Kharkov,,Ukraine,"October 15, 2020"
485,486,NCT05152381,Osteoporosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Osteoporosis,St. John's,,Antigua and Barbuda,January 2022
486,487,NCT05003388,Multiple Sclerosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Multiple Sclerosis,St. John's,,Antigua and Barbuda,February 2022
487,488,NCT05147688,Pulmonary Disease|Asthma|Chronic Obstructive Pulmonary Disease,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Pulmonary Diseases,St. John's,,Antigua and Barbuda,December 2021
488,489,NCT05018832,Traumatic Brain Injury,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Traumatic Brain Injury,St. John's,,Antigua and Barbuda,December 2022
489,490,NCT05018767,Frailty,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty,St. John's,,Antigua and Barbuda,February 2022
490,491,NCT05016804,Systemic Sclerosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Systemic Sclerosis,St. John's,,Antigua and Barbuda,February 2022
491,492,NCT05018845,Chronic Kidney Diseases,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Chronic Kidney Disease.,St. John's,,Antigua and Barbuda,February 2022
492,493,NCT05003947,Inflammatory Bowel Diseases,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Inflammatory Bowel Disease,St. John's,,Antigua and Barbuda,February 2022
493,494,NCT05016817,Idiopathic Pulmonary Fibrosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Idiopathic Pulmonary Fibrosis,St. John's,,Antigua and Barbuda,February 2022
494,495,NCT05003921,Amyotrophic Lateral Sclerosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for the Treatment of Amyotrophic Lateral Sclerosis,St. John's,,Antigua and Barbuda,February 2022
495,496,NCT05003934,Rheumatoid Arthritis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Rheumatoid Arthritis,St. John's,,Antigua and Barbuda,February 2022
496,497,NCT01291329,ST-Elevation Myocardial Infarction,Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI),intracoronary human umbilical WJ-MSC transfer,Phase 2 Study of Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With ST-segment Elevation Acute Myocardial Infarction (AMI),Beijing,,China,February 2011
497,498,NCT05158114,Testicular Injury|Oligospermia,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Testicular Injury and Oligospermia,St. John's,,Antigua and Barbuda,January 2022
498,499,NCT04625738,COVID19 ARDS,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells|Placebo,Efficacy of Infusions of Mesenchymal Stem Cells From Wharton Jelly in the Moderate to Severe SARS-Cov-2 Related Acute Respiratory Distress Syndrome (COVID-19): A Phase IIa Double-blind Randomized Controlled Trial,Vandœuvre-lès-Nancy,,France,"November 6, 2020"
499,500,NCT05093725,Umbilical Cord of Normal Labor,CD49 in Optimization The Cologenicity of Mesenchymal Stem Cell Culture Passage,flow cytomery,CD49 in Optimization The Cologenicity of Mesenchymal Stem Cell Culture Passage,Sohag,,Egypt,November 2021
500,501,NCT01274975,Spinal Cord Injury,Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury.,Autologous Adipose Derived Mesenchymal Stem Cells,Safety of Autologous Adipose Derived Mesenchymal Stem Cells in Patients With Spinal Cord Injury,,,,July 2009
501,502,NCT04346368,Coronavirus Disease 2019 (COVID-19),Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),BM-MSCs|Placebo,Safety and Efficacy of Intravenous Infusion of Bone Marrow-Derived Mesenchymal Stem Cells in Severe Patients With Coronavirus Disease 2019 (COVID-19): A Phase 1/2 Randomized Controlled Trial,Guangzhou,Guangdong,China,April 2020
502,503,NCT05531266,aGVHD,Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease,hUC-MSCs|glucocorticoids,Clinical Study of Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease,Tianjin,Tianjin,China,"September 1, 2022"
503,504,NCT01300598,Degenerative Arthritis,Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis,Autologous Adipose Tissue derived MSCs Transplantation,Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis,Seoul,,"Korea, Republic of",December 2008
504,505,NCT01759212,Heart Failure|Ischemic Cardiomyopathy,Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.,Allogeneic stem cells implantation,Safety and Efficacy of Intramyocardial Implantation of Allogeneic Mesenchymal Stem Cells in Patients With End-stage Heart Failure Undergoing Left Ventricular Assist Device Implantation,Thessaloniki,,Greece,October 2012
505,506,NCT03392311,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis,Calcipotriol ointment|adipose-derived multipotent mesenchymal stem cells,Efficacy and Safety of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis,Guangzhou,Guangdong,China,"August 17, 2019"
506,507,NCT04385056,Bradykinesia,Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia,MSCTC-0010,"An Open-label, Dose-escalation Study to Evaluate the Use of Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells (UC-MSCs) for the Treatment of Bradykinesia",Paducah|Chesterfield|Brentwood,Kentucky|Missouri|Tennessee,United States|United States|United States,"December 15, 2020"
507,508,NCT04313647,Healthy,A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers,1X level of MSCs-Exo|2X level of MSCs-Exo|4X level of MSCs-Exo|6X level of MSCs-Exo|8X level of MSCs-Exo,A Tolerance Clinical Study On Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers,Shanghai,Shanghai,China,"March 12, 2020"
508,509,NCT04104451,Diabetic Foot Ulcer,"PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS",Corlicyte,"PHASE 1, OPEN-LABEL SAFETY STUDY OF UMBILICAL CORD LINING MESENCHYMAL STEM CELLS (CORLICYTE®) TO HEAL CHRONIC DIABETIC FOOT ULCERS",Aurora,Colorado,United States,"November 12, 2019"
509,510,NCT01739777,Dilated Cardiomyopathy,Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy,ucMSC|Controls,"Phase 1 Randomized-Double Blind Clinical Trial of Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells Transplantation in Heart Failure on Patients With Cardiopathy in Dilated Stage, of Different Etiology",Santiago de Chile,,Chile,December 2012
510,511,NCT04288102,Corona Virus Disease 2019(COVID-19),Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),UC-MSCs|Saline containing 1% Human serum albumin（solution without UC-MSCs）,"A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Severe COVID-19 Patients",Wuhan|Wuhan|Wuhan,Hubei|Hubei|Hubei,China|China|China,"March 5, 2020"
511,512,NCT01728727,Liver Cirrhosis|End Stage Liver Disease,Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis,UC-MSC transplantation|conventional treatment,Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver Cirrhosis,Xi'an,Shaanxi,China,September 2012
512,513,NCT02490020,Disorder Related to Renal Transplantation|Renal Transplant Rejection,A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death,mesenchymal stem cell,,,,,January 2016
513,514,NCT01624779,Spinal Cord Injury,Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury,autologous adipose tissue derived mesenchymal stem cells,"The Effect of Intrathecal Transplantation of Autologous Adipose Tissue Derived Mesenchymal Stem Cells in the Patients With Spinal Cord Injury, Phase I Clinical Study",Seoul,Seongbukgu,"Korea, Republic of",April 2012
514,515,NCT02968459,Uterine Scar,Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars,Umbilical cord MSCs|0.9% Saline,"A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars",Foshan,Guangdong,China,October 2021
515,516,NCT05042206,Chronic Kidney Disease Stage 3B|Chronic Kidney Disease stage4,Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease,Cellgram-CKD,"An Open Label, Single-center, Phase 1 Study to Evaluate the Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Patients With Chronic Kidney Disease",Seoul,,"Korea, Republic of",October 2021
516,517,NCT01233102,Liver Cirrhosis,Mesenchymal Stem Cells Treat Liver Cirrhosis,Conserved Therapy|Hepatic artery infusion or Intravenous infusion,Umbilical Cord Mesenchymal Stem Cell Transfusion in Patients With Severe Liver Cirrhosis,Suzhou,Jiangsu,China,October 2009
517,518,NCT04056819,Acute Myocardial Infarction,Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction,Allogeneic umbilical cord mesenchymal stem cells,"A Phase I, Open Label Study to Evaluate the Safety and to Explore Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With ST-elevation Acute Myocardial Infarction",Taichung,Non-US,Taiwan,"May 27, 2019"
518,519,NCT01954147,Type 2 Diabetes,Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus,GLP-1|SC|Standard Medical Treatment,Umbilical Cord Mesenchymal Stem Cell Infusion With Liraglutide in Type 2 Diabetes Mellitus,Fuzhou,Fujian,China,October 2013
519,520,NCT01484574,Critical Limb Ischemia|Buerger's Disease,A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease,Allogeneic Mesenchymal Stem Cells|Allogeneic Mesenchymal Stem Cells,"A Non-randomized, Open Label, Multicentric, Dose Ranging , Phase II Study Assessing the Efficacy and Safety of Intramuscular Administration of Stempeucel - CLI™ (ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients With Critical Limb Ischemia Due to Buerger's Disease",New Delhi|Gurgaon|Bangalore|Bangalore|Mangalore|Chennai|Chennai|Chennai|Kolkata|Kolkata,Delhi|Haryana|Karnataka|Karnataka|Karnataka|Tamil Nadu|Tamil Nadu|Tamil Nadu|West Bengal|West Bengal,India|India|India|India|India|India|India|India|India|India,January 2012
520,521,NCT04219657,Accidental Wound|Heel Injury|Stem Cell Transplant,Comparison Between Skin Graft Versus Skin Graft and Stem Cell Application,mesenchymal stem cell application,Comparison of Outcome of Mesenchymal Stem Cells And Skin Graft With Skin Graft In Management of Traumatic Heel Pad Injuries of Children,Lahore,Punjab,Pakistan,"October 29, 2016"
521,522,NCT01591200,Alcoholic Liver Cirrhosis,Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis,Allogeneic Mesenchymal Stem Cells|Allogeneic Mesenchymal Stem Cells|Allogeneic Mesenchymal Stem Cells,"A Parallel Group Randomized Open Blinded End Point Evaluation, Multicentric, Dose Escalation, Phase -II Study Assessing the Safety and Efficacy of Intraarterial (Hepatic) Ex-vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With Alcoholic Liver Cirrhosis",Hyderabad|Hyderabad|Bangalore|Mangalore|Mumbai|Mumbai|Pune|Pune|Jaipur|Lucknow,Andhra Pradesh|Andhra Pradesh|Karnataka|Karnataka|Maharashtra|Maharashtra|Maharashtra|Maharashtra|Rajasthan|Uttar Pradesh,India|India|India|India|India|India|India|India|India|India,June 2012
522,523,NCT03169231,Aging Frailty,Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty,Longeveron Mesenchymal Stem Cells (LMSCs)|Placebo,"A Phase 2b, Randomized, Blinded and Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Longeveron Allogenic Human Mesenchymal Stem Cells Infusion in Patients With Aging Frailty",Aventura|Coral Gables|Fort Myers|Miami Lakes|Miami|Miami|Naples,Florida|Florida|Florida|Florida|Florida|Florida|Florida,United States|United States|United States|United States|United States|United States|United States,"July 6, 2017"
523,524,NCT01678534,Ischemic Stroke,"Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial",Allogenic mesenchymal stem cells from adipose tissue|Placebo,"Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue. Safety Assessment. A Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial.(AMASCIS-01/2011)",Madrid,,Spain,September 2014
524,525,NCT04611256,Covid19,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,MSC|Control,Adjuvant Therapy With Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 in Critical Condition,Mexico City,Ciudad De Mexico CDMX (Mexico City),Mexico,"August 1, 2020"
525,526,NCT02449005,Chronic Periodontitis,Autologous Alveolar Bone Marrow Mesenchymal Stem Cells for the Reconstruction of Infrabony Periodontal Defects,BM-MSCs/fibrin glue/collagen fleece|Fibrin glue/collagen fleece|Open flap debridement,A Phase I/II Double-Blind Randomised Controlled Clinical Trial To Study The Safety and Efficacy Of A Novel Regenerative Treatment Of Infrabony Periodontal Defects Using Autologous Alveolar Bone-Marrow Mesenchymal Stem Cells (aBM-MSCs).,Thessaloniki,,Greece,March 2014
526,527,NCT03726255,Perianal Fistula,Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula,Mesenchymal Stem Cell injection,Retrospective Evaluation of Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula.,Madrid,,Spain,"April 1, 2014"
527,528,NCT05224960,Decompensated Cirrhosis,Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2),UC-MSCs|Placebo(solution without UC-MSCs),"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Decompensated Cirrhosis Patients(MSC-DLC-2)",Lanzhou|Sanya|Wuhan|Wuhan|Shanghai|Beijing,Gansu|Hainan|Hubei|Hubei|Shanghai,China|China|China|China|China|China,"April 1, 2022"
528,529,NCT04064957,Spinal Cord Injuries,Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Chronic Spinal Cord Injury,HB-adMSCs,Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cell Therapy for Chronic Spinal Cord Injury,Sugar Land,Texas,United States,
529,530,NCT04822922,Acute-On-Chronic Liver Failure,Safety of UC-MSC Transfusion for ACLF Patients,Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs),Safety of Human Umbilical Cord-derived Mesenchymal Stem Cell (UC-MSC) Transfusion for Acute-on-chronic Liver Failure Patients,Shanghai,Shanghai,China,"September 30, 2021"
530,531,NCT04212728,Knee Osteoarthritis,Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells,Auotologous AMSCs plus autologous PRP|Auotologous PRP,Treatment of Knee Osteoarthritis With Autologous Adipose-derived Mesenchymal Stem Cells,Yantai,Shandong,China,"December 29, 2019"
531,532,NCT05121870,Decompensated Cirrhosis,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis,UC-MSCs|Saline containing 1% Human serum albumin（solution without UC-MSCs）,"A Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Human Umbilical Cord-derived Mesenchymal Stem Cells Combined With Standard Therapy in Patients With Decompensated Cirrhosis",Lanzhou|Sanya|Wuhan|Shanghai|Beijing,Gansu|Hainan|Hubei|Shanghai,China|China|China|China|China,"September 1, 2021"
532,533,NCT04453111,Knee Osteoarthritis,Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis,Placenta-derived MMSCs|Bone marrow-derived MMSCs|Hyalgan 20 mg in 2 ML Prefilled Syringe,Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis,Kyiv,,Ukraine,"January 2, 2020"
533,534,NCT02336646,Critical Limb Ischemia,Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease,Allogenic MSC|Normal saline,Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease,Taipei,,Taiwan,"May 1, 2015"
534,535,NCT01483248,Liver Cirrhosis|Fibrosis|Liver Disease|Digestive System Disease,Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis,conventional therapy plus MenSC transplantation|Conventional therapy plus placebo treatment,Phase 1/2 Study of Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation for the Evaluation of the Efficacy and Safety in Patients With Liver Cirrhosis,Hangzhou,Zhejiang,China,October 2010
535,536,NCT05402748,Fistula Perianal,Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula,placenta-MSCs derived exosomes,Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula,Tehran,,"Iran, Islamic Republic of","December 22, 2021"
536,537,NCT01453738,Osteoarthritis of Knee,Allogeneic Mesenchymal Stem Cells in Osteoarthritis,Ex- vivo cultured adult allogeneic MSCs|Plasmalyte-A,"A Randomized, Double Blind, Multicentric, Placebo Controlled, Phase -II Study Assessing the Safety and Efficacy of Intraarticular Ex-vivo Cultured Adult Allogeneic Mesenchymal Stem Cells in Patients With Osteoarthritis of Knee",Bangalore|Manipal|Mumbai|Pune|Lucknow,Karnataka|Karnataka|Maharashtra|Maharashtra|Uttar Pradesh,India|India|India|India|India,November 2011
537,538,NCT04087889,Pancreatic Cancer,Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer,HB-adMSCs,Individual Patient Expanded Access IND of Hope Biosciences Allogeneic First Blood Relative Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer,Sugar Land,Texas,United States,
538,539,NCT04551456,Coronary Artery Disease,WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease,Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS,"Randomised, Double-blind, Placebo-controlled, Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Coronary Artery Disease",,,,"November 30, 2020"
539,540,NCT02966717,"Renal Insufficiency, Chronic|Nephrotic Syndrome",Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD),Rituximab|conventional therapy|Mesenchymal stem cells,The Clinical Study of Rituximab Combined With Mesenchymal Stem Cells in the Treatment of Primary Nephrotic Syndrome (3-4 Stage of Chronic Kidney Disease),Guangzhou,Guangdong,China,August 2016
540,541,NCT03967275,Bone Marrow Donor,Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn,bone marrow harvest,Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn SyMbOL Pre Clinical Study,Paris,,France,"September 9, 2020"
541,542,NCT02286128,Type 2 Diabetes,Effect of NF-кB Dependent Proinflammation on Osteogenic Differentiation of the Mesenchymal Stem Cells in Type 2 Diabetes,,The Effect of NF-кB Dependent Proinflammation on the Overexpression of Receptor of Advanced Glycation End Products (RAGE) and the Osteogenic Differentiation Defect in the Mesenchymal Stem Cell-isolated From Patients With Type 2 Diabetes,Chiang Mai,,Thailand,November 2014
542,543,NCT01690247,Evidence of Liver Transplantation,Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance,Conventional plus UC-MSC|Conventional plus placebo,Human Umbilical Cord Mesenchymal Stem Cell Induce Liver Allografts Tolerance,Beijing,,China,February 2012
543,544,NCT03336996,Characterize and Evaluate Functional After Transplantation|Determine the Therapeutic Efficiency|Correlate the Imaging Results,Assessement the Reconstruction of Motor Circuits in Nerve Fiber Injuries After the Treatment of Umbilical Cord Mesenchymal Stem Cells With Blood Oxygen Level-dependent Drived Diffusion Tensor Imaging,stem cell transplantation|BOLD-fMRI drived DTI scanning,Assessement the Reconstruction of Motor Circuits in Nerve Fiber Injuries After the Treatment of Umbilical Cord Mesenchymal Stem Cells With Blood Oxygen Level-dependent Drived Diffusion Tensor Imaging,Yinchuan|Yinchuan,Ningxia|Ningxia,China|China,March 2018
544,545,NCT01844063,Liver Failure,Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure,Conventional plus BM-MSC treatment|Conventional plus UC-MSC treatment|Conventional treatment,Clinical Comparison of Safety and Efficacy of Allogeneic Umbilical-Cord and Bone Marrow-derived Mesenchymal Stem Cells Transplantation for HBV-related Liver Failure,Guangzhou,Guangdong,China,July 2013
545,546,NCT00993941,Liver Cirrhosis,Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein,Autologous BMSCs transplantation|Conserved therapy,Evaluation the Efficacy and Safety of Autologous Bone Marrow Mesenchymal Stem Cells (MSCs) Transplantation in Patients With Early and Middle Stage of Liver Cirrhosis,Guangzhou,Guangdong,China,October 2009
546,547,NCT04315025,Retinitis Pigmentosa,Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa,Umbilical Cord Mesenchymal Stem Cell (UC-MSC)|Conditioned Medium (CM),Safety Issues of Peribulbar Injection of Umbilical Cord Mesenchymal Stem Cell (UC-MSC) in Patients With Retinitis Pigmentosa,Jakarta|Yogyakarta,DKI Jakarta|Special Region,Indonesia|Indonesia,"October 7, 2018"
547,548,NCT02635464,Chronic Ischemic Cardiomyopathy,Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy,hUC-MSCs+Injectable collagen scaffold+CABG|hUC-MSCs+CABG|CABG,The Safety and Efficacy Assessment of Human Umbilical Cord-derived Mesenchymal Stem Cells (hUC-MSCs) With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy,Nanjing,Jiangsu,China,October 2015
548,549,NCT04753476,Covid-19|Cytokine Storm,Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia,Injection of Secretome-MSCs|Standard treatment of Covid-19,The Effect of Secretome of Hypoxia-Mesenchymal Stem Cells in Improving Survival of Severe Covid-19 Patients,Bantul|Yogyakarta|Bekasi|Makassar|Jakarta|Jakarta,Central Java|Central Java|Jakarta|South Celebes,Indonesia|Indonesia|Indonesia|Indonesia|Indonesia|Indonesia,"June 8, 2020"
549,550,NCT03003364,"Spinal Cord Injury, Chronic",Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury,XCEL-UMC-BETA|Placebo,"A Phase I/IIa, Randomized, Double-blind, Single-dose, Placebo Controlled, Two-way Crossover Clinical Trial to Assess the Safety and to Obtain Efficacy Data in Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury",Badalona,Barcelona,Spain,"December 27, 2016"
550,551,NCT00752479,Kidney Transplant,Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance,"Mesenchymal stem cells infusion, Basiliximab,Methylprednisolone,RATG ,Cyclosporine ,Mycophenolate mofetil|Basiliximab, Methylprednisolone,RATG,Cyclosporine,Mycophenolate mofetil",Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance,Bergamo,BG,Italy,May 2008
551,552,NCT05308342,Premature Ovarian Insufficiency,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency,transplantation of human UC-MSCs into ovaries of POI patients|hormone replacement treatment,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency,Nanjing,Jiangsu,China,"November 20, 2019"
552,553,NCT03166189,"Infertility, Female|Infertility of Uterine Origin|Asherman Syndrome",Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures,bone marrow-derived MSC and HRT|hormonal replacement therapy,Open Randomized Trial of Clinical Efficiency and Safety of Cell Product of Autologous Bone Marrow-derived Mesenchymal Stem Cells for Reparative Treatment of Destructively Changed Endometrium in Patients With Repeated IVF Failures,Saint Petersburg,,Russian Federation,"December 20, 2017"
553,554,NCT00885729,Defect of Articular Cartilage,Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects,stem cells|Chondrocytes|Rehabilitation program,Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects,Oslo,,Norway,April 2009
554,555,NCT02812121,Liver Failure,UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure,umbilical cord blood mesenchymal stem cells,Umbilical Cord Blood Derived Mesenchymal Stem Cells Infusion for HBV-Related Acute-on-Chronic Liver Failure: A Randomized Controlled Trial,,,,June 2016
555,556,NCT03115749,Inflammatory Bowel Diseases,Intestinal Mesenchymal Stem Stells and Inflammatory Bowel Diseases,Intestinal biopsies during colonoscopy|Biopsies taken on surgical specimen,Characterization of Mesenchymal Stem Cells From the Colon and Small Intestine of Patients With Inflammatory Bowel Disease - The COSMIC Study,Montpellier,,France,"November 21, 2018"
556,557,NCT01531348,Retinitis Pigmentosa,Intravitreal Injection of MSCs in Retinitis Pigmentosa,BM-MSC,Feasibility and Safety of Adult Human Bone Marrow-Derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa,Bangkoknoi,Bangkok,Thailand,April 2012
557,558,NCT05512988,Chronic Kidney Diseases,Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 ),UC-MSC|Saline solution,"A Randomized, Double-blind, Controlled Clinical Study of Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 )",Wuhan,Hubei,China,"April 13, 2021"
558,559,NCT02395029,Peyronie's Disease,Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD,Placental Matrix-Derived Mesenchymal Stem Cells (PMD-MSCs),Evaluate the Safety and Feasibility of Injecting Placental Matrix-Derived Mesenchymal Stem Cells Into the Penis to Treat the Symptoms of Peyronie's Disease,Coral Springs,Florida,United States,August 2013
559,560,NCT02398370,Erectile Dysfunction,Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED,Placental Matrix-Derived Mesenchymal Stem Cells (PMD-MSCs),Evaluate the Safety and Feasibility of Injecting Placental Matrix-Derived Mesenchymal Stem Cells Into the Penis to Treat the Symptoms of Mild to Moderate Erectile Dysfunction,Coral Springs,Florida,United States,July 2013
560,561,NCT02083718,"Stem Cell Transplantation, Hematopoietic|Poor Graft Function|Hematological Diseases",Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function,PBSC|MSCs,G-CSF Mobilized Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant,Guangzhou,Guangdong,China,January 2014
561,562,NCT01144962,Crohn's Disease|Fistula,Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease,"Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection.|Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection.",Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease,Leiden,Zuid Holland,Netherlands,June 2010
562,563,NCT05017298,Corona Virus Infection|Covid19,Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells,Allogeneic adipose-derived stem cells,Clinical Study for Subjects With Coronavirus 2019 (COVID-19) Using Multiple Dose Intravenous Infusions of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs),,,,"November 1, 2022"
563,564,NCT05507762,Cirrhosis Due to Hepatitis B,Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage),UC-MSCs|Saline solution,"A Randomized, Double-blind, Controlled Clinical Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage)",Wuhan,Hubei,China,"July 20, 2021"
564,565,NCT01443689,Burns,Allogenic Stem Cell Therapy in Patients With Acute Burn,human umbilical cord mesenchymal stem cells|human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells|Conventional therapy,A Phase Ι/Π Study of Human Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Acute Burn,Kunming,Yunnan,China,July 2011
565,566,NCT04252118,COVID-19,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,MSCs,Safety and Efficiency of Mesenchymal Stem Cell in Treating Pneumonia Patients Infected With COVID-19,Beijing,,China,"January 27, 2020"
566,567,NCT04670302,Supraspinatus Tear,Mesenchymal Stem Cells and Amniotic Membrane Composite for Supraspinatus Tendon Repair Augmentation,Tendon repair procedure|Tendon repair augmented with AAdMSC-HAM composite,The Efficacy of Using Allogeneic Adipose-derived Mesenchymal Stem Cells and Human Amniotic Membrane (AAdMSC-HAM) Composite for Supraspinatus Tendon Repair Augmentation,Surabaya,East Java,Indonesia,"October 17, 2019"
567,568,NCT03774537,Bronchopulmonary Dysplasia,Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia,Transplantation of hUC-MSCs|No transplantation of hUC-MSCs,Intravenous Human Umbilical-Cord-Derived Mesenchymal Stem Cells For Premature Infants Ａt High Risk For Bronchopulmonary,Chongqing,Chongqing,China,"March 1, 2019"
568,569,NCT03795974,"Cerebral Palsy, Spastic",Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy,MNC|MSC|Control,"Evaluation of the Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic Stem Cells and Mesenchymal Stromal Cells in Patients With Spastic Cerebral Palsy on Developmental Function , A Clinical Trial phase2",Tehran|Tehran|Tehran|Tehran,,"Iran, Islamic Republic of|Iran, Islamic Republic of|Iran, Islamic Republic of|Iran, Islamic Republic of","July 23, 2017"
569,570,NCT02439541,Chronic Ischemic Heart Disease|Heart Failure|Angina,Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy,UCMSC group,Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Ischemic Cardiomyopathy,Beijing,,China,May 2015
570,571,NCT00698191,Refractory Systemic Lupus Erythematosus,Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE),Allogeneic MSC (AlloMSC),Phase I/IIa: Allogeneic Bone Marrow Derived Mesenchymal Stem Cells Transplantation For Refractory Systemic Lupus Erythematosus,Nanjing,Jiangsu,China,March 2007
571,572,NCT02442037,Ulcerative Colitis,Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis,UCMSC group|Control group(Normal saline),Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Active Ulcerative Colitis.,Beijing,,China,May 2015
572,573,NCT02494752,Romberg's Disease|Craniofacial Microsomia|Lipodystrophy|Mixed Connective Tissue Disease,Role of Mesenchymal Stem Cells in Fat Grafting,Fat graft enriched with ex vivo expanded stem cells|Fat graft not enriched with ex vivo expanded stem cells,Potential of Mesenchymal Stem Cell Enriched Adipose Tissue Grafting for Contour Deformities of Face,,,,August 2015
573,574,NCT04174898,Aging Well|Regenerative Medicine,MSC Infusion for Anti-aging and Regenerative Therapy,human Mesenchymal Stem Cell (MSC) infusion therapy,Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy,Johor Bahru,Johor Darul Takzim,Malaysia,"April 15, 2020"
574,575,NCT02444455,Acute Lung Injury|Acute Respiratory Distress Syndrome,Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Acute Lung Injury,UCMSC group,Safety and Efficacy of Human Umbilical-Cord-Derived Mesenchymal Stem Cell Transplantation in Acute Lung Injury,Beijing,,China,May 2015
575,576,NCT02529566,Lumbar Degenerative Disc Disease|Lower Back Pain|Chronic Lower Back Pain,Human Autograft Mesenchymal Stem Cell Mediated Stabilization of The Degenerative Lumbar Spine,,Human Autograft Mesenchymal Stem Cell Mediated Stabilization of The Degenerative Lumbar Spine,Odessa,Florida,United States,July 2013
576,577,NCT03291366,Central Nervous System Injury,Mesenchymal Stem Cells in Central Nervous System injury2017,UCMSCC|conventional treatment,Intrathecal Injection of Mesenchymal Stem Cells in Central Nervous System injury2017,,,,January 2017
577,578,NCT02368587,Ischemic Cardiomyopathy,Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy,WJMSCs Vs. placebo|Placebo,"Randomised, Double-blind, Placebo-controlled, Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy",,,,"January 1, 2020"
578,579,NCT02444858,Paraquat Poisoning|Lung Injury,Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury,UCMSC group|Control group(Normal saline),Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Paraquat Poisoning Induced Lung Injury,Beijing,,China,May 2015
579,580,NCT05501418,COVID-19 Infection,Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19,Allogeneic umbilical cord mesenchymal stem cells|Controlled normal saline,A Seamless Phase I/IIa Clinical Study to Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Severe and Critical COVID-19 Condition,Taichung,Non-US,Taiwan,"August 5, 2020"
580,581,NCT01913886,Ischemic Cardiomyopathy,Mesenchymal Stem Cells to Treat Ischemic Cardiomyopathy,MSCs injection,Autologous Grafting of Mesenchymal Stem Cells in Severe Refractory Ischemic Cardiomyopathy,Curitiba,Paraná,Brazil,January 2010
581,582,NCT02698813,"Senescence Wrinkles, Acne, Pitting Scar",Safety Study of Filler Agent Composed of Umbilical Cord Mesenchymal Stem Cells and Hyaluronic Acid,umbilical cord mesenchymal stem cells and hyaluronic acid|hyaluronic acid,,,,,December 2016
582,583,NCT01606215,Multiple Sclerosis,Stem Cells in Rapidly Evolving Active Multiple Sclerosis,Mesenchymal stem cells|Placebo,Stem Cells in Rapidly Evolving Active Multiple Sclerosis,London,,United Kingdom,January 2013
583,584,NCT03355365,Multiple Sclerosis,Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis,Intrathecal MSC-NP injection|Intrathecal saline injection,"Autologous, Bone Marrow-Derived Mesenchymal Stem Cell-Derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo; Administered Intrathecally",New York,New York,United States,"September 21, 2018"
584,585,NCT01933802,Multiple Sclerosis,Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis,intrathecal administration of autologous MSC-NP,"Phase 1 Safety Study of Autologous Bone Marrow-derived Mesenchymal Stem Cell-derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo, Administered Intrathecally in Patients With Multiple Sclerosis",New York,New York,United States,April 2014
585,586,NCT05532943,Multiple Sclerosis,Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis,Allogeneic umbilical cord mesenchymal stem cells|Control group,A Seamless Phase I/IIa Clinical Study to Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis,Taichung,Non-US,Taiwan,"December 31, 2022"
586,587,NCT00851162,Bone Neoplasms,Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions,Trinity multipotent stem cells|Demineralized bone matrix(DBM),Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions,Atlanta,Georgia,United States,March 2009
587,588,NCT01142050,Type 2 Diabetes Mellitus,Stem Cell Therapy for Type 2 Diabetes Mellitus,mesenchymal stem cells,"A Open Labeled and Self Controlled, Safety/Efficacy Assessed Pilot Study on Transplantation Therapy Using Bone Marrow Mesenchymal Stem Cells for Insulin Resistance of Type 2 Diabetes Mellitus",Beijing,,China,August 2010
588,589,NCT02013700,Idiopathic Pulmonary Fibrosis (IPF),Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER),Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)|matched placebo,"A Phase I, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Idiopathic Pulmonary Fibrosis",Miami,Florida,United States,"November 13, 2013"
589,590,NCT04834609,Perianal Fistula|Adipose Tissue|Tissue Transplantation,Adipose Derived Mesenchymal Stem Cell Characteristics in Anal Fistulas,Injection of autologous adipose tissue in anal fistula,Identification of Molecular Differences of Adipose-derived Mesenchymal Stem Cells Between Non- Responders and Responders in Treatment of Transsphincteric Perianal Fistulas Using Autologous Fat Graft Injection,,,,January 2015
590,591,NCT04889963,Adypose Mesenchimal Stem Cell|Ligament Rupture|Ligament Derived Conditined Medium,Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium,adypose mesenchymal conditioned medium and ligament derived conditioned medium,Regeneration of Posterior Cruciate Ligament Injury Using Hypoxia Conditioned Allogenic Adipose Mesenchymal Stem Cell (AdMSC) and Ligament Derived Condition Medium (Secretome),Sleman,Yogyakarta,Indonesia,"January 1, 2021"
591,592,NCT02557724,Liver Failure|Liver Neoplasm,Mobilization of Mesenchymal Stem Cells During Liver Transplantation,blood samples|blood samples,Mobilization of Mesenchymal Stem Cells During Liver Transplantation,Newark,New Jersey,United States,September 2015
592,593,NCT03933995,Erectile Dysfunction,Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction,no Intervention,Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cell in Erectile Dysfunction,Seoul,,"Korea, Republic of","March 11, 2019"
593,594,NCT00361049,Cancer,Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant,graft versus host disease prophylaxis/therapy|fluorescence in situ hybridization|immunoenzyme technique|immunohistochemistry staining method|laboratory biomarker analysis|in vitro-treated bone marrow transplantation|management of therapy complications,Donor Mesenchymal Stem Cell Infusion for Treatment of Graft Versus Host Disease: A Phase I Trial,Cleveland|Cleveland|Cleveland|Cleveland|Cleveland|Cleveland|Cleveland|Cleveland,Ohio|Ohio|Ohio|Ohio|Ohio|Ohio|Ohio|Ohio,United States|United States|United States|United States|United States|United States|United States|United States,September 2004
594,595,NCT04749667,Multiple Sclerosis|Progressive Multiple Sclerosis,Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis,MSCs|Saline,Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis,Tromsø|Trondheim|Bergen|Lørenskog,Troms Og Finnmark|Trøndelag|Vestland|Viken,Norway|Norway|Norway|Norway,"August 9, 2021"
595,596,NCT01448434,Osteoarthritis of Knee Joint,Allogeneic Mesenchymal Stem Cells for Osteoarthritis,Ex- vivo cultured adult allogeneic MSCs|Plasmalyte-A,"A Randomized, Double Blind, Multicentric, Placebo Controlled, Phase -II Study Assessing the Safety and Efficacy of Intraarticular Ex-vivo Cultured Adult Allogeneic Mesenchymal Stem Cells in Patients With Osteoarthritis of Knee",Kuala Lumpur|Kuala Lumpur|Kuala Lumpur|Kuala Lumpur,Federal territory|Selangor|Selangor|Selangor,Malaysia|Malaysia|Malaysia|Malaysia,September 2011
596,597,NCT04610359,Interstitial Cystitis|Stem Cell Transplant|Mesenchymal Stem Cell,Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis,MR-MC-01,"Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis; Open-labelled, Single Center, Phase 1 Study",Seoul,,"Korea, Republic of","October 20, 2020"
597,598,NCT04366063,Covid-19,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,Cell therapy protocol 1|Cell therapy protocol 2,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 2-3 Clinical Trial,Tehran,,"Iran, Islamic Republic of","April 5, 2020"
598,599,NCT01879046,Knee Osteoarthritis,Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells,arthroplasty,Regenerative Medicine of Articular Cartilage: Characterization and Comparison of Chondrogenic Potential and Immunomodulatory Adult Mesenchymal Stem Cells,Nantes,,France,October 2015
599,600,NCT04313322,Use of Stem Cells for COVID-19 Treatment,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,WJ-MSCs,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,Amman,,Jordan,"March 16, 2020"
600,601,NCT04276987,Coronavirus,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,MSCs-derived exosomes,A Pilot Clinical Study on Aerosol Inhalation of the Exosomes Derived From Allogenic Adipose Mesenchymal Stem Cells in the Treatment of Severe Patients With Novel Coronavirus Pneumonia,Shanghai,Shanghai,China,"February 15, 2020"
601,602,NCT01957826,Primary Idiopathic Dilated Cardiomyopathy,Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy,bone marrow-derived MSCs injection|placebo intervention,Phase I/II Randomized Clinical Trial to Assess the Safety and Feasibility of Transendocardial Injection of Bone Marrow Autologous Mesenchymal Stem Cells in Patients With Idiopathic Dilated Cardiomyopathy.,Madrid|Valladolid,,Spain|Spain,March 2013
602,603,NCT05116761,Covid19|Postviral Syndrome|Dyspnea,ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles|Saline,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Post-Acute and Chronic Post-COVID-19 Syndrome: A Phase I/II Clinical Trial,,,,February 2023
603,604,NCT03047772,"Myocardial Infarction|Stem Cell Transplantation|Angioplasty, Transluminal, Percutaneous Coronary",Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients,Atorvastatin|Intensive Atorvastatin|Low dose BMMSC|Middle dose BMMSC|High dose BMMSC|Transplantation,The Randomized Double-blind Placebo-Controlled Multi-center Clinical Trial of Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in Acute Myocardial Infarction Patients,,,,"March 6, 2018"
604,605,NCT01275612,Solid Tumors|Acute Kidney Injury,Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers,Mesenchymal stromal cell infusion,Ex-Vivo Expanded Mesenchymal Stem Cells To Repair The Kidney And Improve Function In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers,Bergamo,BG,Italy,November 2010
605,606,NCT02574572,Spinal Cord Injury,Autologous Mesenchymal Stem Cells Transplantation in Cervical Chronic and Complete Spinal Cord Injury,Autologous mesenchymal cells transplantation,Evaluation of the Safety and Potential Effectiveness of Autologous Mesenchymal Stem Cells Transplantation in Subjects With Cervical Chronic and Complete Spinal Cord Injury,Salvador,Bahia,Brazil,"September 6, 2017"
606,607,NCT03397095,Ischemic Heart Disease,Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study,CSWT+BMMSCs|CSWT+Sham operation,Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells in Patients With ischEmic Heart Disease : the S-CURE Study,Shanghai,Shanghai,China,"April 3, 2018"
607,608,NCT02327832,Liver Regeneration,Safety Study of Liver Regeneration Therapy Using Cultured Autologous BMSCs,Autologous BMSCs|bone marrow-derived mesenchymal stem cells,Safety Study of a Less Invasive Liver Regeneration Therapy Using Cultured Autologous Bone Marrow-derived Mesenchymal Stem Cells for Compensated Liver Cirrhotic Patient,"Ube, Yamaguchi",Yamaguchi,Japan,December 2014
608,609,NCT02474342,Rotator Cuff Disease,Autologous Adipose Tissue Derived Mesenchymal Stem Cells for Rotator Cuff Disease,Autologous Adipose Tissue Derived MSCs Transplantation|Autologous Adipose Tissue Derived MSCs Transplantation|Autologous Adipose Tissue Derived MSCs Transplantation,Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Rotator Cuff Disease,Seoul,,"Korea, Republic of","July 7, 2015"
609,610,NCT03866330,Osteoarthritis|Hip Osteoarthritis|Knee Osteoarthritis|Glenohumeral Osteoarthritis,Wharton's Jelly-derived Mesenchymal Stem Cells in Osteoarthritis,Intraarticular injection of WJMSC,"Effectiveness of Wharton's Jelly-derived Stem Cells in Patients With Osteoarthritis of the Knee, Hip or Glenohumeral Joint and Analysis of the Regeneration Processes Based on Inflammatory Markers, microRNAs and Clinical Features",Warsaw,Mazovian,Poland,"March 1, 2019"
610,611,NCT05106972,Liver Cirrhosis,Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis,UC-MSC infusion,"A Single Center, Prospective Study of Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis",Haikou,,China,"December 1, 2021"
611,612,NCT02472002,Coronary Disease|Heart Transplant,Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients,Mesenchymal cell therapy,Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients,Paris,,France,January 2014
612,613,NCT04349631,COVID-19,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,HB-adMSCs,"A Phase II, Open Label, Single-Center, Clinical Trial to Assess Efficacy of HB-adMSCs to Provide Immune Support Against Coronavirus Disease",Sugar Land,Texas,United States,"April 22, 2020"
613,614,NCT00658073,Renal Transplant Rejection,Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts,Kidney transplantation with MSCs infusion|kidney transplantation without MSC infusion,Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Recipients of Living Kidney Allografts,Fuzhou,Fujian,China,March 2008
614,615,NCT03766217,Cleft Lip and Palate,Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft Repair,Mesenchymal stem cells associated with biomaterials|Iliac crest autogenous bone graft,Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft Repair,São Paulo,,Brazil,"April 5, 2019"
615,616,NCT04457609,COVID|Pulmonary Infection|Sars-CoV2,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,Oseltamivir|Azithromycin|Umbilical Cord Mesenchymal Stem Cells,Application of Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy for Critically-Ill COVID-19 Patients,Jakarta Pusat|Jakarta|Jakarta|Depok,DKI Jakarta|DKI Jakarta|DKI Jakarta|West Java,Indonesia|Indonesia|Indonesia|Indonesia,July 2020
616,617,NCT02123368,Osteoarthritis,Treatment of Knee Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells,Hyaluronic acid|10 million Bone marrow mesenchimal stem cells|100 million Bone marrow mesenchimal stem cells,Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells,Salamanca|Pamplona,Castilla y León|Navarra,Spain|Spain,May 2012
617,618,NCT04340609,Acute Myocardial Infarction,Stem Cell in Acute Myocardial Infarction,Mesenchymal Stem Cells,Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Acute Myocardial Infarction,Jakarta,,Indonesia,"March 11, 2019"
618,619,NCT02325843,Chemical Burns,the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn,human bone marrow MSC,"The Subconjunctival Injection of Human Bone Marrow Mesenchymal Stem Cells for Ocular Corneal Burn: Prospective, Case Series Study",,,,July 2015
619,620,NCT04213248,Dry Eye,Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD,Umbilical Mesenchymal Stem Cells derived Exosomes,Effect of Umbilical Mesenchymal Stem Cells Derived Exosomes on Dry Eye in Patients With Chronic Graft Versus Host Diseases,Guangzhou,Guangdong,China,"February 21, 2020"
620,621,NCT01182662,Aplastic Anemia,Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia,Human umbilical cord-derived MSCs and cyclosporin A|cyclosporin A,Phase II Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat SAA,Jinan,Shandong,China,August 2010
621,622,NCT01420432,Ankylosing Spondylitis,Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Ankylosing Spondylitis (AS),Human umbilical cord-derived MSCs,Phase II Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat AS,Jinan,Shandong,China,January 2011
622,623,NCT03994666,Critical Limb Ischemia,Cell Therapy in Critical Limb Ischemia,allogeneic umbilical cord-derived mesenchymal stem cells|Placebo (NaCl),Cell Therapy in Critical Limb Ischemia by Implantation of Allogeneic Umbilical Cord-derived Mesenchymal Stem Cells,Reims,,France,September 2019
623,624,NCT05080465,Liver Cirrhosis,Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis,Autologous BM MSC,Long Term Follow up Autologous Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis,Kharkov,,Ukraine,"December 2, 2018"
624,625,NCT02290041,Discordant Immunological Response in HIV Infected Subjects,Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response,Infusion of MSC|Infusion of placebo,"Clinical Trial Phase I/II, of Test of Concept, Blind Double, Randomized, Controlled With Placebo, to Assess the Safety and Efficiency of the Treatment With Allogenic Adult Mesenchymal Stem Cells From Adipose Tissue Expanded, in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response",Seville,,Spain,"February 8, 2017"
625,626,NCT04785027,Traditional Chinese Medicine|Drug Effect|Drug Safety|Psoriasis|Mesenchymal Stromal Cells,Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis,PSORI-CM01 formula|Gu Ben Hua Yu formula|adipose-derived multipotent mesenchymal stem cells,Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis: a Pilot Study for a Randomized Controlled Trial,Guangzhou,Guangdong,China,"March 17, 2021"
626,627,NCT01129739,Myelodysplastic Syndromes,Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes,Human umbilical cord-derived MSCs|cyclosporine A (CsA),Phase II Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat RA and RARS of MDS,Jinan,Shandong,China,May 2010
627,628,NCT03187431,Stem Cell Transplant Complications,Role of Stem Cell Therapy in Interstitial Pulmonary Fibrosis,autologous bone marrow mesenchymal stem cells,Mesenchymal Stem Cell as Therapeutic Modality in Interstitial Pulmonary Fibrosis,,,,"December 11, 2017"
628,629,NCT05261360,"Knee; Injury, Meniscus (Lateral) (Medial)|Meniscus Tear|Meniscus Lesion|Meniscus; Degeneration|Meniscus; Laceration|Meniscus Injury, Tibial|Knee Injuries|Knee Pain Swelling|Arthralgia",Clinical Efficacy of Exosome in Degenerative Meniscal Injury,SF-MSC-EX|SF-MSC,A Phase II Trial to Investigate Clinical Efficacy of Autologous Synovial Fluid Mesenchymal Stem Cell-Derived Exosome Application in Patients With Degenerative Meniscal Injury,Eskisehir,,Turkey,March 2022
629,630,NCT02445547,Crohn Disease,Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease,UC-MSCs by peripheral intravenous infusion|received hormone maintenance therapy,Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease: A Randomized Controlled Clinical Trial,Xi Ail,Shaanxi,China,June 2012
630,631,NCT01840540,Atherosclerotic Renal Artery Stenosis|Ischemic Nephropathy|Renovascular Hypertension,MSC for Occlusive Disease of the Kidney,Arterial infusion of autologous mesenchymal stem cells,Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis,Rochester,Minnesota,United States,April 2013
631,632,NCT02587572,Metabolic Disease|Endothelial Dysfunction,Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial,Peripheral Intravenous (IV) infusion of LMSCs,"A Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Efficacy of Allogeneic Human Mesenchymal Stem Cells in Patients With Metabolic Syndrome.",,,,December 2022
632,633,NCT05125562,COVID-19,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19: A Phase II Clinical Trial,ExoFlo,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19: A Phase II Clinical Trial,Austin,Texas,United States,"December 7, 2022"
633,634,NCT04336254,COVID-19,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)|Intravenous saline injection (Placebo),"Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe Pneumonia of COVID-19：a Single-center, Prospective, Randomised Clinical Trial",Wuhan,Hubei,China,"May 6, 2020"
634,635,NCT04356300,Multiple Organ Failure,Exosome of Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection,Exosome of MSC,Exosome of Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection: a Pilot Study,,,,"September 1, 2020"
635,636,NCT03585855,Interventional,Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR),MSC transplantation,Autologous Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR),Ljubljana,,Slovenia,"January 1, 2019"
636,637,NCT04744051,Post-Concussion Syndrome,"ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion",50 Adipose Derived Stem Cell Infusion|150 Adipose Derived Stem Cell Infusion|300 Adipose Derived Stem Cell Infusion|Placebo Infusion,"ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion for the Treatment of Post Concussion Syndrome (PCS) in Retired Military and Athletes",La Mesa,California,United States,"February 1, 2021"
637,638,NCT01741857,Systemic Lupus Erythematosus,Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus,human umbilical cord derived MSC transplantation for SLE,Phase I/II: Umbilical Cord Derived Mesenchymal Stem Cells Transplantation For Active And Refractory Systemic Lupus Erythematosus,Nanjing,Jiangsu,China,January 2012
638,639,NCT04501341,T2D,BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients,"Bone-marrow aspiration, Intra-pancreatic Catheterisation of BM-MNC|Intravenous Infusion of UC-MSC","Effectivity and Safety of Autologous BM-MNC Stem Cell Therapy and Allogenic Umbilical Cord Mesenchymal Stem Cell for Type 2 Diabetes Mellitus Patients""",Jakarta Pusat,DKI Jakarta,Indonesia,"March 14, 2016"
639,640,NCT00976287,Liver Cirrhosis,Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery in Patients With Liver Cirrhosis,Hepatic artery infusion|Conserved Therapy,Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery in Patients With Liver Cirrhosis,,,,January 2008
640,641,NCT02055625,Graft -Versus-host-disease,Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease,Mesenchymal stromal cells,Treatment of Oral Mucosa in Patients With Graft-versus-host Disease Following Injection of Mesenchymal Stem Cells - Human Pilot Study,Stockholm,Huddinge,Sweden,January 2014
641,642,NCT01494480,Amyotrophic Lateral Sclerosis,The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis,stem cell transplantation,The Clinical Study on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis,Beijing,,China,March 2012
642,643,NCT03592849,"Infertility, Female|Endometrium",The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring,UC-MSCs therapy,The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring,Nanjing,Jiangsu,China,"September 10, 2018"
643,644,NCT02888704,Atopic Dermatitis,Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis,ADSTEM Inj. (Adult human mesenchymal stem cells),"Phase I Clinical Trial to Evaluate the Safety, Tolerance, and Exploratory Efficacy of ADSTEM Inj. in Patients With Moderate to Severe, Subacute and Chronic Atopic Dermatitis",Daejeon,Chungcheongnam-do,"Korea, Republic of",July 2016
644,645,NCT03798028,Rheumatoid Arthritis,The Safety and Effects of Mesenchymal Stem Cell (MSCs) in the Treatment of Rheumatoid Arthritis,UC-MSCs,The Effects and Safety of Mesenchymal Stem Cells in the Treatment of Moderate/Severe Rheumatoid Arthritis， a Multicenter Randomized Controlled Clinical Study,Xi'an,Shaanxi,China,"December 26, 2017"
645,646,NCT03602872,Knee Osteoarthritis,Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis,Human allogeneic mesenchymal bone marrow derived stem cells,"Phase I, Open Label Study to Assess the Safety and Tolerance of a Single Intraarticular Dose of STEMEDICA's Human Allogeneic Bone Marrow Derived Mesenchymal Stem Cells, in Subjects With Knee Osteoarthritis.",Tijuana,Baja California,Mexico,August 2019
646,647,NCT05210309,"Safety|Efficacy, Self",National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study),Stem Cell Therapy,National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study),Elche|Vigo|Barcelona|Valencia,Alicante|Pontevedra,Spain|Spain|Spain|Spain,"January 1, 2020"
647,648,NCT04998058,"Bone Loss, Osteoclastic|Bone Loss, Alveolar|Alveolar Bone Loss|Alveolar Bone Atrophy|Grafting Bone",Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting,Maxillary sinus floor elevation grafting with synthetic bone substitute.,Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting,Porto Alegre,RS,Brazil,"December 15, 2022"
648,649,NCT02587715,"Multiple Sclerosis, Relapsing-Remitting",A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS,Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells|Liberation therapy,"An Open-label, Non-randomized, Phase I/II Study of Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSC) and Liberation Therapy (When Associated With Chronic Cerebrovascular Venous Insufficiency) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)",San Fernando,Trinidad,Trinidad and Tobago,February 2015
649,650,NCT02418325,"Multiple Sclerosis, Relapsing-Remitting",A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS,Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells|Liberation therapy,"An Open-label, Non-randomized, Phase I/II Study of Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSC) and Liberation Therapy (When Associated With Chronic Cerebrovascular Venous Insufficiency) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)",San Fernando,Trinidad,Trinidad and Tobago,February 2015
650,651,NCT04490486,COVID-19|Acute Respiratory Distress Syndrome|Corona Virus Infection,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,UCMSCs|Placebo,"Phase I, Randomized, Double Blinded, Placebo Control Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 With Moderate to Severe Symptoms",,,,"October 1, 2022"
651,652,NCT05043610,"Myocardial Infarction, Acute|Myocardial Infarction First|Myocardial Infarction, Anterior Wall|Cardiac Remodeling, Ventricular|STEMI|Regenerative Medicine|Heart Failure",MSCs for Prevention of MI-induced HF,Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs)|Conventional Treatment,Transplantation of Mesenchymal Stem Cells for Prevention of Acute Myocardial Infarction Induced Heart Failure: A Phase III Randomized Clinical Trial,Shiraz|Shiraz|Shiraz,Fars|Fars|Fars,"Iran, Islamic Republic of|Iran, Islamic Republic of|Iran, Islamic Republic of","January 1, 2021"
652,653,NCT01489267,Hereditary Cerebellar Ataxia.,A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation,stem cell transplantation,The Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Transplantation in Hereditary Cerebellar Ataxia Patients,Beijing,,China,December 2011
653,654,NCT02365142,Knee Osteoarthritis,Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells With Platelet Rich Plasma,100 million Bone marrow mesenchimal stem cells|Platelet Rich plasma (PRGF),Phase I/II. Treatment of Osteoarthritis by Intra-articular Injection of Bone Marrow Mesenchymal Stem Cells With Platelet Rich Plasma(PRGF),Salamanca|Pamplona,Castilla-León|Navarra,Spain|Spain,June 2014
654,655,NCT03460223,Renal Cirrhosis,Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis,MSC,Phase 1 Clinical Trial Using Mesenchymal Stem Cell as Individualized Medicine to Evaluate the Safety and Efficacy in Kidney Fibrosis,,,,"April 1, 2018"
655,656,NCT01687777,Chronic Disease,Mensenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair,Mesenchymal Stem Cells (MSCs)|OrthADAPT,Treatment of Rotator Cuff Tears Using Autologous Bone Marrow Mensenchymal Stem Cell Transplantation.,Madrid|Madrid,,Spain|Spain,May 2010
656,657,NCT03078621,Cerebral Palsy,Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy,Stem Cell Therapy,Safety and Efficacy of Transplantation of Specific Populations of Stem Cells and Mesenchymal Stem Cells for the Treatment of Cerebral Palsy,,,,September 2016
657,658,NCT01143168,Type 1 Diabetes Mellitus,Stem Cell Therapy for Type 1 Diabetes Mellitus,autologous bone marrow mononuclear cells and umbilical cord mesenchymal stem cells,A Pilot Study on Transplantation Therapy Using Autologous Bone Marrow Mononuclear Cells and Umbilical Cord Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus,Beijing,,China,August 2010
658,659,NCT04029896,Cerebral Palsy,Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy,HB-adMSCs,Individual Patient Expanded Access IND of Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy,Sugar Land,Texas,United States,
659,660,NCT03337243,Knee Osteoarthritis|Knee Pain Chronic|Joint Disease|Arthritis|Osteo Arthritis Knee|Musculoskeletal Disease,Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis,HAM and HUMCWJ Injections,Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis,Pittsburgh,Pennsylvania,United States,"November 9, 2017"
660,661,NCT01206179,Nonunion Fractures,Treatment of Non Union of Long Bone Fractures by Autologous Mesenchymal Stem Cell,cell injection,Effect of Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Reconstructing Human Bone Defects,Tehran,,"Iran, Islamic Republic of",March 2009
661,662,NCT04273646,2019 Novel Coronavirus Pneumonia|COVID-19,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,UC-MSCs|Placebo,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,Wuhan,Hubei,China,"April 20, 2020"
662,663,NCT02961725,Bronchopleural Fistula,Stem Cells for Treatment of Bronchopleural Fistula,UCMSC,Umbilical Cord Mesenchymal Stem Cells for Treatment of Bronchopleural Fistula,Quanzhou,Fujian,China,April 2016
663,664,NCT02881476,Amyotrophic Lateral Sclerosis,Therapeutic Treatment of Amyotrophic Lateral Sclerosis,Biological: Cell-based therapy,Application of Wharton's Jelly-derived Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis,,,,November 2015
664,665,NCT05018637,Vertebral Compression Fracture|Osteoporotic Fractures,Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture,WJ-MSC|Teriparatide,Efficacy of Wharton's Jelly-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture,Seongnam-si,Gyeonggi-do,"Korea, Republic of","September 1, 2020"
665,666,NCT04972890,Urologic Diseases|Erectile Dysfunction With Diabetes Mellitus,The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction,stem cells|placebo,The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction,Jakarta Pusat,DKI Jakarta,Indonesia,"October 27, 2020"
666,667,NCT03378063,Bronchopulmonary Dysplasia,Stem Cells for Bronchopulmonary Dysplasia,transplantation of mesenchymal stem cell|no transplantation of mesenchymal stem cell,Stem Cells for Bronchopulmonary Dysplasia: a Cohort Study,Chongqing,Chongqing,China,"November 1, 2017"
667,668,NCT02491658,Psoriasis Vulgaris,Safety and Efficacy of UC-MSCs in Patients With Psoriasis Vulgaris,UC-MSCs,A Study to Assess Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs) in Patients With Psoriasis Vulgaris,Beijing,Beijing,China,April 2015
668,669,NCT02501811,Ischemic Cardiomyopathy,Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure,Mesenchymal Stem Cells (MSC)|c-kit+ cells|Placebo (Plasmalyte A),"A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, & Efficacy of Autologous Mesenchymal Stem Cells & C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic HF",Stanford|Gainesville|Miami|Indianapolis|Louisville|Minneapolis|Houston,California|Florida|Florida|Indiana|Kentucky|Minnesota|Texas,United States|United States|United States|United States|United States|United States|United States,October 2015
669,670,NCT04434768,Acute Stroke,Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke,UMSC01,"A Phase I, Open Label Study to Evaluate the Safety and to Explore the Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Acute Ischemic Stroke",Taichung|Taipei City,Non-US,Taiwan|Taiwan,"May 5, 2020"
670,671,NCT01045382,"Leukemia, Myeloid, Acute|Leukemia, Lymphoblastic, Acute|Leukemia, Myelocytic, Chronic|Myeloproliferative Disorders|Myelodysplastic Syndromes|Multiple Myeloma|Leukemia, Lymphocytic, Chronic|Hodgkin's Disease|Lymphoma, Non-Hodgkin",MSC and HSC Coinfusion in Mismatched Minitransplants,Mesenchymal stem cells|Isotonic solution,Co-transplantation of Mesenchymal Stem Cells and HLA-mismatched Allogeneic Hematopoietic Cells After Nonmyeloablative Conditioning: a Phase II Randomized Double-blind Study,Edeghem|Brussels|Leuven|Gent|Brugge|Yvoir|Antwerpen|Brussels|Brussels|Liège,Antwerpen|Brabant|Flamish Brabant|Flanders Ost|Flanders West|Namur,Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Belgium|Belgium,July 2010
671,672,NCT01562002,Limbus Corneae Insufficiency Syndrome,Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome,Stem Cell with Amniotic Membrane Transplant,Advanced Therapy for Ocular Surface Reconstruction. Allogenic Limbus Epithelial Stem-cell Transplant vs Bone Marrow Mesenchymal Stem-cell Transplant in Limbus Insufficiency Syndrome. Double-masked Randomized Trial,Valladolid,,Spain,March 2012
672,673,NCT04448106,"Osteoarthritis, Knee|Osteoarthritis, Hip|Osteoarthritis Shoulder",Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis,Celltex- AdMSCs,"Clinical Study for Subjects With Osteoarthritis of Knees, Hips, and Shoulders Using a Combination of Intravenous Infusions With Intra-articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs)",Houston,Texas,United States,"September 25, 2022"
673,674,NCT04909892,Covid19,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",COVI-MSC,"A Phase 2a Study of Intravenous Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",,,,August 2021
674,675,NCT04652908,Myelomeningocele,Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial,Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix|Untreated contemporaneous cohort,Phase 1/2a Trial of Placental Mesenchymal Stem Cells for Repair of Fetal Myelomeningocele,Sacramento,California,United States,"June 21, 2021"
675,676,NCT04863183,Mesenchymal Stem Cells|Knee Osteoarthritis|Cell Therapy,Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis,CELLISTEM-OA|Triamcinolone acetonide,"Cell Therapy for Patients With Symptomatic Knee Osteoarthritis: Phase I / II, Controlled, Randomized and Double-blind Clinical Trial",,,,"June 1, 2021"
676,677,NCT03460795,Liver Cirrhosis,Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease,MSC and Tregs,Phase 1 Clinical Trial Using Mesenchymal Stem Cell and Regulatory T Cells as Individualized Medicine to Evaluate the Safety and Efficacy in End-stage Liver Disease,Nanjing,Jiangsu,China,"June 1, 2020"
677,678,NCT03724617,Thin Endometrium|Intrauterine Adhesion,Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium,umbilical cord mesenchymal stem cells combined with collagen scaffold,Clinical Study of Stem Cells in the Treatment of Thin Endometrium,Hangzhou,,China,"October 29, 2018"
678,679,NCT00749164,Graft-Versus-Host Disease,Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment,MSC transplantation,Allogeneic Mesenchymal Stem Cell Infusion for Treatment Of Steroid Resistant GVHD,Jerusalem,,Israel,September 2009
679,680,NCT03564808,"Skin Pigmentation Over Contour Deformities of Face|Trauma, Rhomberg Disease","Long Term Effects on Skin Hyper Pigmentation With and Without Mesenchymal Stem Cell Enriched Adipose Tissue Grafting for ""Contour Deformities With Pigmentary Changes on Face""",MSC,"Long Term Effects on Skin Hyper Pigmentation With and Without Mesenchymal Stem Cell Enriched Adipose Tissue Grafting for ""Contour Deformities With Pigmentary Changes on Face""",Lahore,Punjab,Pakistan,"June 27, 2018"
680,681,NCT02398604,Hypoplastic Left Heart Syndrome,Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome,Allo-hMSCs|Placebo,Allogeneic Human MEsenchymal Stem Cell (hMSC) Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.,Baltimore|Baltimore,Maryland|Maryland,United States|United States,April 2015
681,682,NCT03069209,Premature Ovarian Failure,Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF),Stem Cells,Transplantation of Specific Populations of Bone Marrow-Derived Stem Cells and Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure.,Amman,,Jordan,January 2015
682,683,NCT02379442,Graft-Versus-Host Disease,Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids,MSC,A Pilot Study of Early Treatment of Acute Graft Versus Host Disease With Bone Marrow- Derived Mesenchymal Stem Cells and Corticosteroids: Correlation of Disease Severity and Response With Biomarkers,Bethesda,Maryland,United States,"February 23, 2015"
683,684,NCT02943889,Liver Cirrhosis,Stem Cell Transplantation in Cirrhotic Patients,Mesenchymal stem cell transplantation,The Role of Bone-marrow Derived Stem Cell Transplantation in Patients With Decompensated Liver Cirrhosis: Clinical Trial,,,,October 2016
684,685,NCT05094011,Idiopathic Parkinson's Disease,"Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease",Aadipose-Derived Mesenchymal Stem Cells,"A Phase I Open-Label Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of Autologous MitoCell (Adipose-Derived Mesenchymal Stem Cells) Transplantation in Subjects With Idiopathic Parkinson's Disease",,,,"May 1, 2022"
685,686,NCT03058068,Cystic Fibrosis,Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis,Allo-hMSCs|Placebo,"A Phase I, Randomized and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis - HAPI",,,,December 2020
686,687,NCT02331134,Malignant Melanoma|Head and Neck Cancer,Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer,Filgrastim,Pilot Study of Tissue and Hematopoietic/Mesenchymal Stem Cell Collection for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer,Aurora,Colorado,United States,"May 13, 2015"
687,688,NCT02509156,Cardiomyopathy Due to Anthracyclines,Stem Cell Injection in Cancer Survivors,Allo-MSCs|Placebo,"A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy",Stanford|Gainesville|Miami|Indianapolis|Louisville|Minneapolis|Houston,California|Florida|Florida|Indiana|Kentucky|Minnesota|Texas,United States|United States|United States|United States|United States|United States|United States,August 2016
688,689,NCT04063215,Traumatic Brain Injury,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy,HB-adMSCs,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy,Houston,Texas,United States,"January 1, 2020"
689,690,NCT01301664,Mesenchymal Stem Cells,Cartilage Tissue Engineering,total knee / hip replacement,,,,,
690,691,NCT04689152,Alcoholic Cirrhosis,Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis,Cellgram-LC,"A Multicenter, Randomized, Open-label Phase III Clinical Trial to Evaluate Efficacy and Safety of the Cellgram-LC in Patients With Alcoholic Liver Cirrhosis",Bucheon|Cheonan|ChunCheon|ChunCheon|Gangneung-si|Seoul|Seoul|Seoul|Seoul|Wonju|Yongin,,"Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of","March 2, 2021"
691,692,NCT03691909,Rheumatoid Arthritis,Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis,HB-adMSCs,A Phase 1/2a Clinical Trial to Assess Safety of a Single IV Infusion of Autologous Adipose-derived Mesenchymal Stem Cells in Adults With Active Rheumatoid Arthritis,Pasadena,Texas,United States,"September 25, 2018"
692,693,NCT02241018,Acute Graft-versus-host Disease,MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD,CD25 monoclonal antibody|calcineurin inhibitors|MSCs,Mesenchymal Stem Cells Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation,Guangzhou,Guangdong,China,September 2014
693,694,NCT05130983,Crohn Disease|IBD - Irritable Bowel Disease,"A Phase I Study of ExoFlo, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Medically Refractory Crohn's Disease",Bone Marrow MSC Derived Extracellular Vesicle Isolate,"A Phase I Study of ExoFlo, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Medically Refractory Crohn's Disease",,,,"September 1, 2022"
694,695,NCT03254758,Decompensated Liver Cirrhosis,A Study of ADR-001 in Patients With Liver Cirrhosis,Mesenchymal stem cell,A Phase 1/2 Study of ADR-001 in Patients With Liver Cirrhosis,Niigata|Tokyo,,Japan|Japan,"July 20, 2017"
695,696,NCT00956891,Liver Failure|Mesenchymal Stem Cells,Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation,,Therapeutic Effects Including Short-term Changes And Long-term Outcomes of Liver Failure Patients Caused by Chronic Hepatitis B After Single Transplantation With Autologous Bone Marrow Mesenchymal Stem Cells.,Guangzhou,Guangdong,China,May 2005
696,697,NCT03014037,Osteoarthritis,Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration,Unilateral Bone Marrow Procurement|Bilateral Bone Marrow Procurement,Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration,Atlanta,Georgia,United States,"September 7, 2017"
697,698,NCT02013674,Chronic Ischemic Left Ventricular Dysfunction|Myocardial Infarction,The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study),Allogeneic hMSCs,"A Phase II, Randomized, Blinded, Study of the Safety and Efficacy of Transendocardial Injection of Allogeneic Human Mesenchymal Stem Cells (hMSCs) (20 Million or 100 Million Total MSCs) in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction.",Miami,Florida,United States,"February 13, 2014"
698,699,NCT02853942,"Injury of Facial Nerve, Unspecified Side, Initial Encounter",Autologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial Spasm,Autologous adipose stem cell therapy|Mecobalamin,The Research of Autologous Adipose Mesenchymal Stem Cell Transplantation for Treatment of Facial 、Auditory Nerve Dysfunction of Patients With Hemifacial Spasm After Microvascular Decompression.,,,,October 2016
699,700,NCT02561767,Kidney Transplantation|Acute Kidney Tubular Necrosis,Effect of BM-MSCs in DCD Kidney Transplantation,bone marrow-derived mesenchymal stem cells|Saline|Induction therapy (ATG or Basiliximab)|Maintenance therapy (Low-dose CNI + MPA + steroids),The Efficacy and Safety of Bone Marrow-derived Mesenchymal Stem Cells in Kidney Transplantation From Chinese Donation After Citizen Death (DCD): A Multi-center Randomized Controlled Trial,Guangzhou,Guangdong,China,October 2015
700,701,NCT02338375,Osteochondral Lesion of Talus,Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product,Cartistem,Clinical Trial of the Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product With Microfracture for Osteochondral Lesion of Talus Patients,Gangnam-Gu,Seoul,"Korea, Republic of",December 2012
701,702,NCT03877471,Primary Ovarian Insufficiency,Mesenchymal Stem Cells (MSCs) - Like Cell Transplantation in Women With Primary Ovarian Insufficiency,Cell therapy,Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Stem Cell (MSC)-Like Cells Transplantation in Women With Primary Ovarian Insufficiency (POI),Zhengzhou,Henan,China,"April 3, 2019"
702,703,NCT04522986,Severe Acute Respiratory Syndrome Coronavirus 2,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,Mesenchymal stem cell,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,Suita,Osaka,Japan,"August 21, 2020"
703,704,NCT03028428,Osteoarthritis|Stem Cells|MSC,Intra-articular Injection of MSCs in Treatment of Knee OA,Placenta Derived Mesenchymal Stem Cell|Sodium Hyaluronate,Clinical Research on Intra-articular Injection of Human Autologous MSCs in Treatment of Knee OA,,,,December 2016
704,705,NCT04905836,Covid19,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress,COVI-MSC|Placebo,Treatment of COVID-19-Induced Acute Respiratory Distress: A Phase 2 Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells,Brandon|Sarasota|Boise|Boise|Tulsa|Mesquite,Florida|Florida|Idaho|Idaho|Oklahoma|Texas,United States|United States|United States|United States|United States|United States,"November 16, 2021"
705,706,NCT04992247,Covid19,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",COVI-MSC|Placebo,"A Phase 2A Randomized, Placebo-Controlled Study of Intravenous Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",,,,November 2022
706,707,NCT04909879,Acute Respiratory Distress Syndrome|Ards,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome,COVI-MSC|Placebo,Treatment of Non-COVID-19 Acute Respiratory Distress Syndrome: A Phase 2 Study of the Efficacy and Safety of Intravenous Allogeneic Adipose-Derived Mesenchymal Stem Cells,,,,September 2021
707,708,NCT04728698,Covid19|ARDS,Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress,COVI-MSC|Placebo,Treatment of COVID-19-Induced Acute Respiratory Distress: A Phase 2 Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells,Fresno,California,United States,March 2021
708,709,NCT03137199,Asthma,Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma,hMSCs,"A Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Mild Asthma",Miami,Florida,United States,"June 22, 2017"
709,710,NCT01875081,Alcoholic Liver Cirrhosis,REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient),Livercellgram,Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient.,Seoul,,"Korea, Republic of",November 2012
710,711,NCT03684122,Parkinson Disease,Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).,Injection of Umbilical cord derived MSCs,A Safety and Efficacy Study of the Effects of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) on the Motor and Non-motor Symptoms in People With Parkinson's Disease (PD).,Amman,,Jordan,"June 1, 2018"
711,712,NCT04289194,Acute Respiratory Distress Syndrome,Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome,HCR040 (Phase 1)|Placebo (Phase 2)|HCR040 (Phase 2),"Phase 1/2 Clinical Study to Assess the Feasibility, Safety, Tolerability and Preliminary Efficacy of the Administration of HCR040, Allogeneic Adipose-derived Adult Mesenchymal Stem Cells, in Acute Respiratory Distress Syndrome",Barakaldo|Madrid,Bizkaia,Spain|Spain,"December 10, 2019"
712,713,NCT04466007,Limb Ischemia|Diabetic Foot,Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia,High dose allogeneic mesenchymal stromal cells|Low dose allogeneic mesenchymal stromal cells|Placebos,"Multicenter, Randomized, Dose-search, Parallel, Double-blind, and Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Intramuscular Administration of Allogeneic Adipose Tissue Adult Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia Without Possibility of Revascularization",Alicante|Madrid|Madrid|Madrid|Murcia|Pamplona|Salamanca|Sevilla|Valencia|Valladolid,,Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain,"January 11, 2021"
713,714,NCT03174587,Lupus Nephritis,Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis,allogenic bone marrow derived mesenchymal stem cells,A Phase 1 Study to Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis.,Seoul,,"Korea, Republic of","May 30, 2017"
714,715,NCT04355728,"Corona Virus Infection|ARDS|ARDS, Human|Acute Respiratory Distress Syndrome|COVID-19",Use of UC-MSCs for COVID-19 Patients,Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care.|Vehicle + Heparin along with best supportive care,Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients With Acute Respiratory Distress Syndrome (ARDS),Miami,Florida,United States,"April 25, 2020"
715,716,NCT03638154,Periodontal Intrabony Defect,Regenerative Potential of Cultured Gingival Fibroblast- Mesenchymal Stem Cells in Treatment of Periodontitis,GF+GMSCs carried on β TCP|β TCP bone substitute only,Clinical Regenerative Potential of Cultured Gingival Fibroblast- Mesenchymal Stem Cells in Treatment of Periodontal Intrabony Defects (Randomized Clinical and Biochemical Trial),,,,"March 15, 2016"
716,717,NCT05095532,Chronic Pancreatitis|Mesenchymal Stem Cells,Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT,Bone marrow-derived mesenchymal stem cells|Placebo,Autologous Mesenchymal Stromal Cells and Islet Co-transplantation to Enhance Islet Survival and Function in Chronic Pancreatitis Patients Undergo Total Pancreatectomy and Islet Autotransplantation,Charleston,South Carolina,United States,"December 1, 2021"
717,718,NCT01087996,Stem Cell Transplantation,The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study),Auto-hMSCs|Allo-hMSCs,"A Phase I/II, Randomized Pilot Study of the Comparative Safety and Efficacy of Transendocardial Injection of Autologous Mesenchymal Stem Cells Versus Allogeneic Mesenchymal Stem Cells in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction",Miami|Baltimore,Florida|Maryland,United States|United States,March 2010
718,719,NCT02195323,Chronic Kidney Disease,Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD),Intravenous injection,Administration of Autologous Bone Marrow Mesenchymal Stem Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD),Tehran,,"Iran, Islamic Republic of",April 2014
719,720,NCT02962661,Cardiomyopathy|Heart Failure|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines,Best Practice|Laboratory Biomarker Analysis|Mesenchymal Stem Cell Transplantation|Mesenchymal Stem Cell Transplantation,Randomized 3-Arm Trial With Standard of Care Alone vs Either Intravenous Infusion or Transendocardial Injection of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) Plus Standard of Care in Patients With Anthracycline-Associated Cardiomyopathy,Houston,Texas,United States,"July 18, 2020"
720,721,NCT01532076,Osteoporotic Fractures,Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts,Cellularized composite graft augmentation|Acellular composite graft augmentation,Effectiveness of Adipose Tissue Derived Mesenchymal Stem Cells as Osteogenic Component in Composite Grafts Versus Acellular Bone Graft Substitutes for Augmentation in the Treatment of Proximal Humeral Fractures as Model for Fractures of Osteoporotic Bone - a Prospective Randomized First in Men Proof of Principle Trial,Basel,Basel-Stadt,Switzerland,June 2012
721,722,NCT00498316,Myelodysplastic Syndrome|Leukemia,Cord Blood Expansion on Mesenchymal Stem Cells,Cord Blood Infusion|Busulfan|Fludarabine|Rituximab|ATG|Cyclophosphamide|Clofarabine|Total Body Irradiation (TBI)|Melphalan|Tacrolimus|Mycophenolate Mofetil|G-CSF,Cord Blood Expansion on Mesenchymal Stem Cells,Houston,Texas,United States,"July 3, 2007"
722,723,NCT01297218,Dementia of the Alzheimer's Type,The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease,Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells,"Open-Label, Single-Center, Phase 1 Clinical Trial to Evaluate the Safety and the Efficacy of NEUROTSTEM®-AD in Patients With Dementia of the Alzheimer's Type",Seoul,,"Korea, Republic of",February 2011
723,724,NCT00609661,Wound Healing|Burn,Adult Stem Cell Response to Burn Injury,,Comparison of Burn Severity and Patient Outcomes to the Subsets of Mesenchymal Stem Cells Identified in the Blood of Burn Victims,,,,February 2008
724,725,NCT04953572,Cartilage Injury,Treatment of Cartilage Defects With Peripheral Blood Stem Cells,autologous peripheral blood mesenchymal stem cell|Microfracture|Microfracture + collagen membrane|Autologous osteochondral transplantation,Autologous Peripheral Blood Mesenchymal Stem Cell Transplantation for Repair of Degree IV Local Cartilage Injury of Knee Joint,Beijing,Beijing,China,"August 1, 2021"
725,726,NCT04776239,Diabetes Mellitus|Ischemic Heart Disease,Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD),100 million Allogeneic Mesenchymal Human Stem Cells|Placebo,Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease.,Miami,Florida,United States,"August 16, 2021"
726,727,NCT01652209,Acute Myocardial Infarction,To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.,Hearticellgram-AMI,"A Randomized,Open labEled, muLticenter Trial for Safety and Efficacy of Intracoronary Adult Human Mesenchymal stEm Cells Acute Myocardial inFarction",Chuncheon|Chungnam|Gwangju|Gyeonggi-do|Incheon|Incheon|Seoul|Seoul|Seoul|Wŏnju,,"Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of","September 1, 2013"
727,728,NCT03059355,Endothelial Dysfunction|Metabolic Syndrome|Chronic Inflammation,Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.,UCMSCs|BMMSCs|Placebo,"A Phase I/II, Randomized, Placebo-controlled Comparative Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs to Evaluate Cytokine Suppression in Patients With Chronic Inflammation Due to Metabolic Syndrome.",Miami,Florida,United States,"April 12, 2018"
728,729,NCT03626090,Liver Cirrhosis,Mesenchymal Stem Cell Therapy for Liver Cirrhosis,Autologous BM MSC,Mesenchymal Stem Cell Therapy for Liver Cirrhosis: A Phase I/II Study,Singapore|Singapore|Singapore,,Singapore|Singapore|Singapore,"August 18, 2018"
729,730,NCT01159899,Osteoarthritis|Knee Osteoarthritis|Osteochondritis Dissecans|Osteonecrosis,Transplantation of Bone Marrow Stem Cells Stimulated by Proteins Scaffold to Heal Defects Articular Cartilage of the Knee,Transplantation of Bone Marrow Stem Cells Activated in Knee Arthrosis,Pilot Study of A One-Step Procedure for the Use of Autologous Bone Marrow Mesenchymal Stem Cells Stimulated by Proteins Scaffold to Heal Under Arthroscopy Full-Thickness Defects Articular Cartilage and Osteoarthrosis of the Knee.,Marseille,,France,July 2010
730,731,NCT04573270,Covid19|Prophylaxis,Mesenchymal Stem Cells for the Treatment of COVID-19,PrimePro|Placebo,A Pilot Phase Study Evaluating the Effects of a Single Mesenchymal Stem Cell Injection in Patients With Suspected or Confirmed COVID-19 Infection and Healthcare Providers Exposed to Coronavirus Patients,Culver City,California,United States,"April 24, 2020"
731,732,NCT03943940,Type 2 Diabetes Mellitus,BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients,BM-MNC and UC-MSC|Control,A Preliminary Safety and Efficacy Evaluation of Bone Marrow Mononuclear Cells (BM-MNCs) and Umbilical Cord Tissue-derived Mesenchymal Stem Cells (UC-MSC) Infusion for Type 2 Diabetes Mellitus (T2DM) Patients,Ho Chi Minh City,Ho Chi Minh,Vietnam,"April 24, 2019"
732,733,NCT01227694,"Osteoarthritis, Knee|Knee Injuries|Joint Diseases|Rheumatic Diseases|Cartilage Diseases",Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis,Autologous MSC knee implantation,Articular Cartilage Regeneration in Gonarthrosis Grade II and III by Articular Infiltration of Xcel-m-condro-alpha.,Barcelona,,Spain,October 2010
733,734,NCT00543374,Crohn's Disease,Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease,Placebo|PROCHYMAL adult human mesenchymal stem cells,"A Phase III, Multicenter, Placebo-controlled, Randomized, Double-blind Durability and Retreatment Study to Evaluate the Safety and Efficacy of PROCHYMAL® (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Maintenance and Re-induction of Clinical Benefit and Remission in Subjects Experiencing Treatment-refractory Moderate-to-severe Crohn's Disease",Anaheim|Long Beach|Los Angeles|San Francisco|Wheat Ridge|Hamden|Clearwater|Jacksonville|Miami|Winter Park|Atlanta|Chicago|Urbana|Indianapolis|Topeka|Lexington|Louisville|Baton Rouge|Bethesda|Chevy Chase|Boston|Boston|Worcester|Dearborn|Troy|Minneapolis|Saint Louis|Lebanon|Cedar Knolls|Teaneck|New York|New York|Rochester|Rochester|Stony Brook|Charlotte|Pinehurst|Winston-Salem|Dayton|Tulsa|Tulsa|Pittsburgh|Pittsburgh|Germantown|Nashville|Nashville|Dallas|Galveston|Houston|Burlington|Norfolk|Richmond|Seattle|Calgary|Edmonton|Winnipeg|London|Toronto,California|California|California|California|Colorado|Connecticut|Florida|Florida|Florida|Florida|Georgia|Illinois|Illinois|Indiana|Kansas|Kentucky|Kentucky|Louisiana|Maryland|Maryland|Massachusetts|Massachusetts|Massachusetts|Michigan|Michigan|Minnesota|Missouri|New Hampshire|New Jersey|New Jersey|New York|New York|New York|New York|New York|North Carolina|North Carolina|North Carolina|Ohio|Oklahoma|Oklahoma|Pennsylvania|Pennsylvania|Tennessee|Tennessee|Tennessee|Texas|Texas|Texas|Vermont|Virginia|Virginia|Washington|Alberta|Alberta|Manitoba|Ontario|Ontario,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|Canada|Canada|Canada|Canada|Canada,"September 17, 2007"
734,735,NCT02064062,"Achilles Tendinitis, Right Leg|Achilles Tendinitis|Achilles Degeneration|Achilles Tendon Thickening|Tendinopathy|Achilles Tendinitis, Left Leg",Autologous Stem Cells in Achilles Tendinopathy,Autologous Mesenchymal Stem Cells,Autologous Stem Cells in Achilles Tendinopathy,London,,United Kingdom,January 2015
735,736,NCT03822858,Multiple Sclerosis,Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis,Intrathecal MSC-NP injection,"Autologous, Bone Marrow-Derived Mesenchymal Stem Cell-Derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo; Administered Intrathecally",New York,New York,United States,
736,737,NCT04368806,"Osteoarthritis, Knee",A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis,JointStem|Placebo Control,"A 48-Weeks, Phase 2b/3a, Double-Blind, Randomized, Placebo Controlled, Multi-center, Superiority Study to Evaluate the Efficacy and Safety of JointStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells in Patients Diagnosed as Knee Osteoarthritis",El Cajon|La Mesa|Napa|Santa Monica|Washington|Egg Harbor Township|New York,California|California|California|California|District of Columbia|New Jersey|New York,United States|United States|United States|United States|United States|United States|United States,"May 26, 2021"
737,738,NCT01399749,Articular Cartilage Lesion of the Femoral Condyle,Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects,Implantation of autologous cells,A Comparative Clinical Trial for the Repair of Chondral Knee Defects: Transplantation of Autologous Cultured Chondrocytes vs. Autologous Mesenchymal Stem Cells Derived From Adipose Tissue,Madrid,,Spain,September 2011
738,739,NCT00883727,Myocardial Infarction,Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI,Stem cell|Plasmalyte A,"A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intravenous ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With st Elevated Acute Myocardial Infarction (Stemi)",Hyderabad|Ahmedabad|Bangalore|Bangalore,Andhra Pradesh|Gujarat|Karnataka|Karnataka,India|India|India|India,April 2009
739,740,NCT04348435,COVID-19,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",HB-adMSCs|Placebos,"A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs to Provide Immune Support Against COVID-19",Sugar Land,Texas,United States,"May 14, 2020"
740,741,NCT05131412,Pneumonia|Hematopoietic Stem Cell Transplantation,Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation,,Mesenchymal Stem Cells for the Treatment of Pneumonia Post Haematopoietic Stem Cell Transplantation: a a Retrospective Cohort Study,Guangzhou,Guangdong,China,"August 8, 2018"
741,742,NCT00690066,"Type 1 Diabetes Mellitus|Type 1 Diabetes|Diabetes Mellitus, Insulin-Dependent|Juvenile Diabetes",PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM),PROCHYMAL®|Placebo,"A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL® (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus",Birmingham|La Jolla|Stanford|Gainesville|Miami|Lexington|Minneapolis|Henderson|Las Vegas|Chapel Hill|Charlotte|Cincinnati|Dayton|Carlisle|Bartlett|Dallas|Salt Lake City|Norfolk|Madison|Milwaukee,Alabama|California|California|Florida|Florida|Kentucky|Minnesota|Nevada|Nevada|North Carolina|North Carolina|Ohio|Ohio|Pennsylvania|Tennessee|Texas|Utah|Virginia|Wisconsin|Wisconsin,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States,"June 11, 2008"
742,743,NCT02666391,Acute Myocardial Infarction|Myocardial Infarction|Ischemic Cardiomyopathy,Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD),umbilical cord mesenchymal stem cells,,,,,May 2016
743,744,NCT04706312,Diminished Ovarian Response,Transplantation of hAMSCs for Woman With DOR,stem cells,The Safety and Efficacy Assessment of Human Amniotic Mesenchymal Stem Cells(hAMSCs) Transplantation in Woman With Diminished Ovarian Reserve (DOR),Nanjing,Jiangsu,China,April 2021
744,745,NCT02062931,Premature Ovarian Failure,Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure,Stem Cell Preparation and Injection,Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure,Cairo,,Egypt,March 2012
745,746,NCT02381366,Bronchopulmonary Dysplasia,Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study,Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells,"A Phase I/II, Open-Label Dose Escalation Trial to Evaluate the Safety and Efficacy of Two Dose Levels of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD)",Chicago,Illinois,United States,March 2015
746,747,NCT04377334,ARDS|COVID-19,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),MSC,Prospective Phase II Study: MSCs in Inflammation-Resolution Programs of SARS-CoV-2 Induced ARDS,Tuebingen,,Germany,May 2022
747,748,NCT03920397,Type 1 Diabetes Mellitus,Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus,Infusion of adipose tissue-derived stem/stromal cells and oral Cholecalciferol supplementation,Allogenic Adipose Derived Mesenchymal Stem Cells and Vitamin D Supplementation in Patients With Recent-onset Type 1 Diabetes Mellitus,Rio de Janeiro,,Brazil,"March 1, 2015"
748,749,NCT03562715,Preeclampsia,microRNAs Role in Pre-eclampsia Diagnosis,,"Role of Mesenchymal Stem Cells Exosomes Derived microRNAs; miR-136, miR-494 and miR-495 in Pre-eclampsia Diagnosis and Evaluation",,,,"November 28, 2016"
749,750,NCT02442817,Schizophrenia,Linagliptin and Mesenchymal Stem Cells: A Pilot Study,Linagliptin,Linagliptin and Mesenchymal Stem Cells: A Pilot Study,Reno,Nevada,United States,"March 2, 2015"
750,751,NCT04914403,Frailty Syndrome,Mesenchymal Stem Cells for The Treatment of Frailty Syndrome,UMC119-06-05,"A Phase I, Open Label, Dose Escalation Study to Evaluate the Safety and Tolerability After Intravenous Infusion of UMC119-06-05 in Elderly Subjects With Mild to Moderate Frailty Syndrome.",New Taipei City,,Taiwan,"September 1, 2021"
751,752,NCT03847844,Acute-graft-versus-host Disease,UCMSCs as Front-line Approach of Treatment for Patients With aGVHD,Umbilical cord derived mesenchymal stem cell|Placebo,Cytopeutics® Umbilical Cord Mesenchymal Stem Cells (Cyto-MSC) for Patients With Grade II -IV Acute Graft-Versus-Host Disease: A Phase I/II Clinical Study,Ampang,Selangor,Malaysia,"February 1, 2019"
752,753,NCT03631420,Bronchopulmonary Dysplasia,Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants,Human Umbilical Cord Derived-Mesenchymal Stem Cells,The Safety and Feasibility of UMC119-01 Cell Therapy in Infants at High Risk for Bronchopulmonary Dysplasia,Tainan City,,Taiwan,"October 26, 2018"
753,754,NCT00976430,Parkinson's Disease,Autologous Mesenchymal Stem Cell Transplant for Parkinson's Disease,Autologous Bone marrow derived stem cells transplant,To Study the Safety and Efficacy of Bone Marrow Derived Mesenchymal Stem Cells Transplant in Parkinson's Disease,Mumbai,Maharashtra,India,July 2009
754,755,NCT05132972,Covid 19,Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients,Normoxic Allogenic UCMSC|Normal saline solution,Efficacy and Safety of Normoxic Allogenic Umbilical Cord Mesenchymal Stem Cells Administered as Adjuntive Treatment to Standard Treatment in Severe Patients With COVID-19,Surakarta|Bandung|Yogyakarta,Central Java|West Java,Indonesia|Indonesia|Indonesia,"January 17, 2021"
755,756,NCT04476901,Non-ischemic Dilated Cardiomyopathy,Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy,allogeneic human mesenchymal stem cells (hMSCs)|Placebo,"A Phase IIB Randomized, Placebo-Controlled, Multicenter Study of the Comparative Efficacy and Safety of Transendocardial Injection of Allogeneic-MSC Versus Placebo in Patients With Non- Ischemic Dilated Cardiomyopathy",Stanford|Miami|Louisville|Houston,California|Florida|Kentucky|Texas,United States|United States|United States|United States,"May 7, 2021"
756,757,NCT04206007,Chronic Obstructive Pulmonary Disease Moderate,Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease,UMC119-06,The Safety and Feasibility of UMC119-06 Cell Therapy in Subjects With Chronic Obstructive Pulmonary Disease,New Taipei City,,Taiwan,"June 11, 2020"
757,758,NCT03522545,Treatment-resistant Bipolar Depression,Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression,Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)|Placebo,Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression,Houston,Texas,United States,"June 1, 2021"
758,759,NCT01663376,Critical Limb Ischemia,Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia,Autologous Adipose Tissue derived MSCs Transplantation,Effects of Adipose Tissue Derived Stem Cells Implantation in Patients With Critical Limb Ischemia,Pusan,,"Korea, Republic of",January 2009
759,760,NCT05279768,Polycystic Ovary Syndrome,Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.,UC-MSCs|Secretomes|UC-MSCs and Secretomes|Control,Potential Use of Umbilical Cord Mesenchymal Stem Cells and Secretoms for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.,Jakarta,,Indonesia,"September 1, 2022"
760,761,NCT05315661,Frontotemporal Dementia,The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia,ET-STEM,Clinical Assessment on the Safety and Potential Efficacy of Mesenchymal Stem Cells Preconditioned With Ethionamide (ET-STEM) in Patients With Frontotemporal Dementia (FTD),,,,"May 17, 2022"
761,762,NCT00827398,Graft-versus-host-disease,Treatment of Steroid Resistant GVHD by Infusion MSC,MSC (hPPL),Treatment of Steroid Resistant Grade II to IV GVHD by Infusion MSCof Mesenchymal Stem Cells Expanded With Human Plasma and Platelet Lysate a Phase I/II Study,Utrecht|Utrecht,,Netherlands|Netherlands,January 2009
762,763,NCT02848131,Chronic Kidney Disease,Senescence in Chronic Kidney Disease,Group 2: Dasatinib|Group 2: Quercetin,"Senescence, Frailty, and Mesenchymal Stem Cell Functionality in Chronic Kidney Disease: Effect of Senolytic Agents",Rochester,Minnesota,United States,July 2016
763,764,NCT01394432,Acute Myocardial Infarction|Heart Failure,"""ESTIMATION Study"" for Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction",PCI and Stem Cells or Placebo injections,Endocardial Mesenchymal Stem Cells Implantation in Patients After Acute Myocardial Infarction,Novosibirsk,,Russian Federation,July 2011
764,765,NCT02982915,Aging Frailty,Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty,Longeveron Mesenchymal Stem Cells (LMSCs)|Fluzone High Dose Vaccine,Effects of Intravenous Delivery of Lomecel-B (Formerly Allogenic Longeveron Human Mesenchymal Stem Cells (LMSCs)) on VaccinE-Specific Antibody Responses in Subjects With Aging Frailty,Coral Gables|Fort Myers|Miami|Miami|Baltimore|Rockville,Florida|Florida|Florida|Florida|Maryland|Maryland,United States|United States|United States|United States|United States|United States,November 2016
765,766,NCT04893174,"Osteoarthritis, Knee",Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).,UMC119-06-05|Hyaluronic acid,"A Phase 1, Open Label, Dose Escalation Study to Evaluate the Safety and Tolerability After Intra Articular (IA) Injection of UMC119-06-05 in Adult Subjects With Mild to Moderate Knee Osteoarthritis(KOA).",Taipei,,Taiwan,January 2022
766,767,NCT01844661,Children|Solid Tumors|Metastases,Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.,CELYVIR,Phase 1 Trial of Celyvir in Children and Adults With Metastatic and Refractory Solid Tumors.,Madrid,,Spain,January 2013
767,768,NCT02003131,Osteoarthritis of the Knee,Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis,Trophic factors from umbilical cord mesenchymal stem cells,Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis,Panama City,,Panama,December 2013
768,769,NCT03123458,Immune Related Disorder|Tissue Damage,Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders,clonal fetal MSCs,Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders,Beijing|Shenzhen|Beijing,Beijing|Guangdong,China|China|China,"January 1, 2016"
769,770,NCT03631589,Steroid-resistant Severe aGVHD,MSC for Severe aGVHD,MSCs,Treatment of Steroid-resistant Severe Acute Graft-versus-host Disease With Mesenchymal Stem Cells,Fuzhou,Fujian,China,"December 1, 2017"
770,771,NCT02192736,Asthma,Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma,Trophic factors from umbilical cord mesenchymal stem cells,Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma,Panama City,,Panama,July 2014
771,772,NCT03516006,Primary Sclerosing Cholangitis,Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis,UCMSC|UDCA,Intra-arterial Injection of Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis,,,,January 2017
772,773,NCT02083731,"Stem Cell Transplantation, Hematopoietic|CMV Infection|Hematological Diseases",MSC for Treatment of CMV Infection,MSCs,Mesenchymal Stem Cells for Treatment of CMV Infection After Hematopoietic Stem Cell Transplant,Guangzhou,Guangdong,China,January 2014
773,774,NCT01981330,Improved Healing of Scarred Vocal Folds|Improved Vocal Fold Status|Improved Vocal Fold Function,Pilot Study of Stem Cell Treatment of Patients With Vocal Fold Scarring,aMSC|aMSC+hyaluronan gel,Pilot Study of Patients With Severe Hoarseness and Vocal Fold Scarring Treated With Mesenchymal Stem Cells With and Without Hyaluronan Gel,Stockholm,,Sweden,January 2012
774,775,NCT02917681,AMYOTROPHIC LATERAL SCLEROSIS,Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis,Two intrathecal MSC injections,,Sao Paulo,SP,Brazil,September 2016
775,776,NCT03743155,Xerostomia Due to Radiotherapy,Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy,mesenchymal cells,"Phase II Clinical Trial to Evaluate the Effect and Safety of MSV * in Xerostomia * Adult Autologous Bone Marrow Mesenchymal Stem Cells, Expanded Under GMP of IBGM",Barcelona,,Spain,"December 15, 2018"
776,777,NCT02958267,Knee Osteoarthritis,Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee,BMAC injection|PRP injection|Gel-One® hyaluronate injection,Investigation of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee: Effect on Pain and Quality of Life,Columbus,Ohio,United States,December 2016
777,778,NCT05333029,Graft Versus Host Disease,Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD,Allogeneic mesenchymal stromal cells (MSCs)|Extracorporeal photopheresis (ECP),A Phase II Study of Combination Treatment With Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for High-Risk and Steroid-Refractory Acute GVHD,Cleveland,Ohio,United States,October 2022
778,779,NCT04939337,Crohn's Disease,A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.,TH-SC01,"Study to Assess the Safety and Efficacy of Allogeneic Umbilical Cord-derived Mesenchymal Stem Cells(TH-SC01), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.",Nanjing,Jiangsu,China,"November 12, 2020"
779,780,NCT04339660,COVID-19,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,UC-MSCs|Placebo,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,Wuhan,Hubei,China,"February 1, 2020"
780,781,NCT05152368,Peripheral Neuropathy|Trigeminal Neuralgia,Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy,AlloRx,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Trigeminal Neuralgia and Peripheral Neuropathy,St. John's,,Antigua and Barbuda,January 2022
781,782,NCT03925324,Ischemic Heart Disease|Non-ischemic Cardiomyopathy,Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device,Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)|Placebo,"A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of the Safety and Efficacy of Intravenous Delivery of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients and Implanted Left Ventricular Assist Device",Washington,District of Columbia,United States,"May 3, 2019"
782,783,NCT03033277,Primary Ovarian Insufficiency,Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI),Placebo transplantation|HUC-MSCs transplantation,Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI),Beijing,Beijing,China,February 2016
783,784,NCT05167188,Graft Vs Host Disease,Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells,no intervention,Prospective Multicenter Study for the Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells - GvHD Damage on MSCs,Torino,,Italy,"October 14, 2021"
784,785,NCT05288725,"Osteoarthritis, Knee",Mesenchymal Stem Cell Therapy for Knee Osteoarthritis,Bone Marrow Derived MSCs|Corticosteroid|Bone Marrow Aspirate,"A Study to Evaluate the Safety, and Efficacy of Minimally Manipulated Autologous Bone Marrow Aspirate to Treat Knee Osteoarthritis in Patients",Chesterfield|Steubenville|Salt Lake City,Missouri|Ohio|Utah,United States|United States|United States,August 2022
785,786,NCT05147779,Erectile Dysfunction|Peyronie's Disease|Interstitial Cystitis,"Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis",AlloRx,"Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Peyronie's Disease, Erectile Dysfunction, and Interstitial Cystitis",St. John's,,Antigua and Barbuda,December 2021
786,787,NCT01824121,Progressive Supranuclear Palsy,"Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism",stem cell therapy,"Autologous Mesenchymal Stem Cell Therapy in Progressive Supranuclear Palsy: a Randomized, Double-blind, Controlled Clinical Trial",Milano,,Italy,December 2012
787,788,NCT03158896,Acute Graft Versus Host Disease,Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease,MSCTC-0010 Dose Escalation,"A Phase I Study To Evaluate the Safety of Umbilical Cord - Derived, Ex-Vivo Cultured and Expanded Wharton's Jelly Mesenchymal Stem Cells for the Treatment of De Novo High Risk Acute or Steroid Refractory Acute Graft Versus Host Disease",Kansas City,Kansas,United States,"July 9, 2018"
788,789,NCT02237547,Spinal Cord Injury,Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury,Intravenous and intrathecal human umbilical cord tissue-derived mesenchymal stem cells and bone marrow mononuclear cells,Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury,Panama City,,Panama,September 2014
789,790,NCT03509025,Knee Osteoarthritis,Follow-up Study for Participants Jointstem Clinical Trial,Jointstem,"Open, Multicenter Follow-up Trial About Active Group of Phase IIb Clinical Trial of JOINTSTEM in Patients With Degenerative Arthritis",Seoul|Seoul,,"Korea, Republic of|Korea, Republic of","February 8, 2017"
790,791,NCT04520945,"Osteoarthritis, Knee",Phase 2B Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis,Chondrogen|Placebo,Phase 2B: Randomized Double-Blinded Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis,Cheras,Kuala Lumpur,Malaysia,"October 31, 2020"
791,792,NCT01318330,Graft-vs-Host Disease,Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD),Homeo-GH,"Five-Week, Multi-center, Phase I Clinical Trial to Evaluate Safety of Homeo-GH After Intra Venus Administration for the Treatment of Graft Versus Host Disease Patients",In Cheon|Seoul|Seoul|Seoul,,"Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of",November 2010
792,793,NCT05507697,Diabetic Peripheral Neuropathy Type 2,Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy,HUC-MSCs|Lipoic Acid,Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Refractory Diabetic Peripheral Neuropathy,Wuhan,Hubei,China,"May 19, 2022"
793,794,NCT02672280,Wounds|Diabetic Foot Ulcers|Burns,Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects,Medical Collagen Membrane with MSC|Medical Collagen Membrane,,,,,May 2016
794,795,NCT01454336,Liver Fibrosis,Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone,Cell injection,Phase 1 Trial of Combined Pioglitazone Plus Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients With Compensated Cirrhosis,Tehran,,"Iran, Islamic Republic of",June 2010
795,796,NCT05354141,COVID-19 Acute Respiratory Distress Syndrome,Bone Marrow Mesenchymal Stem Cell Derived EVs for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS): A Phase III Clinical Trial,EXOFLO,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles as Early Goal Directed Therapy for COVID-19 Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS):,Mesquite,Texas,United States,"July 1, 2022"
796,797,NCT00683722,"Pulmonary Disease, Chronic Obstructive|Pulmonary Emphysema|Chronic Bronchitis",PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD),Prochymal™|Placebo,"A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL™ (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Treatment of Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)",Los Angeles|Torrance|Charlotte|Greenville|Spartanburg|Burlington,California|California|North Carolina|South Carolina|South Carolina|Vermont,United States|United States|United States|United States|United States|United States,"March 20, 2008"
797,798,NCT02352077,Spinal Cord Injury,NeuroRegen Scaffold™ With Stem Cells for Chronic Spinal Cord Injury Repair,NeuroRegen scaffold with BMMCs or MSCs transplantation,Safety and Efficacy of NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells or Mesenchymal Stem Cells for Chronic Spinal Cord Injury Repair,Beijing|Suzhou|Tianjin,,China|China|China,January 2015
798,799,NCT01742533,Premature Ovarian Failure，,Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure,human umbilical cord mesenchymal stem cells|hUCMSCs and hCBMNCs|human cord blood mononuclear cells|Hormone Replacement Therapy,A Phase Ι/Π Study of Human Cord Blood Mononuclear Cells and Human Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Hormone Replacement Therapy in Patients With Premature Ovarian Failure,Shenzhen,Guangdong,China,March 2012
799,800,NCT02809781,"Spondylitis|Spondylitis, Ankylosing|Ankylosis|Arthritis|Spondylarthritis|Spondylarthropathies|Spinal Diseases|Musculoskeletal Diseases|Bone Diseases",A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis,Intravenous infusion of MSCs|Etanercept,Phase III Study of Human Bone Marrow-Derived Mesenchymal Stem Cells to Treat AS,Guangzhou,Guangdong,China,June 2016
800,801,NCT02326935,Multiple Sclerosis,Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis,Autologous adipose derived mesenchymal cells,"Proposal for a Non-randomized, Patient Sponsored, Multi-center Study Studying the Impact and Safety of the Utilization of Culture Expanded Autologous, Adipose-derived Mesenchymal Stem Cells Deployed Via Intravenous Injection for the Treatment of Multiple Sclerosis",George Town,,Cayman Islands,November 2014
801,802,NCT02570932,Spinal Cord Injury,Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries,Autologous Mesenchymal Bone Marrow Cell,Intrathecal Administration (Pattern 100/3) of Expanded Autologous Adult Bone Marrow Mesenchymal Stem Cells in Established Chronic Spinal Cord Injuries,Majadahonda,Madrid,Spain,July 2015
802,803,NCT01539902,Lupus Nephritis,Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis,Human Umbilical Cord derived MSCs|Cyclophosphamide,"A Randomized, Double Blind, Parallel Group, Placebo Controlled Research of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis",Kunming,Yunan,China,February 2012
803,804,NCT01696591,"Alzheimer Disease|Dementia|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases|Tauopathies|Neurodegenerative Diseases|Delirium, Dementia, Amnestic, Cognitive Disorders|Mental Disorders",The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD,NEUROSTEM®-AD,The Long-Term Safety and Efficacy Follow-up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD,Seoul,,"Korea, Republic of",March 2012
804,805,NCT04776538,Xerostomia Following Radiotherapy,Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients,Stem cells|Placebo,"A Single-centre, Double-blinded, Randomised, Placebo-controlled, Phase II Study to Investigate the Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients (MESRIX-III)",Copenhagen,,Denmark,"February 9, 2021"
805,806,NCT04623606,Osteogenesis Imperfecta,Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones,BOOST cells,"Exploratory, Open Label, Multiple Dose, Phase I/II Trial Evaluating Safety, Efficacy of Intravenous and Intraosseous Infusion of Allogeneic Fetal Mesenchymal Stem In Treatment of Severe Osteogenesis Imperfecta Compared With Historical and Untreated Prospective Controls",Vellore,Tamil Nadu,India,"May 20, 2019"
806,807,NCT00284986,Graft Versus Host Disease,Safety and Efficacy of Prochymal® for the Salvage of Treatment-Refractory Acute GVHD Patients,Prochymal®,A Phase II Open Label Study to Evaluate the Safety and Efficacy of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Salvage of Treatment-Refractory Acute GVHD Patients,Durham,North Carolina,United States,"November 18, 2005"
807,808,NCT02210624,Anoxic Brain Injury,Safety and Efficacy Assessment of Autologous Bone-marrow Derived Adult Mesenchymal Stem Cell Therapy in Patients With Anoxic(or Hypoxic) Brain Injury Pilot Trial,HYNR-CS inj.,"An Open-label, Safety and Efficacy Assessment of Autologous Bone-marrow Derived Mesenchymal Stem Cell Therapy in Anoxic (or Hypoxic) Brain Injury.",Seoul,,"Korea, Republic of",March 2013
808,809,NCT05176366,Ulcerative Colitis,Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis,ExoFlo,"A Phase I Study of ExoFlo, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Medically Refractory Ulcerative Colitis",,,,"December 1, 2022"
809,810,NCT00482092,Crohn's Disease,Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease,Prochymal®|Placebo,"A Phase III, Multicenter, Placebo-controlled, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of PROCHYMAL® (ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion for the Induction of Remission in Subjects Experiencing Treatment-refractory Moderate-to-severe Crohn's Disease",Los Angeles|San Francisco|Wheat Ridge|Clearwater|Jacksonville|Winter Park|Atlanta|Chicago|Urbana|Indianapolis|Topeka|Lexington|Louisville|Baton Rouge|Baltimore|Bethesda|Chevy Chase|Boston|Boston|Worcester|Dearborn|Troy|Minneapolis|Saint Louis|Lebanon|New York|New York|Rochester|Rochester|Stony Brook|Charlotte|Pinehurst|Winston-Salem|Tulsa|Tulsa|Pittsburgh|Pittsburgh|Germantown|Nashville|Nashville|Dallas|Galveston|Houston|Burlington|Norfolk|Richmond|Seattle|Adelaide|Melbourne|Calgary|Edmonton|Winnipeg|London|Toronto|Christchurch|Hamilton,California|California|Colorado|Florida|Florida|Florida|Georgia|Illinois|Illinois|Indiana|Kansas|Kentucky|Kentucky|Louisiana|Maryland|Maryland|Maryland|Massachusetts|Massachusetts|Massachusetts|Michigan|Michigan|Minnesota|Missouri|New Hampshire|New York|New York|New York|New York|New York|North Carolina|North Carolina|North Carolina|Oklahoma|Oklahoma|Pennsylvania|Pennsylvania|Tennessee|Tennessee|Tennessee|Texas|Texas|Texas|Vermont|Virginia|Virginia|Washington|South Australia|Victoria|Alberta|Alberta|Manitoba|Ontario|Ontario,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|Australia|Australia|Canada|Canada|Canada|Canada|Canada|New Zealand|New Zealand,"September 17, 2007"
810,811,NCT04527224,Covid19 Pneumonia,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,AstroStem-V,A Phase I/Ⅱa Trial to Explore the Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stem Cell (AstroStem-V) Therapy in Patients With COVID-19 Pneumonia,Phoenix|Dallas,Arizona|Texas,United States|United States,"October 1, 2022"
811,812,NCT02484560,Duchenne Muscular Dystrophy,Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2,Biological: Umbilical Cord Based Allogenic Mesenchymal Stem Cell,Efficacy of Allogenic Mesenchymal Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2,Gaziantep,,Turkey,June 2015
812,813,NCT03887208,Skin|Scar|Cutis Laxa|Keloid|Cicatrix,Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells,Laser therapy|Autologous ADSC injection|Normal saline injection,Evaluation the Safety and Efficacy of the Treatment of Scars and Cutis Laxa Syndrome With the Use of Autologous (Fresh and Stored) Stem Cells Isolated From Adipose Tissue.,Warsaw|Warsaw|Warsaw,,Poland|Poland|Poland,"January 31, 2018"
813,814,NCT05520086,Chronic Conjunctivitis|Stevens-Johnson Syndrome|Lyell Syndrome|Pemphigoid,Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.,Single Dose|Double Dose,"Phase IIa Multicenter Clinical Trial to Determine the Feasibility and Safety of the Use of Adipose-derived Mesenchymal Stem Cells (ASC) in the Treatment of Patients With Cicatricial Conjunctivitis Associated With Lyell's Syndrome, Stevens-Johnson Syndrome and Pemphigoid of the Mucous Membranes With Ocular Involvement.",Oviedo|Barakaldo|Alcázar De San Juan|Córdoba|Madrid|Madrid|Madrid|Valladolid,Asturias|Bizkaia|Ciudad Real,Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain,September 2022
814,815,NCT03706482,Osteogenesis Imperfecta,Boost Brittle Bones Before Birth,BOOST cells,"An Exploratory, Open Label, Multiple Dose, Multicentre Phase I/II Trial Evaluating Safety and Efficacy of Postnatal or Prenatal and Postnatal Intravenous Administration of Allogeneic Expanded Fetal Mesenchymal Stem Cells for the Treatment of Severe Osteogenesis Imperfecta Compared With a Combination of Historical and Untreated Prospective Controls",Stockholm,,Sweden,"August 12, 2019"
815,816,NCT03589287,Knee Osteoarthritis,Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis,Chondrochymal®,A Phase I/IIa Clinical Study of Treatment for Knee Osteoarthritis by Intra-articular Injection of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells.,Taipei,,Taiwan,"May 2, 2018"
816,817,NCT05349565,Knee Osteoarthritis,Effects of Muscle Energy Technique in Knee Osteoarthritis Patients,CONVENTIONAL PHYSICAL THERAPY|MUSCLE ENERGY TECHNIQUE,Effects of Muscle Energy Technique Along Conventional Physical Therapy After Mesenchymal Stem Cell Transplantation in Knee Osteoarthritis Patients,Islamabad,,Pakistan,"September 13, 2022"
817,818,NCT03525418,HLHS,Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS),Longeveron Mesenchymal Stem Cells,Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS),Atlanta|Baltimore|Baltimore|Cincinnati|Salt Lake City,Georgia|Maryland|Maryland|Ohio|Utah,United States|United States|United States|United States|United States,"February 21, 2018"
818,819,NCT01297205,Bronchopulmonary Dysplasia,Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia,Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells,"Open Label, Single-Center, Phase 1 Clinical Study to Evaluate the Safety and the Efficacy of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia",Seoul,,"Korea, Republic of",December 2010
819,820,NCT03799718,"Multiple Sclerosis, Chronic Progressive",Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS,NurOwn (MSC-NTF cells),"A Phase 2 Open-label Multicenter Study to Evaluate the Safety and Efficacy of Repeated Administration of NurOwn® [Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors (NTF), MSC-NTF] Cells in Participants With Progressive MS",Los Angeles|Redwood City|New York|Cleveland,California|California|New York|Ohio,United States|United States|United States|United States,"March 13, 2019"
820,821,NCT05387278,COVID-19 Acute Respiratory Distress Syndrome|Respiratory Distress Syndrome,Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19),EV-Pure™ and WJ-Pure™|Placebo,Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19),Liberty,Missouri,United States,June 2022
821,822,NCT01393977,Spinal Cord Injuries,Difference Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With Spinal Cord Injury in China,rehabilitation of limb function|Stem Cells Transplantation,Efficacy Difference Between Rehabilitation Therapy and Umbilical Cord Derived Mesenchymal Stem Cells Transplantation in Patients With Acute or Chronic Spinal Cord Injury in China,Beijing,,China,January 2011
822,823,NCT04497805,Diabetic Foot Ulcer,Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers,ALLO-ASC-SHEET,A Phase 2 Clinical Study to Evaluate The Efficacy and Safety of ALLO-ASC-SHEET in the Subjects With Diabetic Wagner Grade II Foot Ulcers,Los Angeles,California,United States,"August 1, 2020"
823,824,NCT04536233,MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries,Effects of MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries,MSCs Derived Pleiotropic Factors|physiological saline,The Safety and Effectiveness of Mesenchymal Stem Cell-derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries,,,,"October 10, 2020"
824,825,NCT02923375,Graft vs Host Disease,A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease,Mesenchymoangioblast-derived mesenchymal stem cells,An Open-Label Phase 1 Study to Investigate the Safety and Efficacy of CYP-001 for the Treatment of Adults With Steroid-Resistant Acute Graft Versus Host Disease,Sydney|Adelaide|Bristol|Leeds|Liverpool|Manchester|Nottingham,New South Wales|South Australia,Australia|Australia|United Kingdom|United Kingdom|United Kingdom|United Kingdom|United Kingdom,"March 1, 2017"
825,826,NCT01873547,Spinal Cord Injury,Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China,cell therapy|rehabilitation,Different Efficacy Between Rehabilitation Therapy and Umbilical Cord Derived Mesenchymal Stem Cells Transplantation in Patients With Chronic Spinal Cord Injury in China,Beijing,Beijing,China,June 2012
826,827,NCT01719640,"Diabetes Mellitus, Type 2",MSC and BMMNC in Type 2 Diabetes Mellitus,infusion of BMMSCs|infusion BMMNCs|insulin,Autologous Bone Marrow Mesenchymal Stem Cell and Bone Marrow Mononuclear Cell Infusion in Type 2 Diabetes Mellitus,Fuzhou,Fujian,China,January 2011
827,828,NCT02107118,Erectile Dysfunction|Cardiac Disease,Stem Cells for the Improvement of Erectile and Cardiac Function in Aging Men,ARM 1: AdMSC: adipose stem cells|ARM 2: Placebo,H-34570: PHASE I Study: The Use of Autologous Adipose Tissue-Derived Mesenchymal Stem Cell (AdMSC) for the Improvement of Erectile and Cardiac Function in Aging Men,Houston,Texas,United States,May 2015
828,829,NCT01220492,Liver Cirrhosis,Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis,conventional plus MSC treatment|conventional plus placebo treatment,Phase 1/2 Study of UC-MSC Treatment for the Evaluation the Efficacy and Safety in Patients With Liver Cirrhosis,Beijing,Beijing,China,May 2009
829,830,NCT03369275,Septic Shock|Sepsis|Pathologic Processes|Shock|Infection|Systemic Inflammatory Response Syndrome|Inflammation,Cellular Immunotherapy for Septic Shock,Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|Placebo,Cellular Immunotherapy for Septic Shock (CISS2) A Phase II Randomized Controlled Trial,,,,March 2018
830,831,NCT03325504,Non Union Fracture,A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union,Cultured Mesenchymal Stem Cells|Autologous iliac crest graft,"A Multi-centre, Open-label, Randomized, Comparative Clinical Trial of Two Doses of Bone Marrow Autologous MSC+ Biomaterial vs Iliac Crest Autologous Graft, for Bone Healing in Non-union After Long Bone Fractures",Clermont-Ferrand|Créteil|Nantes|Toulouse|Tours|Frankfurt|Freiburg|Munich|Ulm|Bologna|Brescia|Milano|Majadahonda|Madrid|Madrid|Madrid|Madrid|Madrid|Madrid,Madrid,France|France|France|France|France|Germany|Germany|Germany|Germany|Italy|Italy|Italy|Spain|Spain|Spain|Spain|Spain|Spain|Spain,"September 5, 2017"
831,832,NCT00826046,Graft-Versus-Host Disease,Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute Graft Versus Host Disease (GVHD),Prochymal®,Expanded Access of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD,Beech Grove|Boston|New York,Indiana|Massachusetts|New York,United States|United States|United States,
832,833,NCT03865394,Diabetic Foot Ulcer,Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells,Application of allogeneic ADSC stem cells in fibrin gel|Standard care in diabetic foot ulcer,Evaluation of the Safety and Efficacy of the Treatment of Chronic Wounds in Diabetic Foot Syndrome With the Use of Allogeneic Stem Cells Isolated From Adipose Tissue,Warsaw,,Poland,"July 1, 2019"
833,834,NCT03828344,Rheumatoid Arthritis,Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis,hUC-MSC suspension|Placebo,"A Phase 1 Randomized, Placebo-Controlled, Double-Blind Study of the Safety and Tolerability of a Single Intravenous Infusion of BX-U001, a Human Umbilical Cord Tissue Derived Mesenchymal Stem Cell Product, for Refractory Rheumatoid Arthritis",,,,July 2023
834,835,NCT03356821,Perinatal Arterial Ischemic Stroke|Neonatal Stroke,Perinatal Arterial Stroke Treated With Stromal Cells Intranasally,Mesenchymal Stem Cells,Adult Mesenchymal Stromal Cells to Regenerate the Neonatal Brain: the PASSIoN Trial (Perinatal Arterial Stroke Treated With Stromal Cells IntraNasally),Utrecht,,Netherlands,"February 11, 2020"
835,836,NCT02513238,Xerostomia,Mesenchymal Stemcells for Radiation Induced Xerostomia,Mesenchymal stem cell|Isotonic NaCl,Mesenchymal Stem Cells for Radiation-induced Xerostomia (MESRIX) in Previous HPV-positive Oropharyngeal Head and Neck Cancer Patients - A Safety and Feasibility Study,,,,"August 8, 2015"
836,837,NCT02054208,Alzheimer's Disease,Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease,human umbilical cord blood derived mesenchymal stem cells|Normal saline 2mL,"A Double-blind, Single-center, Phase 1/2a Clinical Trial to Evaluate the Safety and Exploratory Efficacy of Intraventricular Administrations of NEUROSTEM® Versus Placebo Via an Ommaya Reservoir in Patients With Alzheimer's Disease",Seoul,,"Korea, Republic of",March 2014
837,838,NCT04297813,Alveolar Bone Atrophy,Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting,Advanced medicinal Therapy (MSC combined with biomaterial)|Autologous bone graft,Randomized Controlled Clinical Trial to Assess the Efficacy of a Combination of Autologous Mesenchymal Stem Cells and Biomaterial in Jaw Bone Regeneration Prior to Dental Implant Placement in Comparison to Standard Autologous Bone Grafting,Odense|Créteil|Nantes|Bergen|Madrid|Barcelona,"Hordaland|Calle Fernando De Castro Rodriguez,",Denmark|France|France|Norway|Spain|Spain,March 2020
838,839,NCT00515307,"Hypercholesterolemia, Familial",Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia,Cellular transplantation,In-Vitro Transdifferentiation of Mesenchymal Stem Cells to Hepatocytes and Allogenic Transplantation of Hepatocytes to the Patients With Homozygous Familial Hypercholesterolemia,Tehran,,"Iran, Islamic Republic of",June 2007
839,840,NCT02290886,Amyotrophic Lateral Sclerosis,A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral,Intravenous administration of placebo|Intravenous administration of 1 million of MSC|Intravenous administration of 2 million of MSC|Intravenous administration of 4 million of MSC,"A Multicenter Phase I/II Clinical Trial, Randomized, Controlled With Placebo, Triple Blind to Evaluate Safety, and Indications of Efficiency of the Intravenous Administration of the Therapy With 3 Doses of MSC in Patients With ASL Moderated to Severe",Cordoba|Málaga|Seville|Seville,,Spain|Spain|Spain|Spain,July 2014
840,841,NCT02789995,Sepsis,Dysfunctions of Human Muscle Stem Cells in Sepsis,Human biological samples,Dysfunctions of Human Muscle Stem Cells in Sepsis,Créteil|Paris|Paris|Paris|Paris|Paris|Paris,,France|France|France|France|France|France|France,"June 23, 2016"
841,842,NCT03325322,Chronic Kidney Diseases|Diabetes Mellitus|Diabetic Nephropathies,Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease,Fisetin|Placebo oral capsule,"Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease",Rochester,Minnesota,United States,"January 2, 2018"
842,843,NCT01754454,Acute GVH Disease,Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease,Human Umbilical Cord Derived MSC,"Open-Label, Single-Center, Self Control, Phase Ⅰ/Ⅱ Clinical Trial to Evaluate the Safety and the Efficacy of Umbilical Cord-derived Mesenchymal Stem Cells in Patients With Acute Graft-versus-host Disease",Beijing|Beijing,,China|China,December 2012
843,844,NCT04551443,Acute Myocardial Infarction,WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction,Intravenous infusion placebo|Intravenous infusion WJMSCs,"Randomised, Double-blind, Placebo-controlled, Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Acute Myocardial Infarction",,,,"November 1, 2020"
844,845,NCT03855631,Kabuki Syndrome 1,Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders,Intervention on primary cultured cells,Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders,Montpellier,Herault,France,"September 28, 2020"
845,846,NCT05155657,Alcoholic Cirrhosis,Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells,Conventional therapy plus low dose UCMSCs treatment|Conventional therapy plus medium dose UCMSCs treatment|Conventional therapy plus high dose UCMSCs treatment,"A Pilot Clinical Study to Evaluate Safety, Tolerability and Preliminary Efficacy of Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cell in the Treatment of Decompensated Alcoholic Cirrhosis",Yantai,Shandong,China,"June 13, 2022"
846,847,NCT04288934,Spinal Cord Injuries,Treatment of Spinal Cord Injuries With (AutoBM-MSCs)vs (WJ-MSCs).,Collection and expansion of BM-MSC|VI-SCI evaluation and patients' follow up,Assessment of Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Spinal Cord Injury (SCI) Patients.,Amman,,Jordan,"August 15, 2017"
847,848,NCT02407470,Severe Aplastic Anemia,Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia,Rabbit antithymoglobulin (ATG)|Adipose derived mesenchymal stem cells ( AD-MSCs)|AD-MSC transdifferentiated HSCs (AD-HSCs),"A Multicenter, Randomized, Controlled Study of the Efficacy and Safety of the Combination of Adipose Tissue-derived Hematopoietic Stem Cells (AD-HSCs) and ATG in the Treatment of Severe Aplastic Anemia",Beijing,Beijing,China,January 2015
848,849,NCT01849159,Pulmonary Emphysema,"Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema",Mesenchymal stem cells|Reference therapy: 400 mL of 0.9% NaCl solution,"Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema",Moscow,Moscow Region,Russian Federation,March 2014
849,850,NCT05151133,Allergic Rhinitis,Clinical Study of Allergic Rhinitis Therapy by Stem Cells,Low dose UCMSCs|Moderate dose UCMSCs|High dose UCMSCs,Clinical Study of Moderate to Severe Persistent Allergic Rhinitis Therapy by Human Umbilical Cord Mesenchymal Stem Cells,Yantai,Shandong,China,"June 13, 2022"
850,851,NCT02815423,Fracture|Bone Nonunion,Safety and Exploratory Efficacy Study of UCMSCs in Patients With Fracture and Bone Nonunion,UCMSCs|Percutaneous,,,,,January 2017
851,852,NCT04428801,COVID-19,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,autologous adipose-derived stem cells,Clinical Study for the Prophylactic Efficacy of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) Against Coronavirus 2019 (COVID-19),,,,September 2022
852,853,NCT02240992,"Stem Cell Transplantation, Hematopoietic|Poor Graft Function|Delayed Platelet Engraftment|Hematological Diseases",MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment,PBSC|MSCs,Mesenchymal Stem Cells With or Without G-CSF Mobilized Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplant,Guangzhou,Guangdong,China,September 2014
853,854,NCT04657315,"Glioblastoma|Adult Gliosarcoma|Neoplasms, Brain|Neoplasms, Germ Cell and Embryonal|Recurrent Glioblastoma","Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients",MSC11FCD,"Investigator-initiated and Open-labeled Clinical Trial for Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients",Seongnam,Kyunggido,"Korea, Republic of","June 24, 2020"
854,855,NCT04223622,Osteoarthritis,Effects of ASC Secretome on Human Osteochondral Explants,ASC secretome,Secretome From Mesenchymal Stem/Stromal Cells on Human Osteochondral Explants: Cocktail of Factors Secreted by Adipose-derived Stromal Cells (ASC) for the Treatment of Osteoarthritis and/or for Articular Regeneration,Milano,MI,Italy,"April 12, 2021"
855,856,NCT04888949,SARS-CoV-2 Infection( COVID-19 ),A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19),Mesenchymal stem cell|Placebo,An Phase2 Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,Suita,Osaka,Japan,"June 15, 2021"
856,857,NCT04850469,Sepsis|Critical Illness,Study of MSC-Exo on the Therapy for Intensively Ill Children,,Study of Exosomes Derived From Mesenchymal Stem Cells on the Therapy for Children With Severe Infection,Shanghai,Shanghai,China,"September 1, 2022"
857,858,NCT00877903,Myocardial Infarction,Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI),Prochymal®|Placebo,"A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL® (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction",Gilbert|Tucson|Sacramento|San Diego|Miami Beach|Miami|Chicago|Indianapolis|Iowa City|Topeka|Baltimore|Boston|Springfield|Worcester|Royal Oak|Saginaw|Minneapolis|New Brunswick|Buffalo|Stony Brook|Winston-Salem|Cincinnati|Columbus|Portland|Hershey|Philadelphia|Pittsburgh|Germantown|Austin|Houston|Burlington|Madison|Montreal,Arizona|Arizona|California|California|Florida|Florida|Illinois|Indiana|Iowa|Kansas|Maryland|Massachusetts|Massachusetts|Massachusetts|Michigan|Michigan|Minnesota|New Jersey|New York|New York|North Carolina|Ohio|Ohio|Oregon|Pennsylvania|Pennsylvania|Pennsylvania|Tennessee|Texas|Texas|Vermont|Wisconsin|Quebec,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|Canada,"March 30, 2009"
858,859,NCT02900014,Cleft Palate,Validation of a Production Method of Stem Cell Isolated From the Nasal Cavity for an Innovative Cell Therapy of Cleft Palate,sampling mesenchymal stem cells,,Marseille,,France,August 2015
859,860,NCT05279157,Ophthalmological Disorder|Corneal Dystrophy|Treatment|Therapy|Keratoconus,Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD),Implantation|Lipoaspiration,Implantation of Autologous Mesenchymal Stem Cells of Adipose Origin for the Treatment of Corneal Diseases,Alicante,,Spain,"April 19, 2022"
860,861,NCT02600130,Alzheimer's Disease,Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease,Longeveron Mesenchymal Stem Cells|Placebo,"A Phase, I Prospective, Randomized, Double-Blinded, Placebo-controlled, Trial to Evaluate the Safety and Potential Efficacy of Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease",Delray Beach|Miami|Miami,Florida|Florida|Florida,United States|United States|United States,"October 10, 2016"
861,862,NCT04275024,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients,Calcipotriol ointment|PSORI-CM01 Granule|adipose-derived multipotent mesenchymal stem cells,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Patients With Moderate to Severe Psoriasis,Guangzhou,Guangdong,China,"April 1, 2020"
862,863,NCT03818737,Osteoarthritis,Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES),Bone Marrow Derived MSCs|Adipose-derived MSCs|Umbilical Cord Tissue (UCT) MSCs|Corticosteroid injection,"Randomized Multicenter Phase 3 Single-blind Trial Comparing the Efficacy of Corticosteroid Control to Mesenchymal Stem Cell Preparations From Autologous Bone Marrow Concentrate (BMAC), Adipose-derived Stem Cells in the Form of Stromal Vascular Fraction (SVF), and Third-party Human Mesenchymal Stem Cells Manufactured From Umbilical Cord Tissue for the Treatment of Unilateral Knee Osteoarthritis (OA)",Gulf Breeze|Atlanta|Durham|Fargo|Sioux Falls,Florida|Georgia|North Carolina|North Dakota|South Dakota,United States|United States|United States|United States|United States,"March 28, 2019"
863,864,NCT01626625,Healing of Fracture,Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture,stem cells + hydroxy apatite|autograft taken from iliac crest,,Jakarta,,Indonesia,April 2010
864,865,NCT03747913,Healthy,Oxidative Stress as an Acute Exercise-induced Mechanism of Stem and Progenitor Cell Mobilization,Antioxidative supplementation,"Effect of Oxidative Stress on Acute Exercise-induced Mobilization and Apoptosis of Hematopoietic, Endothelial and Mesenchymal Stem and Progenitor Cells and Mature Endothelial Cells in Healthy Young Male Subjects",Zürich,Zurich,Switzerland,"May 2, 2019"
865,866,NCT04348461,COVID|Respiratory Distress Syndrome,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells,"Two-treatment,Randomized, Controlled, Multicenter Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Expanded Allogeneic Adipose Tissue Adult Mesenchymal Stromal Cells in Critically Ill Patients COVID-19",Madrid,,Spain,"May 6, 2020"
866,867,NCT01409954,Pseudarthrosis After Fusion or Arthrodesis,Collecting Bone Graft During Spinal Decompression and Posterolateral Lumbar Fusion to Better Define Bone Making Cells,,Defining the Osteogenic Potential of Mesenchymal Stem Cells and Their Progenitors During Spinal Decompression and Posterolateral Lumbar Fusion,Salt Lake City,Utah,United States,October 2011
867,868,NCT04281797,Transplantation Infection|Kidney Transplant; Complications|Stem Cell Transplant Complications|Liver Transplant; Complications|Microbial Colonization,Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients,Intestinal microbiome new generation sequencing,"Intestinal Microbiome Composition Dynamics Over the Course of Kidney Transplantation, Liver Transplantation, Allogeneic Hematopoietic Stem Cells and Mesenchymal Stem Cells Transplantation",Minsk,,Belarus,"January 1, 2020"
868,869,NCT05292625,Ischemic Stroke,Stem Cell Infusion in the Treatment of Patients With Neurological Complications After Ischemic Stroke,UC-MSC infusion via intravenous route|UC-MSC infusion via intrathecal route|standard stroke treatment and rehabilitation therapy,Outcomes of Umbilical Cord Blood-derived Mesenchymal Stem Cell Infusion in Patients With Neurological Complications After Ischemic Stroke,Hanoi,,Vietnam,"July 15, 2021"
869,870,NCT02890953,Cell Transplantation,Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a),Pneumostem|Normal saline,Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of IVH in Premature Infants (Phase 2a),Seoul|Seoul,,"Korea, Republic of|Korea, Republic of","March 28, 2017"
870,871,NCT05508191,Skin Aging|Transepidermal Water Loss,Microneedle Versus Fractional CO₂ Laser for Skin Aging Treatment With Stem Cell Secretome in Indonesian Adult Women,Fractional CO₂ Laser|Microneedle,"Microneedling Versus Fractional CO₂ Laser Resurfacing for Skin Rejuvenation With Adipose-derived Mesenchymal Stem Cells Secretome: a Single-blind, Randomized Clinical Trial",Jakarta Pusat,DKI Jakarta,Indonesia,"August 17, 2022"
871,872,NCT04243681,"Cirrhosis, Liver",Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis,CD 34 and MSC infusion|Standard of care for Cirrhosis management,Combination of Autologous Mesenchymal and Hematopoietic Stem Cell Infusion in Patients With Decompensated Cirrhosis: A Pilot Study,Hyderabad,Telangana,India,"July 1, 2019"
872,873,NCT03857841,Bronchopulmonary Dysplasia,A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD,UNEX-42|Phosphate-buffered saline,A Safety Study of Intravenous Infusion of Bone Marrow Mesenchymal Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia,Aurora|Boston|Boston|Boston|Jackson|Kansas City,Colorado|Massachusetts|Massachusetts|Massachusetts|Mississippi|Missouri,United States|United States|United States|United States|United States|United States,"October 9, 2019"
873,874,NCT05027581,"Osteoarthritis, Knee",Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA),Bone marrow mesenchymal stem cells|hyaluronic acid,A Phase IIb Study to Evaluate the Efficacy and Safety of Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA),Taipei,,Taiwan,"September 15, 2021"
874,875,NCT03639506,Repetition Failure,Clinical Application of Autologous Mitochondria Transplantation for Improving Oocyte Quality.,autologous mitochondria transplantation|autologous mitochondria from bone marrow mesenchymal stem cells into oocyte as well as intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (ICSI),A Pilot Study of the Effect of Autologous Mitochondria Transplantation in Assisted Reproductive Technology Clinical Outcome.,,,,September 2018
875,876,NCT03186417,Rheumatoid Arthritis,Mesenchymal Stem Cells in Early Rheumatoid Arthritis,2 million hMSC/kg|4 million hMSC/kg|6 million hMSC/kg|placebo,Cell-Based Therapy in Rheumatoid Arthritis: Proof of Concept Phase 1 Trial,Cleveland|Cleveland,Ohio|Ohio,United States|United States,"December 15, 2017"
876,877,NCT02334878,"Urinary Incontinence, Stress",Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence,"Stem Cells,Mesenchymal|surgery (TVT)",Autologous Bone Marrow-derived Mesenchymal Stem Cells Versus Tension-free Vaginal Tape for Treatment of Female Stress Urinary Incontinence: An Open-label Clinical Trial,Cairo,,Egypt,"October 1, 2015"
877,878,NCT03990805,Degenerative Arthritis|Knee Osteoarthritis,A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis,JOINTSTEM|saline,"Multi-center, Randomized, Double-Blind, Placebo Controlled Phase 3 Clinical Trial to Evaluate Efficacy and Safty of Mesenchymal Stem Cells JointStem in Patients With Knee Osteoarthritis",Cheongju-si|Daegu|Daegu|Jeonju|Jinju-si|Seoul|Seoul|Seoul|Seoul|Seoul|Seoul|Seoul|Seoul,,"Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of","June 11, 2019"
878,879,NCT05066334,Intervertebral Disc Degeneration|Chronic Low-back Pain,Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD,Autologous BM-MSC|Sham,Intervertebral Disc Regeneration Mediated by Autologous Mesenchymal Stem/Stromal Cells Intradiscal Injection: a Phase IIB Randomized Clinical Trial - DREAM Trial,Roma,,Italy,"March 22, 2021"
879,880,NCT01496339,Type 1 Diabetes Mellitus,Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients,MenSCs transplantation|exogenous indulin injection daily,Phase 1/2 Clinical Study of MenSCs Infusion in Type 1 Diabetes,Hangzhou,Zhejiang,China,January 2012
880,881,NCT02648386,Rectal Cancer|Erectile Dysfunction,Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery,Laparoscopic surgery|NeuroRegen scaffold transplantation|NeuroRegen scaffold/BMMCs transplantation|NeuroRegen scaffold/HUC-MSCs transplantation,Bone Marrow Mononuclear Cells or Human Umbilical Cord-derived Mesenchymal Stem Cells Combined With NeuroRegen Scaffold™ Transplantation for the Improvement of Erectile Function in Men After Rectal Cancer Surgery,Nanjing,Jiangsu,China,January 2016
881,882,NCT04325594,Chronic Heart Failure|Non-ischemic Cardiomyopathy|Non-ischemic Dilated Cardiomyopathy,The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Chronic Heart Failure of Non-ischemic Etiology,Cardiac catheterization|Intracoronary administration of the umbilical cord-derived mesenchymal stromal cells,Optimization of the Complex Treatment of Nonischemic Dilated Cardiomyopathy Due to the Addition to the Standard Drug Therapy of Intracoronary Administration of Umbilical Cord-derived Mesenchymal Stromal Cells,Taraz,Zhambyl,Kazakhstan,"March 1, 2020"
882,883,NCT04240873,"Osteoarthritis, Knee",Clinical Study of Intra Articular Injection of Catholic MASTER Cell (Bone Marrow Derived Mesenchymal Stem Cell) in Knee Osteoarthritis,Catholic MASTER cell|Saline,Randomized Double-blind Clinical Study of Intra Articular Injection of Catholic MASTER Cell in Knee Osteoarthritis,Seoul,,"Korea, Republic of","November 15, 2019"
883,884,NCT04877067,Methanol Poisoning|Toxic Optic Neuropathy|Stem Cell Tyrosine Kinase 1 Y842X|Magnetic Field Exposure,Therapy of Toxic Optic Neuropathy Via Combination of Stem Cells With Electromagnetic Stimulation,Wharton jelly derived mesenchymal stem cell|Repetitive electromagnetic stimulation,Bioretina Inc Ankara University Technopolis,Ankara|Ankara,Türkiye,Turkey|Turkey,"April 1, 2019"
884,885,NCT01547689,Alzheimer's Disease,Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's Disease,Human Umbilical Cord Derived MSC,"Open-Label, Single-Center, Self Control, Phase Ⅰ/Ⅱ Clinical Trial to Evaluate the Safety and the Efficacy of UC-MSC in Patients With Alzheimer's Disease",Beijing,,China,March 2012
885,886,NCT00759018,Graft vs Host Disease|Graft-Versus-Host Disease,Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD,remestemcel-L,Expanded Access of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD,Phoenix|Orange|San Francisco|Washington|Jacksonville|Miami|Chicago|Indianapolis|New Orleans|Detroit|Kansas City|Saint Louis|Hackensack|New York|New York|Charlotte|Durham|Portland|Charleston|Nashville|Houston|San Antonio|Richmond|Milwaukee|Calgary|Montreal|Montreal,Arizona|California|California|District of Columbia|Florida|Florida|Illinois|Indiana|Louisiana|Michigan|Missouri|Missouri|New Jersey|New York|New York|North Carolina|North Carolina|Oregon|South Carolina|Tennessee|Texas|Texas|Virginia|Wisconsin|Alberta|Quebec|Quebec,United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|United States|Canada|Canada|Canada,
886,887,NCT01343511,Autism,Safety and Efficacy of Stem Cell Therapy in Patients With Autism,human cord blood mononuclear cells|human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells,Phase Ι/Π Study of Stem Cell Therapy in Patients With Autism,Jinan,Shandong,China,March 2009
887,888,NCT02563340,Kidney Transplantation,Effect of BM-MSCs on Chronic AMR After Kidney Transplantation,"BM-MSCs|Desensitization therapy (PP, IVIG, rituximab or Bortezomib)",Efficacy and Safety of Bone Marrow-derived Mesenchymal Stem Cells (BM-MSCs) on Chronic Antibody-mediated Rejection (cAMR) After Kidney Transplantation: A Multi-center Perspective Study,Guangzhou,Guangdong,China,November 2015
888,889,NCT03925649,Spinal Cord Injury at C5-C7 Level,Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI,HB-adMSCs,Individual Patient Expanded Access IND (Investigational New Drug) of Autologous HB-adMSCs for the Treatment of Spinal Cord Injury,Houston,Texas,United States,
889,890,NCT02145897,Critical Limb Ischemia,To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI,Autologous Stromal Vascular Fraction (SVF)|Autologous Adipose Derieved MSCs|Control,"A Prospective, Multicentric, Phase I/II, Open Label, Randomized, Interventional Study to Evaluate the Safety and Efficacy of Intramuscular and Intravenous Administration of Autologous ADMSCS for Treatment of Critical Limb Ischemia (CLI).",Thane,Maharashtra,India,August 2014
890,891,NCT03860155,Acute-On-Chronic Liver Failure,Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure,allo-APZ2-ACLF,"An Interventional, Single Arm, Multicenter, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-ACLF for the Treatment of Acute-on-Chronic Liver Failure (ACLF)",Dresden|Essen|Frankfurt|Magdeburg|Mannheim,,Germany|Germany|Germany|Germany|Germany,"March 22, 2019"
891,892,NCT04097652,Acute Ischemic Stroke,Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke,UMC119-06,The Safety and Tolerability After Intravenous Infusion of UMC119-06 in Subjects With Acute Ischemic Stroke.,New Taipei City,,Taiwan,"December 5, 2019"
892,893,NCT03000712,Degenerative Arthritis|Knee Osteoarthritis,Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.,Autologous Adipose Tissue derived MSCs 1x10^8cells/3ml,"Single-center, Randomized, Open Label, Negative-controlled Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC(Autologous Adipose Tissue Derived Mesenchymal Stem Cells) After High Tibial Osteotomy Compared to Negative Control in the Osteoarthritis Patients.",Seoul,,"Korea, Republic of","November 2, 2016"
893,894,NCT04347967,Acute Respiratory Distress Syndrome,Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS),UMC119-06,The Safety and Tolerability After Intravenous Infusion of UMC119-06 in Subjects With Acute Respiratory Distress Syndrome (ARDS).,New Taipei City,,Taiwan,September 2021
894,895,NCT04739930,Cartilage Injury,Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation,Autologous bone marrow aspirate will be harvested and concentrated to a bone marrow aspirate concentrate (BMAC) containing bone marrow derived mesenchymal stem cells and delivered to site of operation|Control group incision,"Prospective, Randomized, Single Blind Clinical Trial to Investigate the Impact of Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation",Chicago,Illinois,United States,"March 2, 2018"
895,896,NCT02563366,Kidney Transplantation|Acute Kidney Tubular Necrosis,Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.,BM-MSCs|Saline,Effect of Bone Marrow-derived Mesenchymal Stem Cells (BM-MSCs) on Recovery of Poor Early Graft Function Post Kidney Transplantation From Chinese Donation After Citizen Death (DCD): A Multi-center Randomized Controlled Trial,Guangzhou,Guangdong,China,November 2015
896,897,NCT02104440,Cytopenia,Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro,"Sequential infusion of allogeneic mesenchymal stem cells expanded ""in vitro""",,Salamanca,Salamanca/Castilla León,Spain,October 2013
897,898,NCT04535856,Covid19|Corona Virus Infection|SAR,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,allogeneic mesenchymal stem cell|Placebo,"Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients: Randomized, Double-blind, and Placebo-controlled",Makassar,,Indonesia,"November 14, 2020"
898,899,NCT02672306,Alzheimer's Disease,Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease,UCMSCs|Placebo,Clinical Study on the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Mild and Moderate Alzheimer's Disease,Guangzhou,Guangdong,China,"October 20, 2017"
899,900,NCT01213186,Human Immunodeficiency Virus|Disorder of Immune Reconstitution,Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients,high dose of MSC|low dose of MSC treatment,"Phase 2 Study of UC-MSC in Restoring CD4 T Cell Counts and Reducing Immune Activation in HIV-infected Patients Underlying Long-term Antiviral Therapy: a Multicenter, Does-escalating, Randomized, Double-blind, Controlled Trial.",Beijing|Urumqi|Kunming,Beijing|Xinjiang|Yunnan,China|China|China,January 2013
900,901,NCT02045745,Postoperative Air Leaks in Risk Patients,"Clinical Trial Phase I/II Prospective, Open Nonrandomized for Treatmen of Postoperative Air Leak After Lung Resection in High Risk Patients Through the Administration of Mesenchymal Autologous Cells","Implantation of autologous mesenchymal stem cells (CSM) expanded ""in vitro"" and administered directly into the lung suture line","CLINICAL TRIAL PHASE I / II, PROSPECTIVE, OPEN, NONRANDOMIZED, FOR TREATMENT OF POSTOPERATIVE AIR LEAK AFTER LUNG RESECTION IN HIGH RISK PATIENTS THROUGH THE ADMINISTRATION OF MESENCHYMAL AUTOLOGOUS CELLS.",Salamanca,Salamanca/Castilla León,Spain,December 2013
901,902,NCT02065167,Avascular Necrosis of the Femoral Head,Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip,Cultured autologous Mesenchymal Cells,Evaluation of Safety and Feasibility of Bone Marrow Derived Autologous MSCs to Enhance Bone Healing in Patients With Avascular Necrosis of the Femoral Head,Créteil|Tours|Tübingen|Ulm|Bologna|Madrid,,France|France|Germany|Germany|Italy|Spain,February 2014
902,903,NCT03839238,Meniscus Injury,Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury,hESC derived MSC like cell,Safety Observation on Human Embryonic Stem Cell (hESC) Derived Mesenchymal Stem Cells(MSC) Like Cell for the Meniscus Injury,Wuhan,Hubei,China,"January 4, 2019"
903,904,NCT01803347,Anal Fistula,Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells,◦Drug: ASCs. + fibrin glue|fibrin glue,"Multicentre,Randomized,Comparative,Add-on,Into Two Parallel Groups Clinical Trial to Evaluate Efficacy and Safety of Autologous Mesenchymal Stem Cells Derived From Expanded Adipose Tissue (ASC), for Treatment of Complex Perianal Fistulizing Disease in Patients Without IBD.",Zaragoza|Salamanca|Valencia|Madrid|Pamplona,Aragón|Castilla-Leon|Comunidad Valenciana,Spain|Spain|Spain|Spain|Spain,February 2013
904,905,NCT01309061,Progressive Hemifacial Atrophy|Romberg's Disease,The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease,Autologous Adipose Tissue derived MSCs Transplantation,Preliminary Investigation of the Effect of Human Adipose Tissue-derived Mesenchymal Stem Cell in Progressive Hemifacial Atrophy(Romberg's Disease),Seoul,,"Korea, Republic of",March 2008
905,906,NCT02917291,Acute Traumatic Spinal Cord Injury,Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury,FAB117-HC|Control group|FAB117-HC,"Clinical Trial of Phase 1/2 to Evaluate the Feasibility, Safety, Tolerability and Preliminary Efficacy of the Administration of FAB117-HC, a Drug Whose Active Ingredient is HC016, Allogeneic Adipose Derived Adult Mesenchymal Stem Cells Expanded and Pulsed With H2O2, in Acute Traumatic SCI Patients.",A Coruña|Barcelona|Granada|Madrid|Sevilla|Toledo|Valencia|Zaragoza|Zaragoza,,Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain|Spain,December 2016
906,907,NCT01733186,Degeneration Articular Cartilage Knee,"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects",CARTISTEM®,"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects: A Phase I/IIa Clinical Trial in Patients With Focal, Full-thickness Grade 3-4 Articular Cartilage Defects of the Knee",Chicago|Chestnut Hill,Illinois|Massachusetts,United States|United States,"January 7, 2013"
907,908,NCT01033552,Epidermolysis Bullosa,"Biochemical Correction of Severe EB by Allo HSCT and ""Off-the-shelf"" MSCs",Cyclophosphamide|Fludarabine|Anti-thymocyte globulin|Cyclosporine A|Mycophenolate mofetil|Mesenchymal stem cell transplantation|Total body irradiation|Bone marrow or umbilical cord blood (UCG) stem cell transplantation,"MT2009-09: Biochemical Correction of Severe Epidermolysis Bullosa by Allogeneic Stem Cell Transplantation and ""Off-the-shelf"" Mesenchymal Stem Cells",Minneapolis,Minnesota,United States,January 2010
908,909,NCT01091701,Stroke,Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke,Ex vivo cultured adult allogenic MSCs|Plasmalyte-A,"A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase -I/ II Study Assessing The Safety And Efficacy Of Intravenous Ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells In Patients With Ischemic Cerebral Stroke","Jalan Hospital, 30990,|Jalan Pahang, 50586|Jalan Mufti Haji Khalil, 75400|Prai|Jalan Hospital, 47000|Km 6 Jalan Langgar, 5460 Alor Setar, Kedah","Ipoh, Perak|Kuala Lumpur|Melaka|Pulau Pinang|Sungai Buloh, Selangor",Malaysia|Malaysia|Malaysia|Malaysia|Malaysia|Malaysia,December 2011
909,910,NCT02767817,Brain Injury,Injectable Collagen Scaffold™ Combined With MSCs Transplantation for Brain Injury,Stereotactic Hematoma Evacuation|MSCs Transplantation|Injectable Collagen Scaffold with MSCs Transplantation,The Safety and Efficacy Assessment of Injectable Collagen Scaffold™ Combined With Mesenchymal Stem Cells Transplantation in Patients With Brain Injury,Tianjin,,China,March 2016
910,911,NCT04825730,Degenerative Arthritis|Knee Arthritis,Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy,JOINTSTEM,Long-Term Extension Study of Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy in Patients With K-L Grade III Knee Osteoarthritis After 『JOINTSTEM』 Administration,,,,"December 1, 2023"
911,912,NCT04040348,Alzheimer Disease,Alzheimer's Disease Stem Cells Multiple Infusions,Approximately 100 million cells allogeneic hMSC,"A Phase I, Prospective, Open-label Trial to Evaluate the Safety, Tolerability and Exploratory Outcomes of Multiple Allogeneic Human Mesenchymal Stem Cells (HMSC) Infusions in Patients With Mild to Moderate Alzheimer's Disease",Miami,Florida,United States,"October 8, 2019"
912,913,NCT02313415,Infertility|Intrauterine Adhesions,Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells,UC-MSCs therapy,Clinical Study of the Treatment of Infertility Caused by Recurrent Intrauterine Adhesions by Collagen Scaffold Loaded With Umbilical Cord -Derived Mesenchymal Stem Cells (UC-MSCs),Nanjing,Jiangsu,China,"November 28, 2014"
913,914,NCT03902067,Left Ventricular Dysfunction|Acute Myocardial Infarction,UC-MSC Transplantation for Left Ventricular Dysfunction After AMI,UC-MSC|Control Group,Safety and Efficacy Evaluation of Umbilical Cord Mesenchymal Stem Cells Transcatheter Transplantation to Treat Left Ventricular Dysfunction After Acute Myocardial Infarction,Shanghai,Shanghai,China,"December 1, 2022"
914,915,NCT04461925,COVID-19 Pneumonia,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells|Antibiotics|Hormones|Anticoagulant Therapy|Оxygen therapy,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic Multipotent Mesenchymal Stem Cells of the Placenta and Umbilical Cord,Kyiv,,Ukraine,"May 2, 2020"
915,916,NCT02669199,MSCs,MSCs Source of Sweat Gland Cells of Large Area Skin Injury Patients Transplant of the Wound,MSCs,"Between Umbilical Cord Mesenchymal Stem Cells Sources Sweat Gland Samples of Large Area Skin Wound Injury Patients Before and After the Transplant Center, Open, Random, Own More Controlled Clinical Trials",Beijing,Beijing,China,January 2012
916,917,NCT02543073,"Lung Diseases, Interstitial|Hematopoietic Stem Cell Transplantation|Bronchiolitis Obliterans",MSC for Treatment of Interstitial Lung Disease After Allo-HSCT,MSCs|AZM|Glucocorticoid,Mesenchymal Stem Cell for Treatment of Interstitial Lung Disease After Allogenetic Hematopoietic Stem Cell Transplantation,Guangzhou,Guangdong,China,September 2014
917,918,NCT04427930,Knee Osteoarthritis,Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial,JOINTSTEM,Long-Term Safety and Efficacy Extension Study Of Autologous Adipose-Derived Mesenchymal Stem Cells 『JOINTSTEM』 in Patients With Knee Osteoarthiritis: A Phase III Extension Study,Daegu|Seoul|Seoul|Seoul,,"Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of","April 13, 2020"
918,919,NCT04388982,Alzheimer Disease,the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease,low dosage MSCs-Exos administrated for nasal drip|mild dosage MSCs-Exos administrated for nasal drip|high dosage MSCs-Exos administrated for nasal drip,"Open-Label, Single-Center, Phase I/Ⅱ Clinical Trial to Evaluate the Safety and the Efficacy of Exosomes Derived From Allogenic Adipose Mesenchymal Stem Cells in Patients With Mild to Moderate Dementia Due to Alzheimer's Disease",Shanghai,Shanghai,China,"July 1, 2020"
919,920,NCT02947191,Chronic Nasal Septum Perforation,Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation,Collagen membrane + HUC-MSCs,The Safety and Efficacy Assessment of Collagen Membrane Combined With Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Nasal Septum Perforation,Nanjing,Jiangsu,China,November 2016
920,921,NCT05491681,"ARDS, Human",AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial,intravenous delivery of allogeneic bone marrow-derived MSCs,Phase I/IIa Study to Assess AllogeneiC Expanded Human Mesenchymal Stem Cell Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial (ACE CARD TRIAL),,,,"September 15, 2022"
921,922,NCT02786017,Decompensated Cirrhosis,Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis,Conventional therapy|Injectable Collagen Scaffold + HUC-MSCs,The Safety and Efficacy Assessment of Injectable Collagen Scaffold™ Combined With Human Umbilical Cord-derived Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Decompensated Cirrhosis,Nanjing,Jiangsu,China,May 2016
922,923,NCT03672825,Cartilage Defect,REcycled CartiLage Auto/Allo IMplantation,REcycled CartiLage Auto/Allo IMplantation,RECLAIM: A Phase I Safety and Feasibility Trial of REcycled CartiLage Auto/Allo IMplantation for the Treatment and Repair of Focal Knee Cartilage Defects,Rochester,Minnesota,United States,"September 13, 2018"
923,924,NCT05407766,Rectal Fistula,Mesenchymal Stem Cells (MSCs) for Perianal Fistula,OSSM-001|Placebo,A Phase I Safety Study of Allogeneic Bone Marrow Derived MSCs for Refractory Perianal Fistulizing Crohn's Disease,,,,August 2022
924,925,NCT04953663,Stroke,Clinical Plan of Ischemic Stroke,it-hMSC,"A Multicenter, Blind, Randomized, Placebo-controlled Phase I / IIA Study to Evaluate the Safety, Tolerability, and Initial Efficacy of a Single Injection of Ischemia Tolerant Human Allogeneic Bone Marrow Mesenchymal Stem Cells in Patients With Ischemic Stroke",Beijin,,China,"January 1, 2021"
925,926,NCT03265444,Multiple System Atrophy,Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System Atrophy,CS10BR05,A Phase 1 Study to Evaluate the Safety and Tolerability of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Multiple System Atrophy,Seoul,,"Korea, Republic of","April 13, 2018"
926,927,NCT02619877,Diabetic Foot Ulcer,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers,ALLO-ASC-DFU|Standard therapy,"Phase 2 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers: A Randomized, Comparator-controlled, Single-blind, Parallel-group, Multi-center Study",Guro-gu|Nowon-Gu|Seodaemun-Gu|Songpa-Gu,Seoul|Seoul|Seoul|Seoul,"Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of",October 2015
927,928,NCT02619851,Burn Injury,A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects,ALLO-ASC-DFU|Conventional Therapy,"A Phase II Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects: Controlled, Parallel, Multicenter",Seoul,,"Korea, Republic of",December 2015
928,929,NCT01603836,"Spondyloarthrosis, Spondylosis",Study Confirms or Refutes the Hypothesis That the Autologous Bone Marrow Concentrate Together With the Allograft is a Better Alternative for the Posterolateral Fusion in Spine Surgery Than the Allograft Alone,bone allogaft with bone marrow concentrate,Allograft Alone Versus Allograft With Bone Marrow Concentrate for the Healing of the Instrumented Posterolateral Lumbar Fusion,,,,February 2009
929,930,NCT01207193,Bone Cyst,Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation,cell injection,Effect of Bone Marrow-derived Mesenchymal Stem Cell Transplantation in Reconstructing Bone Defects.,Tehran,,"Iran, Islamic Republic of",October 2009
930,931,NCT04074408,Basal Ganglia Hematoma,Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration,stereotactic surgery|hUMSCs|placebo,"Intracavitary Injection of Human Umbilical Cord Mesenchymal Stem Cells in Acute Basal Ganglia Hematoma After Stereotactic Aspiration: a Randomized, Single-blind, Placebo-Controlled, Phase 2 Trial",Hangzhou,Zhejiang,China,May 2020
931,932,NCT04342325,"Glomerulonephritis , IGA",The Clinical Trial of ADR-001 for IgA Nephropathy,infusion of ADR-001 (Mesenchymal stem cell),"Open-label, Multiple-center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 for the Treatment for Immunoglobulin A (IgA) Nephropathy",Kasugai|Nagoya,Aichi|Aichi,Japan|Japan,"June 15, 2020"
932,933,NCT04494386,Covid19|Corona Virus Infection|SARS-CoV Infection|ARDS|Coronavirus,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,Umbilical Cord Lining Stem Cells (ULSC)|Placebo (carrier control),Phase 1/2a Study of Umbilical Cord Lining Stem Cells (ULSC) in Patients With ARDS Due to COVID-19,Miami|Sioux Falls,Florida|South Dakota,United States|United States,"July 23, 2020"
933,934,NCT02641769,Non-obstructive Azoospermia,Intra-Testicular Transplantation of Autologous Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.,Stem Cell Transplantation,"Intra-Testicular Transplantation of Purified Autologous Clusters of Differentiation (CD) 34+,133+, and Mesenchymal Stem Cells for Treatment of Non-Obstructive Azoospermia Male Infertility.",Amman,,Jordan,January 2014
934,935,NCT03633565,Myopathy,Comparative Study of Strategies for Management of Duchenne Myopathy (DM),Sildenafil (Phosphodiesterase inhibitors)|Prednisolone (Steroids)|Mesenchymal stem cell transplantation,A Comparative Study of Strategies for Management of Duchenne Myopathy in Assiut University Children Hospital,,,,September 2018
935,936,NCT05305833,Temporomandibular Joint Disorders|Temporomandibular Disorder|Temporomandibular Joint Osteoarthritis|Temporomandibular Joint Pain|Temporomandibular Joint Effusion,Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease,Stem Cells,Stem Cells Transplantation for Temporomandibular Joint Disease: Phase I/II Study,Kayseri,,Turkey,"October 1, 2021"
936,937,NCT04951882,Acute Lung Injury,Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research,human derived umbilical cord derived mesenchymal stem cells,Transplatation of Human Umbilcal Cord Derived Mesenchyamal Stem Cells in Acute Lung Injury: a Single Center Prospective Clinical Research,Hanzhou,Zhejiang,China,"June 9, 2021"
937,938,NCT02755376,Deficiency of Anterior Cruciate Ligament,Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell,Cartistem(TM)|hyaluronic acid|ACL reconstruction only,"A Randomized, Single Center, Investigator Initiated Clinical Trial to Evaluate Enhancement of Healing Between Bone Tunnel and Graft in Anterior Cruciate Ligament (ACL) Injury Using Human Umbilical Cord Blood Derived Mesenchymal Stem Cell",Seoul,,"Korea, Republic of","January 1, 2014"
938,939,NCT02672267,Myocardial Infarction,A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction,Stem cells|Placebo,"A Phase III, Double-blinded, Single Center, Randomized, Placebo Controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Single Intravenous Dose of Allogeneic Ischemia Tolerant Human Mesenchymal Bone Marrow Cells to Subjects With Acute Myocardial Infarction",Astana,,Kazakhstan,July 2014
939,940,NCT04339504,Knee Osteoarthritis,Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial,SMUP-IA-01(low-dose)|SMUP-IA-01(mid-dose)|SMUP-IA-01(high-dose),Long-term Follow-up Study of Safety and Explore Efficacy in Subjects Who Completed SMUP-IA-01 Phase Ⅰ Clinical Trial,Seoul,Jongno-gu,"Korea, Republic of","April 14, 2020"
940,941,NCT01909154,Spinal Cord Injury,Safety Study of Local Administration of Autologous Bone Marrow Stromal Cells in Chronic Paraplegia,Mesenchymal stromal cell therapy,"Phase I Pilot Study to Evaluate the Security of Local Administration of Autologous Stem Cells Obtained From the Bone Marrow Stroma, in Traumatic Injuries of the Spinal Cord",Majadahonda,Madrid,Spain,March 2013
941,942,NCT04612465,Crohn's Fistula,Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula,ASC|Fibringlue,Phase 3 Clinical Study to Evaluate Efficacy and Safety of ASC(Autologous Adipose-derived Stem Cells) and Fibringlue or Fibringlue in Patients With Crohn's Fistula.: A Randomized Study,Seoul|Seoul|Seoul,,"Korea, Republic of|Korea, Republic of|Korea, Republic of","January 9, 2020"
942,943,NCT01325103,Spinal Cord Injury,Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury,Stem Cell Transplantation,Phase 1 Study of Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury,Salvador,Bahia,Brazil,July 2010
943,944,NCT04293692,COVID-19,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,UC-MSCs|Placebo,Human Umbilical Cord Mesenchymal Stem Cells Treatment for Pneumonia Patients Infected by 2019 Novel Coronavirus,Wuhan,Hubei,China,"February 24, 2020"
944,945,NCT01210950,Leg Length Inequality,Distraction Osteogenesis in Limb-length Discrepancy With Mesenchymal Cell Transplantation,cell and RPR injection,Autologous Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Distraction Osteogenesis in Patients With Limb-length Discrepancy,Tehran,,"Iran, Islamic Republic of",September 2009
945,946,NCT02492490,Uremia,Effect of SVF Derived MSC in DCD Renal Transplantation,SVFderived MSC transplantations|Basiliximab,Effect of Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cell in Kidney Transplantation From Chinese Donation After Citizen Death (DCD): A Randomized Controlled Trial,Fuzhou,Fujian,China,December 2014
946,947,NCT04173650,Dystrophic Epidermolysis Bullosa,MSC EVs in Dystrophic Epidermolysis Bullosa,AGLE 102,A Safety Study of the Administration of Mesenchymal Stem Cell Extracellular Vesicles in the Treatment of Dystrophic Epidermolysis Bullosa Wounds,,,,October 2023
947,948,NCT04562025,Diabetic Nephropathy,Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy,UC-MSCs|Placebo,Clinical Research of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) in the Treatment of Diabetic Nephropathy,Wuhan,Hubei China,China,"September 25, 2020"
948,949,NCT04170426,Rheumatoid Arthritis,Autologous Adipose-derived Stem Cells (AdMSCs) for Rheumatoid Arthritis,autologous adipose derived stem cells,Phase 1/2a Clinical Study for Subjects With Rheumatoid Arthritis (RA) Using Multiple Dose Intravenous Infusions of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs),,,,December 2022
949,950,NCT03766139,Intrabony Periodontal Defect,Regenerative Potential of Supercell Glue and Platelet Rich Fibrin Matrix,SUPERCELL GLUE|PRFM ALONE,Evaluation of Supercell Glue (Platelet Rich Fibrin Matrix{PRFM} AND Peripheral Blood Mesenchymal Stem Cells {PBMSCs} ) as a Regenerative Material in Human Mandibular Periodontal Intraosseous Defect - A Split Mouth Randomized Controlled Trial,Bangalore,Karnataka,India,December 2018
950,951,NCT04954534,Alzheimer's Disease,Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®,human umbilical cord blood derived mesenchymal stem cells,Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM® Phase-I/IIa Clinical Trial,Seoul,,"Korea, Republic of","July 12, 2021"
951,952,NCT00221130,Adult Periodontitis,Clinical Trials of Regeneration for Periodontal Tissue,surgical operation of cell transplantation,"Clinical Trial of Regenerative Periodontal Tissue by Transplanting Mesenchymal Stem Cells and Osteoblast Cells - I, II Phase-",Kobe,Hyogo Pref.,Japan,July 2004
952,953,NCT02696876,"Defect of Articular Cartilage|Cartilage Injury|Osteoarthritis, Knee",Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair,Arthroscopic synovial brushing|Microfracture,Safety and Efficacy of a Novel Synovium Brushing Method for Endogenous Mesenchymal Stem Cells Mobilisation During Knee Joint Microfracture for Cartilage Repair.,Leeds,West Yorkshire,United Kingdom,January 2017
953,954,NCT02801890,Ultra Filtration Failure,Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF),Intravenous injection,Autologous AD-MSC Transplantation in Peritoneal Dialysis Patients With Ultra Filtration Failure and Evaluation of Cellular and Molecular Effects of Mesenchymal Stem Cell Infusion on Peritoneal Fibrosis,Tehran,,"Iran, Islamic Republic of",August 2015
954,955,NCT04763369,Retinitis Pigmentosa (RP),Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP),Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa|Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa,Investigation of Therapeutic Efficacy and Safety of Umbilical Cord Derived Mesenchymal Stem Cells (UMSCs) for the Management of Retinitis Pigmentosa (RP),Lahore,Punjab,Pakistan,February 2021
955,956,NCT02579148,Erectile Dysfunction|Type 1 Diabetes Mellitus|Type 2 Diabetes Mellitus,Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes,HUCMSC injection|collagen scaffolds/HUCMSC injection,Collagen Scaffolds Loaded With Human Umbilical Cord Mesenchymal Stem Cells for the Improvement of Erectile Function in Men With Diabetes,Nanjing,Jiangsu,China,September 2015
956,957,NCT03370874,Diabetic Foot Ulcer,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.,ALLO-ASC-DFU|Vehicle sheet,"Phase 3 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers: A Randomized, Placebo-controlled, Double-blind, Parallel-group, Multi-center Study",Seoul,,"Korea, Republic of","July 4, 2018"
957,958,NCT03754465,Diabetic Foot Ulcer,Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers,ALLO-ASC-DFU|Hydrogel SHEET(Vehicle control),A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers,Los Angeles,California,United States,"January 2, 2019"
958,959,NCT03056742,Critical Limb Ischemia Due to Buerger's Disease,A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease,Stempeucel(R),"A Single Arm, Open Label, Multicentric, Clinical Study Assessing the Efficacy and Safety of Stempeucel® (ex Vivo Cultured Adult Bone Marrow Derived Allogeneic Mesenchymal Stem Cells) in Patients With CLI Due to Buerger's Disease",New Delhi|Bangalore|Chennai|Chennai|Chennai|Chennai|Kolkata|Kolkata,Delhi|Karnataka|Tamil Nadu|Tamil Nadu|Tamil Nadu|Tamil Nadu|West Bengal|West Bengal,India|India|India|India|India|India|India|India,"February 20, 2017"
959,960,NCT01662973,Primary Biliary Cirrhosis,Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis,conventional plus UC-MSC treatment|Conventional plus placebo treatment,Phase 1/2 Study of UC-MSC Treatment for Evaluation the Efficacy and Safety in Patients With Primary Biliary Cirrhosis,Beijing,Beijing,China,October 2011
960,961,NCT03183726,Diabetic Foot Ulcer,A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial,ALLO-ASC-DFU,A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 1 Clinical Trial of ALLO-ASC-DFU-101,,,,"January 11, 2016"
961,962,NCT05216562,SARS-CoV2 Infection,Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients,Exosome-MSC Intravenous injection|Placebo Intravenous Injection|COVID-19 Standard Treatment,Efficacy and Safety of EXOSOME-MSC (Mesenchymal Stem Cell-Derived Exosomes) Therapy to Reduce Hyper-inflammation In Moderate COVID-19 (2019- New Corona Virus Disease) Patients,Jakarta|Padang|Yogyakarta,DKI Jakarta|West Sumatra,Indonesia|Indonesia|Indonesia,"July 1, 2021"
962,963,NCT03183661,Crohn Disease,A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial,ALLO-ASC-CD,Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in the Subjects With Crohn´s Disease(ALLO-ASC-CD-101),,,,"November 16, 2016"
963,964,NCT03454737,Patellar Tendinopathy,Treatment of Refractory Patellar Tendinopathy With Mesenquimal Trunk Cells. Comparative Study With PRP.,mesenchymal stem cells|Pure platelet-rich plasma,Treatment of Refractory Patellar Tendinopathy With Mesenquimal Trunk Cells. Comparative Study With PRP.,Barcelona,,Spain,"December 13, 2017"
964,965,NCT01392625,Non-ischemic Dilated Cardiomyopathy,PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study),Autologous hMSCs|Allogeneic hMSCs,"A Phase I/II, Randomized Pilot Study of the Comparative Safety and Efficacy of Transendocardial Injection of Autologous Mesenchymal Stem Cells Versus Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Dilated Cardiomyopathy.",Miami,Florida,United States,"May 19, 2011"
965,966,NCT04675970,Primary Ovarian Insufficiency|Premature Ovarian Failure,Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy,Observational,Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy Using Autologous Mesenchymal Stem Cell and Mesenchymal Stem Cell Lyophilisate,Kharkov,,Ukraine,"September 1, 2020"
966,967,NCT03105284,Mesenchymal Stem Cells,Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction,Liposuction,Adipose-tissue Derived Stem Cells: Characterization of Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction,,,,"September 1, 2016"
967,968,NCT01041001,Cartilage Injury|Osteoarthritis,Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury,Cartistem|Microfracture treatment,"Randomized, Open-Label, Multi-Center and Phase 3 Clinical Trial to Compare the Efficacy and Safety of Cartistem® and Microfracture in Patients With Knee Articular Cartilage Injury or Defect",Incheon|Incheon|Seoul|Seoul|Seoul|Seoul|Seoul|Seoul,Gyunggido,"Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of",February 2009
968,969,NCT05344157,"Osteoarthritis, Knee",A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis,XSTEM-OA,"A First-in-Human Open-Label Phase 1/2a Study to Evaluate Safety, Tolerability and Efficacy of a Single Intra-Articular Injection of Allogeneic Mesenchymal Stem Cells Selected for Integrin α10β1 (XSTEM-OA) in Adult Patients With Symptomatic Knee Osteoarthritis",Camberwell,Victoria,Australia,"June 22, 2022"
969,970,NCT01922908,Ischemic Stroke,Mesenchymal Stromal Cells for Ischemic Stroke,MSC Infusion|Placebo Comparator,SAfety of Mesenchymal Stromal Cells for Ischemic Stroke,,,,December 2016
970,971,NCT02378974,Cerebral Infarction,Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of Cordstem-ST in Patients With Cerebral Infarction,Cordstem-ST|Placebo,"A Randomized, Double-blind, Placebo-controlled, Phase I / IIa Clinical Trial for Evaluation of the Safety and Potential Therapeutic Effects After Intravenous Transplantation of Human Umbilical Cord-derived Mesenchymal Stem Cells in Patients With Cerebral Infarction",Seongnam-si,Gyeonggi-do,"Korea, Republic of","February 24, 2015"
971,972,NCT01314092,Complex Perianal Fistula,Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula,Autologous cultured adipose derived stem cells(low dose group)|Autologous cultured adipose derived stem cells(high dose group),Phase II Study to Evaluate Efficacy and Safety of ANTG-ASC (Autologous Cultured Adipose-derived Stem Cells) on the Complex Fistula Patients,Bucheon-si|Seoul|Seoul|Seoul|Seoul|Seoul,,"Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of|Korea, Republic of",January 2011
972,973,NCT04362189,COVID-19,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,HB-adMSC|Placebo,"A Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19",Houston|Houston,Texas|Texas,United States|United States,"June 30, 2020"
973,974,NCT04003857,Bronchopulmonary Dysplasia,Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial,PNEUMOSTEM®|normal saline,Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial,Seoul|Seoul,,"Korea, Republic of|Korea, Republic of","July 5, 2019"
974,975,NCT01897987,Bronchopulmonary Dysplasia,Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial,Pneumostem®|normal saline,Follow-up Safety and Efficacy Evaluation on Subjects Who Completed the Initial Stage of PNEUMOSTEM® Phase-II Clinical Trial,Seoul|Seoul,,"Korea, Republic of|Korea, Republic of",January 2014
975,976,NCT01828957,Bronchopulmonary Dysplasia,Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants,Pneumostem®|Normal Saline,"Randomized, Double-blind, Multi-center, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Pneumostem® Versus a Control Group for Treatment of Bronchopulmonary Dysplasia in Premature Infants",Seoul|Seoul,,"Korea, Republic of|Korea, Republic of",April 2013
976,977,NCT03389919,Mesenchymal Stem Cell Transplantation,Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT,MSC administration (intraosseal),EFFECTIVENESS AND SAFETY OF INTRAOSSEOUS ADMINISTRATION OF MESENCHYMAL STORMAL CELLS FOR PRIMARY GRAFT FAILURE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION,Moscow,,Russian Federation,"January 1, 2017"
977,978,NCT04738981,Graft Vs Host Disease,Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT,UC-MSC|Anti-CD25 mAb,"Efficacy and Safety of UC-MSCS for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT: A Multicenter, Randomized, Open-label Trial",Beijing,Beijing,China,February 2021
978,979,NCT04493242,"Covid19|ARDS|Pneumonia, Viral",Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS,DB-001|Intravenous normal saline,Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Phase II Clinical Trial,Sheffield|Fullerton|Sayre|Lubbock|Mesquite,Alabama|California|Pennsylvania|Texas|Texas,United States|United States|United States|United States|United States,"September 24, 2020"
979,980,NCT01661842,Autoimmune Hepatitis,Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis,conventional plus UC-MSC treatment|Conventional plus placebo treatment,Phase 1/2 Study of UC-MSC Treatment for Evaluation the Efficacy and Safety in Patients With Autoimmune Liver Disease,Beijing,Beijing,China,October 2011
980,981,NCT04903327,Covid19,Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress,COVI-MSC|Placebo,Treatment of COVID-19-Induced Acute Respiratory Distress: A Phase 2 Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells,Salvador|Salvador|Campinas|Jaú|São Bernardo Do Campo|São Paulo,BA|BA|SP|SP|SP|SP,Brazil|Brazil|Brazil|Brazil|Brazil|Brazil,"November 16, 2021"
981,982,NCT02796079,Peripheral Vascular Disease|Ischemia|Diabetic Foot,A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications,mesenchymal stem cells|saline,A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications,Guangzhou,Guangdong,China,January 2015
982,983,NCT02674399,"Osteoarthritis, Knee",A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis,JointStem|Synvisc-One,"A Phase 2, Double-Blind, Randomized, Controlled Study to Evaluate the Efficacy and Safety of JointStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells, in Treatment of Osteoarthritis",Santa Monica|Walnut Creek,California|California,United States|United States,"February 16, 2016"
983,984,NCT03117738,Alzheimer Disease,A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease,AstroStem|Placebo-Control,"A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AstroStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells, in Patients With Alzheimer's Disease",Costa Mesa|Santa Ana|Honolulu,California|California|Hawaii,United States|United States|United States,"May 9, 2017"
984,985,NCT03424629,Moderate and Severe Plaque Psoriasis,Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis,Low-dose UC-MSCs|High-dose UC-MSCs|Methotrexate,"A Randomized, Positive Controlled Trial That Assess the Safety And Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in Moderate and Severe Plaque Psoriasis Patients",Beijing|Beijing,,China|China,"June 1, 2018"
985,986,NCT04482413,Alzheimer Disease,Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease,AstroStem|Placebo,"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of AstroStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells, in Patients With Alzheimer's Disease",,,,"February 1, 2023"
986,987,NCT05116540,Multiple Sclerosis,Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis,HB-adMSCs|Placebo,"A Randomized, Double-Blind, Single-Center, Phase 2, Efficacy and Safety Study of Autologous HB-adMSCs vs Placebo for the Treatment of Patients With Multiple Sclerosis",Sugar Land,Texas,United States,"November 24, 2021"
987,988,NCT02166021,Multiple Sclerosis (MS),Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis,Mesenchymal stem cells,"Phase 2 Trial to Investigate the Clinical Efficacy & the Optimal Administration (Based on the Immunological, Clinical & Neuroradiological Effects) of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis",Jerusalem,,Israel,"January 29, 2015"
988,989,NCT05433298,COVID-19 Pneumonia|COVID-19,Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19.,Mesenchymal stem cell|Placebo,Multicenter Phase I/IIa Study of Mesenchymal Stromal Cells for the Treatment of Patients With SARS-CoV-2 Pneumonia.,Curitiba,Paraná,Brazil,"May 1, 2022"
989,990,NCT01709656,Ankylosing Spondylitis,A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis,"MSC|""celecoxib"", ""Celebrex®""",A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis,Guangzhou,Guangdong,China,March 2012
990,991,NCT04037345,Knee Osteoarthritis,Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis,SMUP-IA-01(low-dose)|SMUP-IA-01(mid-dose)|SMUP-IA-01(high-dose),"A Open, Single-center, Phase 1 Trial to Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis",Seoul,Jongno-gu,"Korea, Republic of","October 7, 2019"
991,992,NCT05549609,Venous Leg Ulcer,A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers,XSTEM-VLU|Vehicle,"A Single-centre, Randomised, Single-blind Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of a Single Topical Dose of Allogeneic Integrin α10β1-selected Mesenchymal Stem Cells (XSTEM-VLU) in Patients With Difficult-to-heal Venous Leg Ulcers",Linköping,,Sweden,September 2022
992,993,NCT04684602,Autoimmune Diseases|Cardiovascular Disorders|Diabetes Complications|Integumentary Disease|Musculoskeletal Disorders|Neurodegenerative Disorders|Neurologic Disorders|Pulmonary Disorders|Sexual Dysfunction|Urologic Disorders|Viral Illness,Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions,PrimePro™/ PrimeMSK™,"Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions",Culver City,California,United States,"July 9, 2020"
993,994,NCT03489564,Pregnancy Related|Physical Activity,Mitochondrial Capacity in Pregnant Women,Active|Sedentary,The Effect of Physical Activity on in Vivo and in Vitro Mitochondrial Capacity in Pregnant Women,Baton Rouge,Louisiana,United States,"March 19, 2018"
994,995,NCT04452097,COVID-19|ARDS|Acute Respiratory Distress Syndrome,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,Human umbilical cord mesenchymal stem cells + best supportive care|Placebo control + best supportive care,A Phase 1/2a Study of the Safety and Efficacy of BX-U001 for the Treatment of Severe COVID-19 Pneumonia With Moderate to Severe Acute Respiratory Distress Syndrome (ARDS).,,,,"July 1, 2023"
995,996,NCT02023788,Bronchopulmonary Dysplasia|Respiratory Tract Infections|Premature Birth of Newborn,Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study,PNEUMOSTEM,Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study,Seoul,,"Korea, Republic of",April 2014
996,997,NCT05283317,Sepsis|Septic Shock,Effect of Mesenchymal Stromal Cells on Sepsis and Septic Shock,Mesenchymal stem cells,The Effect of Mesenchymal Stromal Cells on the Mortality of Patients With Sepsis and Septic Shock: A Promising Therapy,Kayseri,,Turkey,"March 11, 2018"
997,998,NCT04492501,Covid19|Cytokine Release Syndrome|Critical Illness|ARDS,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,Therapeutic Plasma exchange|Convalescent Plasma|Tocilizumab|Remdesivir|Mesenchymal stem cell therapy,"Role of Investigational Therapies Alone or in Combination to Treat Moderate, Severe and Critical COVID-19",Rawalpindi,Punjab,Pakistan,"April 1, 2020"
998,999,NCT03678467,Mandible Tumor|Mandibular Injuries|Mandible; Deformity,Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction,EB-CMF,"An Open-Label, First-in-Human, Single Intervention Study for Evaluation of EpiBone-CMF Engineered Living Bone Graft for Mandibular Ramus Reconstruction",San Francisco|Cleveland|San Antonio,California|Ohio|Texas,United States|United States|United States,"March 31, 2021"
999,1000,NCT05191381,COVID-19|Critical Illness|Hypercytokinemia|Lung Fibrosis,Immune Modulation by Exosomes in COVID-19,Application of exosomes in a whole blood assay,Immune Modulation by Stem Cell Derived Exosomes in Critically Ill COVID-19,Ulm,,Germany,"December 22, 2021"
